
<html lang="en"     class="pb-page"  data-request-id="f9735438-44dd-4fdf-91e3-d98a76a3ab89"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-12;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b00410;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation" /></meta><meta name="dc.Creator" content="Andrew&#xA;S.  Felts" /></meta><meta name="dc.Creator" content="Alice L.  Rodriguez" /></meta><meta name="dc.Creator" content="Anna L.  Blobaum" /></meta><meta name="dc.Creator" content="Ryan D.  Morrison" /></meta><meta name="dc.Creator" content="Brittney S.  Bates" /></meta><meta name="dc.Creator" content="Analisa  Thompson Gray" /></meta><meta name="dc.Creator" content="Jerri M.  Rook" /></meta><meta name="dc.Creator" content="Mohammed N.  Tantawy" /></meta><meta name="dc.Creator" content="Frank W.  Byers" /></meta><meta name="dc.Creator" content="Sichen  Chang" /></meta><meta name="dc.Creator" content="Daryl F.  Venable" /></meta><meta name="dc.Creator" content="Vincent B.  Luscombe" /></meta><meta name="dc.Creator" content="Gilles D.  Tamagnan" /></meta><meta name="dc.Creator" content="Colleen M.  Niswender" /></meta><meta name="dc.Creator" content="J. Scott  Daniels" /></meta><meta name="dc.Creator" content="Carrie K.  Jones" /></meta><meta name="dc.Creator" content="P. Jeffrey  Conn" /></meta><meta name="dc.Creator" content="Craig W.  Lindsley" /></meta><meta name="dc.Creator" content="Kyle A.  Emmitte" /></meta><meta name="dc.Description" content="Preclinical evidence in support of the potential utility of mGlu5 NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such molecules have e..." /></meta><meta name="Description" content="Preclinical evidence in support of the potential utility of mGlu5 NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such molecules have e..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 22, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00410" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00410" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00410" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00410" /></link>
        
    
    

<title>Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00410" /></meta><meta property="og:title" content="Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0012.jpeg" /></meta><meta property="og:description" content="Preclinical evidence in support of the potential utility of mGlu5 NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such molecules have entered clinical trials. Despite some promising results from clinical studies, no small molecule mGlu5 NAM has yet to reach market. Here we present the discovery and evaluation of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (27, VU0424238), a compound selected for clinical evaluation. Compound 27 is more than 900-fold selective for mGlu5 versus the other mGlu receptors, and binding studies established a Ki value of 4.4 nM at a known allosteric binding site. Compound 27 had a clearance of 19.3 and 15.5 mL/min/kg in rats and cynomolgus monkeys, respectively. Imaging studies using a known mGlu5 PET ligand demonstrated 50% receptor occupancy at an oral dose of 0.8 mg/kg in rats and an intravenous dose of 0.06 mg/kg in baboons." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00410"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00410">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00410&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00410&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00410&amp;href=/doi/10.1021/acs.jmedchem.7b00410" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5072-5085</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00401" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00437" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Andrew S. Felts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew S. Felts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew%0AS.++Felts">Andrew S. Felts</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Alice L. Rodriguez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alice L. Rodriguez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alice+L.++Rodriguez">Alice L. Rodriguez</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Anna L. Blobaum</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna L. Blobaum</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna+L.++Blobaum">Anna L. Blobaum</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ryan D. Morrison</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryan D. Morrison</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+D.++Morrison">Ryan D. Morrison</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brittney S. Bates</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brittney S. Bates</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brittney+S.++Bates">Brittney S. Bates</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Analisa Thompson Gray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Analisa Thompson Gray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Analisa++Thompson+Gray">Analisa Thompson Gray</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jerri M. Rook</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jerri M. Rook</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jerri+M.++Rook">Jerri M. Rook</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mohammed N. Tantawy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mohammed N. Tantawy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology and Radiological Sciences, Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mohammed+N.++Tantawy">Mohammed N. Tantawy</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Frank W. Byers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frank W. Byers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frank+W.++Byers">Frank W. Byers</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sichen Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sichen Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sichen++Chang">Sichen Chang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Daryl F. Venable</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daryl F. Venable</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daryl+F.++Venable">Daryl F. Venable</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Vincent B. Luscombe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincent B. Luscombe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincent+B.++Luscombe">Vincent B. Luscombe</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Gilles D. Tamagnan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gilles D. Tamagnan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular NeuroImaging, a Division of inviCRO, New Haven, Connecticut 06510, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gilles+D.++Tamagnan">Gilles D. Tamagnan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Colleen M. Niswender</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Colleen M. Niswender</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Colleen+M.++Niswender">Colleen M. Niswender</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">J. Scott Daniels</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. Scott Daniels</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+Scott++Daniels">J. Scott Daniels</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Carrie K. Jones</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carrie K. Jones</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carrie+K.++Jones">Carrie K. Jones</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">P. Jeffrey Conn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">P. Jeffrey Conn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=P.+Jeffrey++Conn">P. Jeffrey Conn</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Craig W. Lindsley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Craig W. Lindsley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology,Â  Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Craig+W.++Lindsley">Craig W. Lindsley</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0168-1445" title="Orcid link">http://orcid.org/0000-0003-0168-1445</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Kyle A. Emmitte</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kyle A. Emmitte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology,Â  Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e78c9e8b82c9828a8a8e939382a79289938f9484c9828392"><span class="__cf_email__" data-cfemail="ddb6a4b1b8f3b8b0b0b4a9a9b89da8b3a9b5aebef3b8b9a8">[emailÂ protected]</span></a>. Phone: 817-735-0241. Fax: 817-735-2603.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kyle+A.++Emmitte">Kyle A. Emmitte</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6643-3947" title="Orcid link">http://orcid.org/0000-0002-6643-3947</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00410&amp;href=/doi/10.1021%2Facs.jmedchem.7b00410" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5072â5085</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 22, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 March 2017</li><li><span class="item_label"><b>Published</b> online</span>22 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 June 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00410" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00410</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00410"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2309</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00410" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrew\nS.&quot;,&quot;last_name&quot;:&quot;Felts&quot;},{&quot;first_name&quot;:&quot;Alice&quot;,&quot;last_name&quot;:&quot;L. Rodriguez&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;L. Blobaum&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;D. Morrison&quot;},{&quot;first_name&quot;:&quot;Brittney&quot;,&quot;last_name&quot;:&quot;S. Bates&quot;},{&quot;first_name&quot;:&quot;Analisa&quot;,&quot;last_name&quot;:&quot;Thompson Gray&quot;},{&quot;first_name&quot;:&quot;Jerri&quot;,&quot;last_name&quot;:&quot;M. Rook&quot;},{&quot;first_name&quot;:&quot;Mohammed&quot;,&quot;last_name&quot;:&quot;N. Tantawy&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;W. Byers&quot;},{&quot;first_name&quot;:&quot;Sichen&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Daryl&quot;,&quot;last_name&quot;:&quot;F. Venable&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;B. Luscombe&quot;},{&quot;first_name&quot;:&quot;Gilles&quot;,&quot;last_name&quot;:&quot;D. Tamagnan&quot;},{&quot;first_name&quot;:&quot;Colleen&quot;,&quot;last_name&quot;:&quot;M. Niswender&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Scott Daniels&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;K. Jones&quot;},{&quot;first_name&quot;:&quot;P.&quot;,&quot;last_name&quot;:&quot;Jeffrey Conn&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;W. Lindsley&quot;},{&quot;first_name&quot;:&quot;Kyle&quot;,&quot;last_name&quot;:&quot;A. Emmitte&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5072-5085&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00410&quot;},&quot;abstract&quot;:&quot;Preclinical evidence in support of the potential utility of mGlu5 NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such molecules have entered clinical trials. Despite some promising results from clinical studies, no small molecule mGlu5 NAM has yet to reach market. Here we present the discovery and evaluation of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (27, VU0424238), a compound selected for clinical evaluation. Compound 27 is more than 900-fold selective for mGlu5 versus the other mGlu receptors, and binding studies established a Ki value of 4.4 nM at a known allosteric binding site. Compound 27 had a clearance of 19.3 and 15.5 mL/min/kg in rats and cynomolgus monkeys, respectively. Imaging studies using a known mGlu5 PET ligand demonstrated 50% receptor occupancy at an oral dose of 0.8 mg/kg in rats and an intravenous dose of 0.06 mg/kg in baboons.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00410&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00410" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00410&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00410" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00410&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00410" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00410&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00410&amp;href=/doi/10.1021/acs.jmedchem.7b00410" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00410" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00410" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00410%26sid%3Dliteratum%253Aachs%26pmid%3D28530802%26genre%3Darticle%26aulast%3DFelts%26date%3D2017%26atitle%3DDiscovery%2Bof%2BN-%25285-Fluoropyridin-2-yl%2529-6-methyl-4-%2528pyrimidin-5-yloxy%2529picolinamide%2B%2528VU0424238%2529%253A%2BA%2BNovel%2BNegative%2BAllosteric%2BModulator%2Bof%2BMetabotropic%2BGlutamate%2BReceptor%2BSubtype%2B5%2BSelected%2Bfor%2BClinical%2BEvaluation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D12%26spage%3D5072%26epage%3D5085%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291071" title="Nicotinamide">Nicotinamide</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/jmcmar.2017.60.issue-12/20170622/jmcmar.2017.60.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Preclinical evidence in support of the potential utility of mGlu<sub>5</sub> NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such molecules have entered clinical trials. Despite some promising results from clinical studies, no small molecule mGlu<sub>5</sub> NAM has yet to reach market. Here we present the discovery and evaluation of <i>N</i>-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (<b>27</b>, VU0424238), a compound selected for clinical evaluation. Compound <b>27</b> is more than 900-fold selective for mGlu<sub>5</sub> versus the other mGlu receptors, and binding studies established a <i>K</i><sub>i</sub> value of 4.4 nM at a known allosteric binding site. Compound <b>27</b> had a clearance of 19.3 and 15.5 mL/min/kg in rats and cynomolgus monkeys, respectively. Imaging studies using a known mGlu<sub>5</sub> PET ligand demonstrated 50% receptor occupancy at an oral dose of 0.8 mg/kg in rats and an intravenous dose of 0.06 mg/kg in baboons.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The metabotropic glutamate (mGlu) receptors are an eight-membered family of class C G protein-coupled receptors (GPCRs) that are activated by <span class="smallcaps smallerCapital">l</span>-glutamic acid, the major excitatory neurotransmitter of the mammalian central nervous system (CNS). Further stratification of the mGlu receptors is made based on a variety of considerations, including structure, downstream signaling partners, and pharmacology. Whereas group I mGlu receptors (mGlu<sub>1</sub> and mGlu<sub>5</sub>) are found in post-synaptic locations and couple via G<sub>q</sub> to the activation of phospholipase C (PLC), both group II (mGlu<sub>2â3</sub>) and group III (mGlu<sub>4</sub> and mGlu<sub>6â8</sub>) receptors are found mainly in presynaptic locations and couple via G<sub>i</sub>/G<sub>o</sub> to the inhibition of adenylyl cylase activity. Common to all mGlu receptors are a seven transmembrane (7TM) Î±-helical domain that connects to a large bilobed extracellular amino-terminal domain, sometimes termed the âvenus fly trap (VFT)â domain. Located within this VFT domain is the binding site for the native ligand; however, allosteric binding sites for small molecules have thus far been confined to the transmembrane domain. The structural and functional properties of the mGlu receptors have been reviewed extensively.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a></div><div class="NLM_p">In the search for compounds that are sufficiently selective for individual mGlu receptor subtypes, we have found allosteric modulation to be a successful approach. In fact, in many cases, such a strategy can be employed for the design of both positive allosteric modulators (PAMs) and negative allosteric modulators (NAMs) of the same receptor.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Among the most actively investigated and advanced areas within this field is that of mGlu<sub>5</sub> NAMs.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Potential therapeutic applications for small molecule mGlu<sub>5</sub> NAMs are extensive and include addiction,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Alzheimerâs disease (AD),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> anxiety,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> autism spectrum disorder (ASD),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> fragile X syndrome (FXS),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the levodopa-induced dyskinesia (LID) experienced by many patients with Parkinsonâs disease (PD),<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> major depressive disorder (MDD),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and obsessive-compulsive disorder (OCD).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Much of the preclinical work that has served to establish mGlu<sub>5</sub> antagonism as an exciting new mechanism for targeting these various conditions has been conducted with two related tool compounds, methyl-6-(phenylethynyl)-pyridine (<b>1</b>, MPEP)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (<b>2</b>, MTEP)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Both compounds are structurally similar disubstituted alkynes, a motif that has been exploited for the design of several other highly optimized mGlu<sub>5</sub> NAM compounds.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> While results from clinical studies have been reported with nonalkyne based mGlu<sub>5</sub> NAMs such as <b>3</b> (fenobam),<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a><b>4</b> (AZD9272),<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> and <b>5</b> (AZD2066),<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> the most highly studied and advanced clinical compounds are three alkyne mGlu<sub>5</sub> NAMs: <b>6</b> (mavoglurant),<a onclick="showRef(event, 'ref14 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref14 ref21 ref22 ref23 ref24 ref25">(14,21â25)</a><b>7</b> (basimglurant),<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26â29)</a> and <b>8</b> (dipraglurant)<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Still, failures to reach primary clinical end points with <b>6</b><a onclick="showRef(event, 'ref14 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref14 ref22 ref23">(14,22,23)</a> and <b>7</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> point to the continued need for highly optimized mGlu<sub>5</sub> NAMs. It should be noted that a recent report from Pfizer has described cutaneous toxicities in cynomolgus monkey toxicology studies with three structurally related nonalkyne based mGlu<sub>5</sub> NAMs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Given that other mGlu<sub>5</sub> NAMs that are not structurally related to the Pfizer compounds have been used in long-term, repeat dose studies in nonhuman primates (NHPs)<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> and humans<a onclick="showRef(event, 'ref14 ref22 ref23 ref24 ref28'); return false;" href="javascript:void(0);" class="ref ref14 ref22 ref23 ref24 ref28">(14,22â24,28)</a> without notes of a similar significant toxicity, it seems reasonable that such effects are not endemic to the mechanism. Still, these results make a compelling argument for using cynomolgus monkeys as the nonrodent species for toxicology studies in the event that our conclusion is incorrect.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Prototypical mGlu<sub>5</sub> NAM preclinical tools <b>1</b> and <b>2</b> and clinically investigated mGlu<sub>5</sub> NAMs <b>3</b>â<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Alkynes are potentially reactive functional groups. Pfizer has reported an instance of biliary epithelial hyperplasia in a NHP toxicology study with an alkyne-based mGlu<sub>5</sub> NAM developed by Wyeth.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This toxicity was believed to be linked to the reactivity of the alkyne based on metabolic studies that revealed extensive glutathione conjugation.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> While this type of biotransformation does not always manifest in humans with alkyne-containing compounds,<a onclick="showRef(event, 'ref25 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref27">(25,27)</a> many research groups have sought to design novel mGlu<sub>5</sub> NAMs that are outside of this chemotype.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> We have actively pursued a variety of approaches toward that end over the past decade.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> For example, we conducted a high-throughput screen (HTS) of a collection of 160,000 compounds that identified multiple distinct mGlu<sub>5</sub> NAM hits. This same platform functions as our primary assay for lead optimization by measuring the ability of novel compounds to block the mobilization of calcium induced by an EC<sub>80</sub> concentration of glutamate in HEK293A cells that express rat mGlu<sub>5</sub>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Initial Analogs</h3><div class="NLM_p">Recently, we described the discovery of an in vivo tool compound <b>9</b> (VU0409106)<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37â40)</a> that resulted from the optimization of one of these HTS hits (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). That report focused exclusively on compounds with a benzamide core;<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> however, we were also interested in exploring picolinamide analogs as well (<b>10</b>â<b>13</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Moving from the 3-fluorophenyl benzamide core (<b>9</b>) to an unsubstituted picolinamide core (<b>10</b>) reduced potency by approximately 8-fold; however, substitution of the picolinamide core at the 6-position with a methyl group (<b>11</b>) improved potency. In addition, structureâactivity relationships (SARs) established in the benzamide series<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> translated to the picolinamides in the form of enhanced potency with the 5-fluoropyridin-3-yl ether (<b>12</b>). Once again, 6-methyl substitution of the picolinamide core (<b>13</b>) improved potency relative to the unsubstituted analog <b>12</b>. Buoyed by the encouraging results from this limited set of analogs and in search of a compound that represented a step forward from <b>9</b> to a compound worthy of advancement to clinical development, we devised a plan to prepare additional 6-alkyl-picolinamide analogs. Herein, we report the successful execution of that strategy.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Picolinamide Core Analogs of <b>9</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center" char="Â±">mGlu<sub>5</sub> pIC<sub>50</sub> (Â±SEM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mGlu<sub>5</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">% Glu max<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.62Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="char" char="Â±">6.70Â Â±Â 0.15</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.01Â Â±Â 0.09</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.22Â Â±Â 0.23</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char="Â±">1.4Â Â±Â 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char="Â±">8.01Â Â±Â 0.16</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Calcium mobilization mGlu<sub>5</sub> assay; values are an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Amplitude of response in the presence of 30 Î¼M test compound as a percentage of maximal response (100 Î¼M glutamate); an average of <i>n</i> â¥ 3 independent experiments.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis of Compounds</h3><div class="NLM_p">The synthetic routes to the picolinamide analogs largely mirror those described for the benzamide mGlu<sub>5</sub> NAMs.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Briefly, 4-nitropyridine-<i>N</i>-oxides <b>14</b> were refluxed in concentrated hydrochloric acid to afford 4-chloropyridine-<i>N</i>-oxides <b>16</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Alternatively, 4-chloropyridines <b>15</b> were oxidized with a hydrogen peroxide-urea adduct in the presence of trifluoroacetic acid to provide <b>16</b>. Treatment of <b>16</b> with trimethylsilyl cyanide and dimethylcarbamyl chloride generated 2-cyanopyridines <b>17</b>. A nucleophilic aromatic substitution reaction between heteroaryl alcohols <b>18</b> and <b>17</b> was employed to generate ether products <b>19</b>. Hydrolysis of the nitrile moieties of <b>19</b> was accomplished via thermal heating with aqueous sodium hydroxide solution to give the penultimate intermediate acids <b>20</b>. Coupling with the appropriate primary heteroaryl amines (H<sub>2</sub>NR<sup>4</sup>) generated the target analogs.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Picolinamide Analogs <b>10</b>â<b>13</b> and <b>21</b>â<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: R<sup>1</sup> = H, Me, CHF<sub>2</sub>; R<sup>2</sup> = H, Me, C<sub>3</sub>H<sub>5</sub>; A = N, CH, CF, CCl; R<sup>4</sup> = 4-methylthiazol-2-yl or substituted pyridin-2-yl; (a) conc. HCl, reflux, 53â75%; (b) H<sub>2</sub>O<sub>2</sub>Â·urea, (F<sub>3</sub>CCO)<sub>2</sub>O, THF, 0 Â°C to rt, 44â99%; (c) Me<sub>3</sub>SiCN, CH<sub>2</sub>Cl<sub>2</sub>, Me<sub>2</sub>NCOCl, 75â86%; (d) <b>18</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 Â°C, 45â77%; (e) 2 N aq. NaOH, dioxane, reflux, 82â99%; (f) H<sub>2</sub>NR<sup>4</sup>, POCl<sub>3</sub>, pyridine, â15 Â°C, 22â81%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Initial SAR</h3><div class="NLM_p">Even though compound <b>9</b> is a useful tool for acute behavioral studies in mice and rats,<a onclick="showRef(event, 'ref37 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref39">(37,39)</a> it has several properties that prevent its further development. In particular, <b>9</b> has moderate to high clearance in rats (Cl<sub>p</sub> 43 mL/min/kg) and cynomolgus monkeys (Cl<sub>p</sub> 24 mL/min/kg).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In addition, <b>9</b> has poor bioavailability following oral administration in rats (<i>F</i> < 5%) and is an inhibitor of CYP1A2 (IC<sub>50</sub> < 100 nM). Evaluation of the picolinamide analogs of <b>9</b> indicated that the 4-methylthiazol-2-yl amide contributed substantially to the potent inhibition of CYP1A2 (e.g., <b>10</b> CYP1A2 IC<sub>50</sub> < 100 nM), and SAR for mGlu<sub>5</sub> activity within the benzamide series showed limited tolerance for even subtle modifications on the thiazol-2-yl moiety.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Fortunately, analogs with a pyridin-2-yl replacement for the thiazol-2-yl ring appeared more amenable to substitution, and initial work in the picolinamide series was carried out in that context while taking advantage of SAR knowledge gained from the benzamide work (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Substituted 2-Pyridyl Amine Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">protein binding (<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">P450 inhibition IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">series</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="Â±">mGlu<sub>5</sub> pIC<sub>50</sub> (Â±SEM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mGlu<sub>5</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">% Glu max<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">6-Me</td><td class="colsep0 rowsep0" align="char" char="Â±">7.70Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char="Â±">1.4Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.076</td><td class="colsep0 rowsep0" align="char" char=".">0.066</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">6-Me</td><td class="colsep0 rowsep0" align="char" char="Â±">8.04Â Â±Â 0.12</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char="Â±">1.4Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">6-Et</td><td class="colsep0 rowsep0" align="char" char="Â±">8.03Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="char" char=".">0.034</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">6-Et</td><td class="colsep0 rowsep0" align="char" char="Â±">7.49Â Â±Â 0.31</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="char" char="Â±">7.94Â Â±Â 0.21</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">0.132</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="char" char="Â±">8.45Â Â±Â 0.11</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char="Â±">1.4Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="char" char="Â±">7.97Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.106</td><td class="colsep0 rowsep0" align="char" char=".">0.120</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="char" char="Â±">8.51Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="char" char="Â±">8.17Â Â±Â 0.14</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.067</td><td class="colsep0 rowsep0" align="char" char=".">0.049</td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="char" char="Â±">8.02Â Â±Â 0.16</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="Â±">7.27Â Â±Â 0.22</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="Â±">7.72Â Â±Â 0.13</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">27.4</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Calcium mobilization mGlu<sub>5</sub> assay; values are an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Amplitude of response in the presence of 30 Î¼M test compound as a percentage of maximal response (100 Î¼M glutamate); an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last"><i>f</i><sub>u</sub> = fraction unbound; equilibrium dialysis assay.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Assayed in pooled HLM in the presence of NADPH with CYP-specific probe substrates.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Compound was unstable in rat plasma.</p></div></div></div><div class="NLM_p">As expected, the majority of these pyridin-2-yl analogs (<b>21</b>â<b>32</b>) proved to be potent antagonists of mGlu<sub>5</sub> on par with their thiazol-2-yl analogs (<b>11</b> and <b>13</b>). In a majority of instances, analogs with the 5-fluoropyridin-3-yl ether exhibited slightly superior mGlu<sub>5</sub> potency compared to the pyrimidin-5-yl ether analogs; however, the 6-ethylpyridin-2-yl analogs <b>23</b> and <b>24</b> and 5-chloropyridin-2-yl derivatives <b>29</b> and <b>30</b> were an exception to this trend. Assays that measured the degree of binding to rat and human plasma and a human liver microsomes (HLM) cocktail assay with probe substrates for four common P450s<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> were used to profile several selected compounds. SAR with regard to the heteroaryl ether group was clear, as the pyrimidin-5-yl ether (Series A) analogs were consistently less bound to plasma than their 5-fluoropyridin-3-yl ether (Series B) analogs. No activity at 30 Î¼M test compound was noted with regard to inhibition of CYP2D6, and inhibition of CYP3A4 and CYP2C9 ranged considerably. As anticipated, the most consistently potent P450 inhibition was observed with CYP1A2; however, there was another clear SAR with respect to the heteroaryl ether group. In this case, the pyrimidin-5-yl ether (Series A) analogs were less potent CYP1A2 inhibitors than the 5-fluoropyridin-3-yl ether (Series B) analogs.</div><div class="NLM_p">Moving our attention to other portions of the chemotype, we prepared further analogs that revealed additional SAR. Modifications made in the context of the 5-fluoropyridin-2-yl amide found in analogs <b>27</b> and <b>28</b> are depicted here (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Installation of a methyl group at the 2-position of the pyrimidin-5-yl ether (<b>33</b>) resulted in a 3-fold loss in potency relative to <b>27</b>. While this modification increased the extent of binding to plasma, it also reduced inhibition versus CYP1A2 and CYP2C9. Moving to a larger cyclopropyl group at the 2-position of the pyrimidin-5-yl ether (<b>34</b>) substantially eroded potency at mGlu<sub>5</sub>, indicating minimal tolerance for steric bulk at this position. Likewise, replacement of the 6-methyl group on the picolinamide core with a difluoromethyl group (<b>35</b>) led to an approximately 5-fold loss in mGlu<sub>5</sub> potency, illustrating little tolerance for modification at that position. Replacement of the 5-fluoro group of the pyridin-3-yl of <b>28</b> with a 5-chloro group (<b>36</b>) resulted in only a slight drop in potency. Replacement of the <i>meta</i>-halogen atoms found in <b>28</b> and <b>36</b> with the <i>para</i>-methyl group in 6-methylpyridin-3-yl ether <b>37</b> reduced mGlu<sub>5</sub> potency by 50- and 20-fold, respectively.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Analogs of Compound <b>27</b> and <b>28</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">protein binding (<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">P450 inhibition IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center" char="Â±">mGlu<sub>5</sub> pIC<sub>50</sub> (Â±SEM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mGlu<sub>5</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">% Glu max<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.97Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.106</td><td class="colsep0 rowsep0" align="char" char=".">0.120</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.48Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.081</td><td class="colsep0 rowsep0" align="char" char=".">0.074</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>34</b></td><td class="colsep0 rowsep0" align="char" char="Â±">6.60Â Â±Â 0.25</td><td class="colsep0 rowsep0" align="char" char=".">251</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.32Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="char" char="Â±">8.51Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="char" char="Â±">8.14Â Â±Â 0.27</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char="Â±">1.0Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.058</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">21.5</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>37</b></td><td class="colsep0 rowsep0" align="char" char="Â±">6.80Â Â±Â 0.11</td><td class="colsep0 rowsep0" align="char" char=".">158</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Calcium mobilization mGlu<sub>5</sub> assay; values are an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Amplitude of response in the presence of 30 Î¼M test compound as a percentage of maximal response (100 Î¼M glutamate); an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last"><i>f</i><sub>u</sub> = fraction unbound; equilibrium dialysis assay.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Assayed in pooled HLM in the presence of NADPH with CYP-specific probe substrates</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Pharmacokinetics (PK) Studies</h3><div class="NLM_p">Previous studies in our laboratories with pyrimidin-5-yl ethers identified this ring as a substrate for aldehyde oxidase (AO)-mediated metabolism.<a onclick="showRef(event, 'ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref40">(38,40)</a> Thus, given the likelihood that several of our interesting new compounds would be subject to non-P450-mediated metabolism, we decided to move directly into an in vivo setting to evaluate the clearance of a variety of select analogs (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). In these studies, the three analogs with the 5-fluoropyridin-2-yl amide group (<b>27</b>, <b>28</b>, and <b>33</b>) exhibited superior profiles compared to the other compounds that contained pyridin-2-yl amides with 6-alkyl (<b>21</b>â<b>23</b>) or 6-fluoro (<b>26</b>) groups. The plasma clearance of <b>26</b> was greater than hepatic blood flow,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> which suggests that the instability previously observed in rat plasma for this compound (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) is not merely an in vitro phenomenon. Blocking the 2-position of pyrimidin-5-yl ether (<b>33</b>) reduced clearance and lengthened mean residence time relative to unsubstituted analog <b>27</b>. Such a result points toward this position as one potential site for metabolism, which is consistent with prior studies on related analog <b>9</b>.<a onclick="showRef(event, 'ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref40">(38,40)</a> Compounds <b>27</b>, <b>28</b>, and <b>33</b> were subsequently evaluated in tissue distribution studies (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) using oral dosing. Acceptable CNS penetration was achieved with all three compounds, and unbound brain to unbound plasma ratios (<i>K</i><sub>p,uu</sub>) were near unity with <b>27</b> and <b>28</b>, indicating distribution equilibrium between the compartments and a low probability of these two compounds being substrates for transporters in rats.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The <i>K</i><sub>p,uu</sub> observed for <b>33</b> raises the possibility of active transport with this compound; however, additional studies would be required to conclusively determine if that was indeed the case. All compounds achieved unbound brain levels in excess of their respective mGlu<sub>5</sub> functional potency at the dose used in these experiments (10 mg/kg). Compounds <b>27</b> and <b>28</b> were particularly attractive from this perspective, reaching unbound brain levels of 18- and 10-fold over their functional potency, respectively.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Preliminary Rat PK Results Using Intravenous (IV) Dosing<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center" char=".">mGlu<sub>5</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">MRT (min)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub> (mL/min/kg)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>SS</sub> (L/kg)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>21</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">34.2</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">268</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">32.5</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b><a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char=".">404</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">43.7</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">157</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">390</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">19.3</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">281</td><td class="colsep0 rowsep0" align="char" char=".">208</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b><a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">229</td><td class="colsep0 rowsep0" align="char" char=".">191</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Average <i>n</i> = 2, male SpragueâDawley rats; dose = 1.0 mg/kg.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Calcium mobilization mGlu<sub>5</sub> assay; values are an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last"><i>t</i><sub>1/2</sub> = Terminal phase plasma half-life; MRT = mean residence time; Cl<sub>p</sub> = plasma clearance; <i>V</i><sub>SS</sub> = volume of distribution at steady-state.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Vehicle = 10% EtOH, 70% PEG 400, 20% saline.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Vehicle = 10% EtOH, 60% PEG 400, 30% saline.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Vehicle = 10% EtOH, 50% PEG 400, 40% saline.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Tissue Distribution Studies Using Oral Dosing<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">protein binding (<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center" char=".">mGlu<sub>5</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">plasma</th><th class="colsep0 rowsep0" align="center" char=".">brain</th><th class="colsep0 rowsep0" align="center" char=".">total plasma (nM)</th><th class="colsep0 rowsep0" align="center" char=".">total brain (nM)</th><th class="colsep0 rowsep0" align="center" char=".">unbound plasma (nM)</th><th class="colsep0 rowsep0" align="center" char=".">unbound brain (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>p</sub><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>p,uu</sub><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">unbound brain/mGlu<sub>5</sub> IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">0.106</td><td class="colsep0 rowsep0" align="char" char=".">0.078</td><td class="colsep0 rowsep0" align="char" char=".">3000</td><td class="colsep0 rowsep0" align="char" char=".">2580</td><td class="colsep0 rowsep0" align="char" char=".">318</td><td class="colsep0 rowsep0" align="char" char=".">201</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">2570</td><td class="colsep0 rowsep0" align="char" char=".">2870</td><td class="colsep0 rowsep0" align="char" char=".">38.6</td><td class="colsep0 rowsep0" align="char" char=".">31.6</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">0.081</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="char" char=".">4820</td><td class="colsep0 rowsep0" align="char" char=".">3220</td><td class="colsep0 rowsep0" align="char" char=".">390</td><td class="colsep0 rowsep0" align="char" char=".">142</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Average <i>n</i> = 2, male SpragueâDawley rats; dose = 10 mg/kg; vehicle = 10% polysorbate 80 in 0.5% methyl cellulose; <i>t</i> = 1 h post-dose.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Calcium mobilization mGlu<sub>5</sub> assay; values are an average of <i>n</i> â¥ 3 independent experiments.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last"><i>f</i><sub>u</sub> = Fraction unbound; equilibrium dialysis assay; brain = mouse brain homogenates.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>p</sub> = total brain to total plasma ratio.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last"><i>K</i><sub>p,uu</sub> = unbound brain (brain <i>f</i><sub>u</sub> Ã total brain) to unbound plasma (plasma <i>f</i><sub>u</sub> Ã total plasma) ratio.</p></div></div></div><div class="NLM_p">Considering their favorable profiles, compounds <b>27</b> and <b>28</b> were selected for oral pharmacokinetic and bioavailability studies in rats and cynomolgus monkeys (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Cynomolgus monkeys were chosen as a second preclinical species as it has been established that AO activity varies across species. Specifically, AO activity is highest in humans and NHPs, moderate in rats, and undetectable in dogs.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Using in vitro methods described previously for <b>9</b>,<a onclick="showRef(event, 'ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref40">(38,40)</a> we confirmed that AO contributed significantly to the metabolism of <b>27</b> in rats, cynomolgus monkey, and human hepatic S9 fractions (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Oral exposure was significant as bioavailability exceeded 50% with both compounds in rats. Compound <b>27</b> exhibited an earlier and slightly higher plasma <i>C</i><sub>max</sub> than <b>28</b>; however, the lower clearance of <b>28</b> resulted in prolonged exposure and larger area under the curve (AUC) than observed for <b>27</b>. The PK results from analogous studies in cynomolgus monkeys showed these compounds to be similar in that both compounds showed a clearance of approximately one-third of hepatic blood flow.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Bioavailability, while lower than that observed in rats, was still >30% in each case. With largely attractive in vivo PK profiles, both compounds were advanced into further studies to identify additional factors for differentiation.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat and Cynomolgus Monkey Pharmacokinetics of Compounds <b>27</b> and <b>28</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0011.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat IV PK<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat oral PK<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub><b>1/2</b></sub> (min)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">MRT (min)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub> (mL/min/kg)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>SS</sub> (L/kg)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (min)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">%Â <i>F</i><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">390</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">19.3</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">4.34</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">281</td><td class="colsep0 rowsep0" align="char" char=".">208</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char=".">38.0</td><td class="colsep0 rowsep0" align="char" char=".">71</td></tr></tbody></table><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">cynomolgus monkey IV PK<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">cynomolgus monkey oral PK<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub><b>1/2</b></sub> (min)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">MRT (min)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub> (mL/min/kg)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>SS</sub> (L/kg)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (min)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">%Â <i>F</i><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">302</td><td class="colsep0 rowsep0" align="char" char=".">163</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">1.72</td><td class="colsep0 rowsep0" align="char" char=".">7.32</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">563</td><td class="colsep0 rowsep0" align="char" char=".">303</td><td class="colsep0 rowsep0" align="char" char=".">13.3</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">1.36</td><td class="colsep0 rowsep0" align="char" char=".">6.43</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Oral vehicle = 10% polysorbate 80 in 0.5% methyl cellulose; IV vehicle = 10% EtOH, 70% PEG 400, 20% saline.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Average <i>n</i> = 2 male SpragueâDawley rats.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last"><i>t</i><sub>1/2</sub> = Terminal phase plasma half-life; MRT = mean residence time; Cl<sub>p</sub> = plasma clearance; <i>V</i><sub>SS</sub> = volume of distribution at steady-state.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last"><i>T</i><sub>max</sub> = time at which maximum concentration occurs; <i>C</i><sub>max</sub> = maximum concentration; AUC = area under the curve; <i>F</i> = bioavailability.</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Average <i>n</i> = 2 male cynomolgus monkeys.</p></div></div></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolite (<b>38</b>) of <b>27</b> identified in rat, cynomolgus monkey, and human hepatic S9 fractions that is produced predominately by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Ancillary Pharmacology</h3><div class="NLM_p last">To judge the selectivity of these analogs versus the other members of the mGlu receptor family, the effects of both <b>27</b> and <b>28</b> at 10 Î¼M on the orthosteric agonist concentration response curve (CRC) were measured in fold-shift experiments.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> No significant effects on the agonist CRC were noted with either compound, indicating excellent selectivity for mGlu<sub>5</sub>. To assess potential ancillary pharmacology, both compounds were screened at 10 Î¼M in a commercial radioligand binding assay panel of 68 diverse and clinically relevant targets (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> While <b>27</b> had no significant responses at any target, where significant responses are defined as inhibition of more than 50% of radioligand binding, one significant response of 86% inhibition was noted for <b>28</b> at the dopamine transporter (DAT). For comparison, <b>27</b> only inhibited DAT at a level of 34%. A subsequent CRC was obtained, and <b>28</b> was found to inhibit radioligand binding with an IC<sub>50</sub> of 1.54 Î¼M. Since inhibition of DAT is associated with abuse potential,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> we next evaluated <b>28</b> in a functional cell-based assay that measured inhibition of dopamine uptake.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Indeed, consistent with results obtained from the binding assay, <b>28</b> exhibited an IC<sub>50</sub> of 1.38 Î¼M in this assay. While <b>28</b> is more than 400-fold selective for mGlu<sub>5</sub> versus DAT, the lack of concern regarding this target in the case of <b>27</b> was viewed as a positive for that compound. With its preferable P450 inhibition profile (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and the higher unbound brain concentrations achieved in rats also in its favor, the decision was made to proceed with additional detailed characterization of <b>27</b>.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Detailed Characterization of <b>27</b></h3><div class="NLM_p">Having narrowed our interest to analog <b>27</b>, we carried out a more thorough characterization of its interaction with mGlu<sub>5</sub> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). First, to ensure that there was no appreciable species difference in the mGlu<sub>5</sub> activity of <b>27</b>, we carried out our calcium mobilization assay in HEK293A cells expressing the human receptor (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). As anticipated, the potency difference between rat (IC<sub>50</sub> = 11 nM) and human mGlu<sub>5</sub> (IC<sub>50</sub> = 14 nM) was negligible. To study the effects of <b>27</b> on mGlu<sub>5</sub> activity in a native system, experiments in rat cortical astrocytes were conducted (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). As expected, <b>27</b> induced a concentration-dependent rightward shift of the glutamate CRC and decreased the maximal response to glutamate. To investigate whether <b>27</b> interacted with the mGlu<sub>5</sub> allosteric site that is common to many mGlu<sub>5</sub> NAMs such as <b>1</b> and <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), we also carried out a competition radioligand binding assay with [<sup>3</sup>H]-3-methoxy-5-(pyridin-2-ylethynyl)pyridine (<b>39</b>)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C) in membranes prepared from HEK293A cells expressing rat mGlu<sub>5</sub>. This study confirmed the interaction of <b>27</b> with this known binding site (mGlu<sub>5</sub><i>K</i><sub>i</sub> = 4.4 nM). We also performed saturation binding experiments with increasing concentrations of [<sup>3</sup>H]-<b>38</b> in the presence and absence of multiple concentrations of <b>27</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D,E). Increasing concentrations of <b>27</b> had no effect on the <i>B</i><sub>max</sub> of the radioligand but increased the <i>K</i><sub>d</sub> as shown (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D), a finding that suggests a competitive interaction between <b>27</b> and [<sup>3</sup>H]-<b>39</b>. Scatchard analysis (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E) of the results plotting bound/free versus bound ligand demonstrated that addition of <b>27</b> induced a change in slope of the regression line (change in <i>K</i><sub>d</sub>) but had no effect on the <i>x</i>-intercept (no change in <i>B</i><sub>max</sub>). These data are consistent with <b>27</b> competitively displacing [<sup>3</sup>H]-<b>39</b> at the aforementioned known allosteric binding site. A final set of radioligand kinetic binding experiments was conducted that examined the effect of <b>27</b> on the dissociation of [<sup>3</sup>H]-<b>38</b>. In these studies, neither concentration (300 nM or 100 nM) of <b>27</b> had any effect on the dissociation rate of the radioligand (data not shown), a result consistent with prior studies and a competitive interaction. Lastly, we examined the effects of increasing concentrations of the mGlu<sub>5</sub> neutral site ligand 5-methyl-6-(phenylethynyl)-pyridine (<b>40</b>)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> on the calcium mobilization CRC of <b>27</b> in HEK293A cells expressing rat mGlu<sub>5</sub> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F). In these experiments, <b>40</b> induced a parallel rightward shift in the <b>27</b> concentration response relationship, which is consistent with <b>40</b> competing for the known allosteric binding site with <b>27</b>. Furthermore, a Schild analysis (data not shown) of the effects of <b>40</b> on the <b>27</b> concentration response yielded a linear regression with a slope of 0.96, indicating the relationship between the two compounds was competitive. Extrapolation of the line to the <i>x</i>-intercept established a <i>K</i><sub>i</sub> of approximately 240 nM, a result consistent with the <i>K</i><sub>i</sub> value for <b>40</b> at the [<sup>3</sup>H]-<b>39</b> site as described in the literature (388 nM).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Each of these studies combine to conclusively establish that <b>27</b> binds in a competitive manner to the aforementioned known mGlu<sub>5</sub> allosteric binding site.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Ca<sup>2+</sup> mobilization assay CRC for <b>27</b> in HEK293A cells expressing human mGlu<sub>5</sub>. (B) Effects of <b>27</b> on glutamate CRC in rat cortical astrocytes. (C) Competition radioligand binding CRC with <b>27</b> and [<sup>3</sup>H]-3-methoxy-5-(pyridin-2-ylethynyl)pyridine (<b>39</b>). (D) Saturation binding experiment: increasing concentrations of [<sup>3</sup>H]-<b>39</b> in the presence and absence of multiple concentrations of <b>27</b>. (E) Saturation binding experiment: Scatchard analysis of bound/free versus bound ligand. (F) Effects of the neutral mGlu<sub>5</sub> site ligand 5-methyl-6-(phenylethynyl)-pyridine (<b>40</b>) on the functional inhibition of glutamate responses induced by <b>27</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a detailed understanding of the pharmacology of <b>27</b> in hand, we moved the compound into a host of additional assays designed to identify potential risks for clinical development (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Permeability and potential for P-glycoprotein (P-gp)-mediated efflux was assessed in both MadinâDarby canine kidney (MDCK) cells transfected with the human MDR1 gene<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and human colon carcinoma derived Caco-2 cells.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Permeability was moderate, and efflux ratios were near unity in both cell lines, indicating a low potential for transporter-mediated efflux. A definitive and expanded assessment of the ability of <b>27</b> to reversibly inhibit the metabolism of isoform-selective probe substrates of P450s was conducted. Results were generally consistent with the preliminary results (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) with moderate inhibition of CYP1A2 observed. In parallel to these studies, the potential for <b>27</b> to time-dependently inhibit each P450 was assessed with no evidence of time-dependent inhibition noted in any case. To shed further light on the likely human PK profile of <b>27</b>, the stability of the compound was assessed in human cryopreserved hepatocytes, a system which is potentially useful for evaluating compounds with non-P450-mediated routes of metabolism such as AO.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Gratifyingly, the predicted hepatic clearance in humans using this method was low with a half-life of more than 5 h. To assess any potential cardiac liabilities, <b>27</b> was subjected to a commercial ion channel panel.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Fortunately, no significant risks were identified in this panel. Finally, the potential mutagenic activity of <b>27</b> was investigated in the bacterial reverse mutation assay (Ames assay),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and no mutagenic responses were noted in any of the five strains either in the presence or absence of S9 metabolic activation. Encouraged by the overall profile of <b>27</b>, we advanced this compound to behavioral assays in the rat.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Further in Vitro Characterization of <b>27</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="Ã" /></col><col align="char" char="Ã" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center">permeability assays</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char="Ã">Papp (A-B) (cm/s)</th><th class="colsep0 rowsep0" align="center" char="Ã">Papp (B-A) (cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK-MDR1</td><td class="colsep0 rowsep0" align="char" char="Ã">6.2Â ÃÂ 10<sup>â6</sup></td><td class="colsep0 rowsep0" align="char" char="Ã">7.2Â ÃÂ 10<sup>â6</sup></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2</td><td class="colsep0 rowsep0" align="char" char="Ã">6.5Â ÃÂ 10<sup>â6</sup></td><td class="colsep0 rowsep0" align="char" char="Ã">7.9Â ÃÂ 10<sup>â6</sup></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr></tbody></table><table class="table "><colgroup><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">definitive P450 inhibition assays<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">P450</th><th class="colsep0 rowsep0" align="center">probe</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP3A4</td><td class="colsep0 rowsep0">midazolam</td><td class="colsep0 rowsep0">133Â Â±Â 23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP3A4</td><td class="colsep0 rowsep0">testosterone</td><td class="colsep0 rowsep0">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP2D6</td><td class="colsep0 rowsep0">(<i>R</i>)-bufuralol</td><td class="colsep0 rowsep0">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP2C9</td><td class="colsep0 rowsep0">diclofenac</td><td class="colsep0 rowsep0">29.9Â Â±Â 7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP2C19</td><td class="colsep0 rowsep0">(<i>S</i>)-mephenytoin</td><td class="colsep0 rowsep0">106Â Â±Â 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP2C8</td><td class="colsep0 rowsep0">amodiaquine</td><td class="colsep0 rowsep0">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP2B6</td><td class="colsep0 rowsep0">efavirenz</td><td class="colsep0 rowsep0">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CYP1A2</td><td class="colsep0 rowsep0">phenacetin</td><td class="colsep0 rowsep0">2.90Â Â±Â 0.72</td></tr></tbody></table><table class="table "><colgroup><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">stability in human cryopreserved hepatocytes</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">intrinsic clearance (CL<sub>INT</sub>)</td><td class="colsep0 rowsep0">1.43 Î¼L/min/millionÂ cells</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">half-life (<i>t</i><sub>1/2</sub>)</td><td class="colsep0 rowsep0">322Â min</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">predicted hepatic clearance (CL<sub>HEP</sub>)</td><td class="colsep0 rowsep0">3.59 mL/min/kg</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center">cardiac ion channel panel<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ion channel</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">ion channel</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG</td><td class="colsep0 rowsep0" align="char" char=".">73.6</td><td class="colsep0 rowsep0" align="left">hCav1.2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNav1.5 (tonic)</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">hCav3.2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNav1.5 (phasic)</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">hKir2.1</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hKv4.3</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">hHCN2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hKv1.5</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">hHCN4</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr></tbody></table><table class="table "><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="5" align="center">bacterial reverse mutation assay<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">TA98</th><th class="colsep0 rowsep0" align="center">TA100</th><th class="colsep0 rowsep0" align="center">WP2 <i>uvrA</i></th><th class="colsep0 rowsep0" align="center">TA135</th><th class="colsep0 rowsep0" align="center">TA1537</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">negative</td><td class="colsep0 rowsep0">negative</td><td class="colsep0 rowsep0">negative</td><td class="colsep0 rowsep0">negative</td><td class="colsep0 rowsep0">negative</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Assayed in pooled HLM (with and without NADPH) using CYP-specific probe substrates.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Evaluated using IonWorks Quattro system.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">With and without S9 metabolic activation.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Behavioral Pharmacology</h3><div class="NLM_p">It is well-known that mice will bury foreign objects such as glass marbles in deep bedding. Likewise, pretreatment with low doses of benzodiazepines and multiple mGlu<sub>5</sub> NAM tool compounds have been shown to inhibit this behavior.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> It has been argued recently that the marble burying assay models the repetitive and perseverative behavior associated with OCD as opposed to novelty-induced anxiety.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> We have also employed this rapid assay that utilizes naÃ¯ve mice as a frontline behavioral screen for our discovery programs directed toward mGlu<sub>5</sub> NAMs.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Using intraperitoneal (IP) dosing as a convenient route for rapidly and accurately dosing large numbers of animals, we examined the effects of <b>27</b> in this test (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Dose-dependent effects on marble burying were observed, and all doses â¥0.3 mg/kg produced significant effects relative to the vehicle control. The 3.0 mg/kg dose produced an effect on marble burying on par with the positive control <b>2</b> (15 mg/kg) in this study. A satellite experiment was conducted using the 3.0 mg/kg dose, and brain samples were collected and analyzed for exposure of <b>27</b>. At 15 min post-dose of <b>27</b>, which correlates to the initiation time point of the marble burying study, the total brain concentration of <b>27</b> was 1.48 Î¼M. Calculation of the unbound brain concentration using equilibrium dialysis data (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) yields a level of 115 nM, which is approximately 10-fold more than the functional mGlu<sub>5</sub> activity.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Dose-dependent inhibition of marble burying with <b>27</b>; vehicle = 10% polysorbate 80 (IP); male CD-1 mice; <i>n</i> = 10 per treatment group; 15 min pretreatment; 30 min burying time; *, <i>p</i> < 0.05 versus vehicle control group, Dunnettâs test; bars denote marbles buried. (<b>B</b>) Dose-dependent inhibition of immobility in rats with <b>27</b>; vehicle = 10% polysorbate 80 (<b>27</b>, intraperitoneal) and sterile saline (ketamine, subcutaneous); male SpragueâDawley rats; <i>n</i> = 8â10 per treatment group; 30 min pretreatment; 6 min testing session; *, <i>p</i> < 0.05 versus vehicle control group, Dunnettâs test; bars denote duration of immobility in s.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Having observed efficacy in this model of anxiety/OCD, we next studied <b>27</b> in an animal model of depression as well. The forced swim test (FST) measures the duration of immobility observed in rats suspended in a tank of water from which they cannot escape.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Many clinical antidepressants are able to reduce the time that the animals are immobile while increasing the time that they are active. Furthermore, certain mGlu<sub>5</sub> NAMs have also shown efficacy in this model of depression.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Examination of <b>27</b> in this assay showed a dose-dependent ability of the compound to reduce the duration of immobility indicative of antidepressant activity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). This result compares favorably to the literature report for <b>7</b> in the same assay, where that compound had a minimum efficacious dose of 10 mg/kg (PO).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The high dose used in this study (30 mg/kg IP) produced an efficacy equivalent to that of the positive control, ketamine, a known antagonist of the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor. Though ketamine is an older drug and produces undesirable psychotomimetic side effects, more recent clinical studies have shown that it can induce a rapid antidepressant effect in patients with treatment-resistant depression (TRD).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> A report from last year implicated the activation of the Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor by a specific ketamine metabolite rather than direct antagonism of the NMDA receptor by ketamine as the potential source of these rapid antidepressant effects.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Interestingly, prior studies have shown that the antidepressant activity in the FST with mGlu<sub>5</sub> NAM <b>2</b> involved signaling through the NMDA but not the AMPA receptor.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Thus, the mechanisms by which ketamine and mGlu<sub>5</sub> NAMs illicit their antidepressant effects may well be distinct.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Imaging Studies</h3><div class="NLM_p">Recognizing that an ability to study receptor occupancy (RO) in the clinic would represent a potential advantage for advancing <b>27</b>, we decided to investigate RO studies in preclinical species. [<sup>18</sup>F]-3-Fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile ([<sup>18</sup>F]-FPEB, [<sup>18</sup>F]-<b>41</b>)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> is a close structural analog of radioligand [<sup>3</sup>H]-<b>38</b> that has been used both preclinically<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and in the clinic<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> as a positron emission topography (PET) ligand for studying mGlu<sub>5</sub> RO. Thus, we decided to carry out [<sup>18</sup>F]-<b>41</b> Î¼PET studies with <b>27</b> in rats (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In these studies, <b>27</b> was dosed orally 30 min prior to IV dosing of [<sup>18</sup>F]-<b>41</b>. PET imaging was initiated and continued for 1 h. Representative images demonstrating dose-dependent displacement of [<sup>18</sup>F]-<b>41</b> by <b>27</b> are depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A. Maximum occupancy of 80% was achieved at 10 mg/kg <b>27</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Plasma samples were collected throughout the study. Plotting the maximum unbound plasma concentration of <b>27</b> versus RO resulted in an unbound level Occ<sub>50</sub> of 13 nM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Plotting the dose of <b>27</b> versus the RO normalized to the maximum displacement of [<sup>18</sup>F]-<b>41</b> gave an RO<sub>50</sub> of 0.8 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Imaging studies in rodents; <i>n</i> = 4â8 SpragueâDawley rats; <b>27</b> vehicle = 10% polysorbate 80 in 0.5% methyl cellulose; <b>27</b> dosed 30 min prior to [<sup>18</sup>F]-<b>41</b> (IV). (A) Representative images of [<sup>18</sup>F]-<b>41</b> by increasing oral doses of <b>27</b>. (B) mGlu<sub>5</sub> RO obtained with [<sup>18</sup>F]-<b>41</b> and increasing oral doses of <b>27</b>. (C) Unbound maximum plasma concentration of <b>27</b> versus mGlu<sub>5</sub> RO. (D) Dose of <b>27</b> versus mGlu<sub>5</sub> RO; *normalized to the maximum displacement of [<sup>18</sup>F]-<b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the RO results in rats, we next investigated whether similar results would be obtained in NHPs. As such, we advanced <b>27</b> into studies in baboons using the same radiotracer [<sup>18</sup>F]-<b>41</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The design for this experiment was very similar to the aforementioned study in rats; however, in this case, both <b>27</b> and the radiotracer were delivered via IV administration. There was a clear reduction in the uptake of [<sup>18</sup>F]-<b>41</b> relative to baseline that followed a dose-dependent relationship with <b>27</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,D,E). The maximum dose resulted in 89% RO of mGlu<sub>5</sub>. Plasma samples were again taken throughout the study to analyze <b>27</b> levels, and RO was plotted against the plasma maximum to arrive at a total plasma Occ<sub>50</sub> of 56 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). If one assumes that human and baboon plasma protein binding is similar, then this equates to a plasma unbound Occ<sub>50</sub> of 6.7 nM, which is within 2-fold of that observed in the rodent study. The effective IV dose that produces 50% RO (RO<sub>50</sub>) was determined to be 0.06 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Imaging studies in female baboons: subject A received three doses (0.01, 0.1, and 0.18 mg/kg); subject B received two doses (0.03 and 0.56 mg/kg); <b>27</b> vehicle = 10% ethanol, 30% PEG 400, 20% hydroxypropyl-Î²-cyclodextrin in water; <b>27</b> dosed over 20 min, 30 min prior to [<sup>18</sup>F]-<b>41</b> (IV, 3 min bolus) for all doses except the 0.18 mg/kg dose, which was dosed over 2 min, 50 min prior to [<sup>18</sup>F]-<b>41</b>. (A) mGlu<sub>5</sub> RO obtained in two female baboons with [<sup>18</sup>F]-<b>41</b> and increasing IV doses of <b>27</b>. (B) Total maximum plasma concentration of <b>27</b> versus mGlu<sub>5</sub> RO. (C) Dose of <b>27</b> versus mGlu<sub>5</sub> RO. (D) Images for subject A averaged from 0 to 150 min. (E) Images for subject B averaged from 0 to 180 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Continuation of our mGlu<sub>5</sub> NAM discovery program that began with a cell-based HTS has culminated in the identification of the highly optimized compound <b>27</b> (VU0424238).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Compound <b>27</b> is a highly potent and selective antagonist of mGlu<sub>5</sub> with a favorable preclinical profile. The molecule has low-moderate clearance and good oral bioavailability in two species. Compound <b>27</b> displays CNS penetration in rodents, and we believe that the compound is a low risk for transporter-mediated efflux and drugâdrug interactions. While the compound is a moderate inhibitor of CYP1A2, this aspect is considered manageable. Importantly, the compound is active in preclinical models of anxiety/OCD and depression, both of which are assays where mGlu<sub>5</sub> NAMs have shown activity in the past. Moreover, a clinically useful radiotracer has been used to demonstrate mGlu<sub>5</sub> RO by <b>27</b> in both rodents and NHPs. Based on the totality of data, we have selected <b>27</b> for advancement to clinical development including studies designed to enable an investigational new drug (IND) application. Here is the public disclosure of the chemical structure of <b>27</b>, our candidate for clinical studies. Future publications describing detailed metabolic profiling, chemical process development and formulation, and toxicology studies are under preparation and will be communicated in the near future.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthetic Procedures and Characterization Data</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General</h4><div class="NLM_p last">All NMR spectra were recorded on a 400 MHz AMX Bruker NMR spectrometer. <sup>1</sup>H and <sup>13</sup>C chemical shifts are reported in Î´ values in ppm downfield with the deuterated solvent as the internal standard. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, b = broad, m = multiplet), integration, coupling constant (Hz). High-resolution mass spectra were obtained on an Agilent 6540 UHD Q-TOF with ESI source. MS parameters were as follows: fragmentor: 150, capillary voltage: 3500 V, nebulizer pressure: 60 psig, drying gas flow: 13 L/min, drying gas temperature: 275 Â°C. Samples were introduced via an Agilent 1200 UHPLC comprised of a G4220A binary pump, G4226A ALS, G1316C TCC, and G4212A DAD with ULD flow cell. UV absorption was observed at 215 and 254 nm with a 4 nm bandwidth. Column: Agilent Zorbax Extend C18, 1.8 Î¼m, 2.1 Ã 50 mm. Gradient conditions: 5â95% CH<sub>3</sub>CN in H<sub>2</sub>O (0.1% formic acid) over 1 min, hold at 95% CH<sub>3</sub>CN for 0.1 min, 0.5 mL/min, 40 Â°C.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Purity</h4><div class="NLM_p last">Low-resolution reverse phase LCMS analysis was used to assess compound purity at two wavelengths: 215 and 254 nm. All analogs were at least 95% pure according to this analysis. Low-resolution reverse phase LCMS analysis was performed using an Agilent 1200 system comprising a binary pump with degasser, high-performance autosampler, thermostated column compartment, diode-array detector (DAD), and a C18 column. Flow from the column was split to a 6130 SQ mass spectrometer and Polymer Laboratories ELSD. The MS detector was configured with an electrospray ionization source. Data acquisition was performed with Agilent Chemstation and Analytical Studio Reviewer software. Method 1: Samples were separated on a ThermoFisher Accucore C18 column (2.6 Î¼m, 2.1 Ã 30 mm) at 1.5 mL/min, with column and solvent temperatures maintained at 45 Â°C. The gradient conditions were 7â95% acetonitrile in water (0.1% TFA) over 1.4 min. Low-resolution mass spectra were acquired by scanning from 135 to 700 atomic mass units (AMU) in 0.25 s with a step size of 0.1 AMU and peak width of 0.03 min. Drying gas flow was 11 L/min at a temperature of 350 Â°C and a nebulizer pressure of 40 psi. The capillary needle voltage was 3000 V, and the fragmentor voltage was 100 V. Method 2: Samples were separated on a ThermoFisher Accucore C18 column (2.6 Î¼m, 2.1 Ã 30 mm) at 1.5 mL/min, with column and solvent temperatures maintained at 45 Â°C. The gradient conditions were 7â95% acetonitrile in water (0.1% TFA) over 1.1 min. Low-resolution mass spectra were acquired by scanning from 135 to 700 AMU in 0.25 s with a step size of 0.1 AMU and peak width of 0.03 min. Drying gas flow was 11 L/min at a temperature of 350 Â°C and a nebulizer pressure of 40 psi. The capillary needle voltage was 3000 V, and the fragmentor voltage was 100 V. Method 3: Samples were separated on a Restek Aqueous C18 column (3 Î¼m, 3.2 Ã 30 mm) at 1.25 mL/min, with column and solvent temperatures maintained at 45 Â°C. The gradient conditions were 10â100% acetonitrile in water (0.1% TFA) over 2 min. Low-resolution mass spectra were acquired by scanning from 100 to 1500 AMU in 0.25 s with a step size of 0.1 AMU and peak width of 0.03 min. Drying gas flow was 11 L/min at a temperature of 350 Â°C and a nebulizer pressure of 40 psi. The capillary needle voltage was 3000 V, and the fragmentor voltage was 70 V.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Preparation of Compound <b>27</b></h4><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 4-Chloro-2-methylpyridine-<i>N</i>-oxide (<b>16a</b>)</h5><div class="NLM_p">2-methyl-4-nitropyridine 1-oxide <b>14a</b> (5.0 g, 32 mmol, 1.0 equiv) was dissolved in concentrated HCl (80 mL) and refluxed for 3 days. The reaction was cooled, and the excess concentrated HCl was removed in vacuo. The viscous oil was neutralized with 10% K<sub>2</sub>CO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (5Ã). The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel afforded 3.49 g (75%) of the title compound as a yellow solid.</div><div class="NLM_p last">Alternative Procedure: 4-Chloro-2-methylpyridine <b>15a</b> (5.0 g, 39 mmol, 1.0 equiv) and hydrogen peroxide-urea adduct (7.37 g, 78.4 mmol, 2.0 equiv) were dissolved in THF (196 mL) and cooled to 0 Â°C. Trifluoroacetic anhydride (12 mL, 86.3 mmol, 2.2 equiv) was added dropwise over 15 min, and the reaction was allowed to warm to room temperature. After determination of the completion of the reaction by LCMS (approximately 45 min), the reaction was cooled to 0 Â°C and quenched with a 10% aqueous solution of sodium thiosulfate. The reaction was extracted with EtOAc (3Ã), dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel afforded 5.63 g (99%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.23 (d, <i>J</i> = 7.0 Hz, 1H), 7.66 (d, <i>J</i> = 3.0 Hz, 1H), 7.40 (dd, <i>J</i> = 7.0, 3.0 Hz, 1H), 2.32 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 149.53, 139.78, 128.73, 126.41, 124.17, 17.09 ppm; LCMS (Method 1): <i>R</i><sub>T</sub> = 0.302 min, <i>m</i>/<i>z</i> = 144.2 [M + H]<sup>+</sup>; HRMS, calcd for C<sub>6</sub>H<sub>6</sub>ClNO [M], 143.0138; found 143.0139.</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 4-Chloro-6-methylpicolinonitrile (<b>17a</b>)</h5><div class="NLM_p last">Compound <b>16a</b> (8.97 g, 62.5 mmol, 1.0 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and dried over MgSO<sub>4</sub>. The solution was added to a flame-dried round-bottom flask, and CH<sub>2</sub>Cl<sub>2</sub> was added to give a total volume of 188 mL. Trimethylsilyl cyanide (10 mL, 75 mmol, 1.2 equiv) was added, and the reaction stirred for 15 min. Dimethylcarbamyl chloride (6.9 mL, 75 mmol, 1.2 equiv) was added dropwise over 20 min, and the reaction was stirred for 24 h. An additional 1 equiv each of trimethylsilylcyanide and dimethylcarbamyl chloride were added, and the reaction was stirred for another 72 h. The reaction was made basic with 10% K<sub>2</sub>CO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3Ã). The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel afforded 7.2 g (76%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.13 (d, <i>J</i> = 1.6 Hz, 1H), 7.82 (d, <i>J</i> = 1.7 Hz, 1H), 2.52 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ = 161.99, 144.13, 133.01, 127.65, 126.40, 116.60, 23.57 ppm; LCMS (Method 1): <i>R</i><sub>T</sub> = 0.715 min, <i>m</i>/<i>z</i> = 153.2 [M + H]<sup>+</sup>; HRMS, calcd for C<sub>7</sub>H<sub>5</sub>ClN<sub>2</sub> [M], 152.0141; found 152.0139.</div></div><div id="sec4_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 6-Methyl-4-(pyrimidin-5-yloxy)picolinonitrile (<b>19a</b>)</h5><div class="NLM_p last">Compound <b>17a</b> (4.0 g, 26 mmol, 1.0 equiv), 5-hydroxypyrimidine <b>18a</b> (5.56 g, 57.9 mmol, 2.2 equiv), K<sub>2</sub>CO<sub>3</sub> (7.24 mg, 52.4 mmol, 2.0 equiv), and DMF (66 mL) were added to a reaction vessel and heated at 80 Â°C for 16 h. The reaction was filtered and concentrated on silica gel (25 g). The silica gel was loaded on top of a fresh bed of silica gel and washed with 50% EtOAc/hexane. The solvents were removed in vacuo, and the crude solid was purified by flash chromatography on silica gel to afford 4.31 g (77%) of the title compound as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.17 (s, 1H), 8.85 (s, 2H), 7.74 (d, <i>J</i> = 2.4 Hz, 1H), 7.32 (d, <i>J</i> = 2.3 Hz, 1H), 2.48 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ = 164.04, 162.28, 155.51, 150.02, 148.75, 133.54, 117.05, 115.59, 115.04, 23.82 ppm; LCMS (Method 1): <i>R</i><sub>T</sub> = 0.535 min, <i>m</i>/<i>z</i> = 213.2 [M + H]<sup>+</sup>; HRMS, calcd for C<sub>11</sub>H<sub>8</sub>N<sub>4</sub>O [M], 212.0698; found 212.0697.</div></div><div id="sec4_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 6-Methyl-4-(pyrimidin-5-yloxy)picolinic acid (<b>20a</b>)</h5><div class="NLM_p last">Compound <b>19a</b> (4.31 g, 20.3 mmol, 1.0 equiv) was dissolved in dioxane (90 mL), and 2 N NaOH (45 mL) was added. The mixture was refluxed for 18 h, and after cooling, the reaction was neutralized with 2 N HCl (45 mL). The water and solvent were removed in vacuo, and the crude reaction was dissolved in 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>. The undissolved salt was filtered off, and the solvents were removed in vacuo to afford 4.65 g (99%) of the title compound as a white solid which was used without further purification.</div></div><div id="sec4_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>N</i>-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (<b>27</b>)</h5><div class="NLM_p last">Compound <b>20a</b> (16.84 g, 72.83 mmol, 1.0 equiv) and 5-fluoro-2-aminopyridine (16.33 g, 0.15 mol, 2.0 equiv) were dissolved in pyridine (485 mL) in a flame-dried round-bottom flask. The reaction was cooled to â15 Â°C, and phosphorus oxychloride (7.47 mL, 80.14 mmol, 1.1 equiv) was added dropwise while keeping the temperature below â15 Â°C. After stirring for 30 min at â15 Â°C, the reaction was quenched with iceâwater and neutralized with 10% K<sub>2</sub>CO<sub>3</sub>. The mixture was extracted with EtOAc (3Ã), and the combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel afforded 14.3 g (60%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.48 (s, 1H), 9.18 (s, 1H), 8.88 (s, 2H), 8.40 (d, <i>J</i> = 3.0 Hz, 1H), 8.27 (dd, <i>J</i> = 9.2 Hz, 4.10 Hz, 1H), 7.86 (td, <i>J</i> = 8.6, 3.1 Hz, 1H), 7.55 (d, <i>J</i> = 2.3 Hz, 1H), 7.29 (d, <i>J</i> = 2.3 Hz, 1H), 2.58 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ = 165.15, 161.11, 160.57, 156.12 (d, <i>J</i>(C,F) = 249.0 Hz), 155.41, 150.29, 150.07, 149.01, 146.92 (d, <i>J</i>(C,F) = 2.1 Hz), 135.94 (d, <i>J</i>(C,F) = 25.5 Hz), 125.83 (d, <i>J</i>(C,F) = 19.9 Hz), 114.56, 114.27 (d, <i>J</i>(C,F) = 4.7 Hz), 108.01, 23.84 ppm; LCMS (Method 2): <i>R</i><sub>T</sub> = 0.727 min, <i>m</i>/<i>z</i> = 326.2 [M + H]<sup>+</sup>; HRMS, calcd for C<sub>16</sub>H<sub>12</sub>FN<sub>5</sub>O<sub>2</sub> [M], 325.0975; found 325.0979.</div></div><div id="sec4_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>N</i>-(4-Methylthiazol-2-yl)-4-(pyrimidin-5-yloxy)picolinamide (<b>10</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 3): <i>R</i><sub>T</sub> = 1.147 min, <i>m</i>/<i>z</i> = 314.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 6-Methyl-<i>N</i>-(4-methylthiazol-2-yl)-4-(pyrimidin-5-yloxy)picolinamide (<b>11</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.670 min, <i>m</i>/<i>z</i> = 328.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 4-((5-Fluoropyridin-3-yl)oxy)-<i>N</i>-(4-methylthiazol-2-yl)picolinamide (<b>12</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.732 min, <i>m</i>/<i>z</i> = 331.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 4-((5-Fluoropyridin-3-yl)oxy)-6-methyl-<i>N</i>-(4-methylthiazol-2-yl)picolinamide (<b>13</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.740 min, <i>m</i>/<i>z</i> = 345.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 6-Methyl-<i>N</i>-(6-methylpyridin-2-yl)-4-(pyrimidin-5-yloxy)picolinamide (<b>21</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.653 min, <i>m</i>/<i>z</i> = 322.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-((5-Fluoropyridin-3-yl)oxy)-6-methyl-<i>N</i>-(6-methylpyridin-2-yl)picolinamide (<b>22</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.730 min, <i>m</i>/<i>z</i> = 339.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>N</i>-(6-Ethylpyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (<b>23</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.624 min, <i>m</i>/<i>z</i> = 336.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>N</i>-(6-Ethylpyridin-2-yl)-4-((5-fluoropyridin-3-yl)oxy)-6-methylpicolinamide (<b>24</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.777 min, <i>m</i>/<i>z</i> = 353.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>N</i>-(6-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (<b>25</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.780 min, <i>m</i>/<i>z</i> = 326.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-(6-Fluoropyridin-2-yl)-4-((5-fluoropyridin-3-yl)oxy)-6-methylpicolinamide (<b>26</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.840 min, <i>m</i>/<i>z</i> = 343.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-(5-Fluoropyridin-2-yl)-4-((5-fluoropyridin-3-yl)oxy)-6-methylpicolinamide (<b>28</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.822 min, <i>m</i>/<i>z</i> = 343.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-(5-Chloropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (<b>29</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.803 min, <i>m</i>/<i>z</i> = 342.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> <i>N</i>-(5-Chloropyridin-2-yl)-4-((5-fluoropyridin-3-yl)oxy)-6-methylpicolinamide (<b>30</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.874 min, <i>m</i>/<i>z</i> = 359.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>N</i>-(4-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (<b>31</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.744 min, <i>m</i>/<i>z</i> = 326.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i>-(4-Fluoropyridin-2-yl)-4-((5-fluoropyridin-3-yl)oxy)-6-methylpicolinamide (<b>32</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.822 min, <i>m</i>/<i>z</i> = 343.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>N</i>-(5-Fluoropyridin-2-yl)-6-methyl-4-((2-methylpyrimidin-5-yl)oxy)picolinamide (<b>33</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.776 min, <i>m</i>/<i>z</i> = 340.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-((2-Cyclopropylpyrimidin-5-yl)oxy)-<i>N</i>-(5-fluoropyridin-2-yl)-6-methylpicolinamide (<b>34</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 1): <i>R</i><sub>T</sub> = 0.937 min, <i>m</i>/<i>z</i> = 366.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 6-(Difluoromethyl)-<i>N</i>-(5-fluoropyridin-2-yl)-4-(pyrimidin-5-yloxy)picolinamide (<b>35</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 2): <i>R</i><sub>T</sub> = 0.765 min, <i>m</i>/<i>z</i> = 362.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 4-((5-Chloropyridin-3-yl)oxy)-<i>N</i>-(5-fluoropyridin-2-yl)-6-methylpicolinamide (<b>36</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 1): <i>R</i><sub>T</sub> = 0.942 min, <i>m</i>/<i>z</i> = 359.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> <i>N</i>-(5-Fluoropyridin-2-yl)-6-methyl-4-((6-methylpyridin-3-yl)oxy)picolinamide (<b>37</b>)</h5><div class="NLM_p last">Prepared analogous to compound <b>27</b>. LCMS (Method 1): <i>R</i><sub>T</sub> = 0.639 min, <i>m</i>/<i>z</i> = 339.1 [M + H]<sup>+</sup>.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00410" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00410" class="ext-link">10.1021/acs.jmedchem.7b00410</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular pharmacology methods, complete ancillary pharmacology profile details for <b>27</b> and <b>28</b>, drug metabolism and pharmacokinetic (DMPK) methods, behavioral pharmacology methods, and in vivo occupancy methods (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_001.pdf">jm7b00410_si_001.pdf (675.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_002.csv">jm7b00410_si_002.csv (2.17 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00410" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyle A. Emmitte</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology,Â 
    Department of Chemistry,Â 
     and , Vanderbilt University, Nashville, Tennessee 37232, United States</span>;Â 
    <span>Present Address:
                        Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6643-3947" title="Orcid link">http://orcid.org/0000-0002-6643-3947</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bcd7c5d0d992d9d1d1d5c8c8d9fcc9d2c8d4cfdf92d9d8c9"><span class="__cf_email__" data-cfemail="ddb6a4b1b8f3b8b0b0b4a9a9b89da8b3a9b5aebef3b8b9a8">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew
S. Felts</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alice L. Rodriguez</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna L. Blobaum</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan D. Morrison</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brittney S. Bates</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Analisa Thompson Gray</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerri M. Rook</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammed N. Tantawy</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology and Radiological Sciences, Vanderbilt University Institute
of Imaging Science, Vanderbilt University
Medical Center, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank W. Byers</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sichen Chang</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daryl F. Venable</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent B. Luscombe</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilles D. Tamagnan</span> - <span class="hlFld-Affiliation affiliation">Molecular
NeuroImaging, a Division of inviCRO, New Haven, Connecticut 06510, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colleen M. Niswender</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Scott Daniels</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie K. Jones</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">P. Jeffrey Conn</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology and , Vanderbilt University, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig W. Lindsley</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Center for Neuroscience Drug Discovery, Department of
Pharmacology,Â 
    Department of Chemistry,Â 
     and , Vanderbilt University, Nashville, Tennessee 37232, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0168-1445" title="Orcid link">http://orcid.org/0000-0003-0168-1445</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>K.A.E. and C.W.L. directed and designed the chemistry. A.S.F. and B.S.B. performed the medicinal chemistry. P.J.C. and C.M.N. directed and designed the molecular pharmacology experiments. A.L.R. directed and performed molecular pharmacology experiments. D.F.V. and V.B.L. performed molecular pharmacology experiments. J.S.D. directed and designed the DMPK experiments. A.L.B. directed and designed DMPK experiments and performed bioanalytical work. R.D.M. performed bioanalytical work. S.C. performed in vitro DMPK work. F.W.B. performed in vivo DMPK work. C.K.J. directed, designed, and performed behavioral experiments. A.T.G. performed behavioral experiments. J.M.R. designed and performed the rat brain occupancy experiments. M.N.T. performed rat brain occupancy experiments. G.D.T. was the study director for the NHP brain occupancy study.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d46e5508-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge the generous support of the National Institute of Mental Health (U19 MH097056-01) (P.J.C.), the National Institute on Drug Abuse (R01 DA023947-01) (C.W.L.), Seaside Therapeutics (VUMC33842), and The William K. Warren Foundation for their support of our programs focused on the development of mGlu<sub>5</sub> NAMs.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimerâs disease</p></td></tr><tr><td class="NLM_term">AMU</td><td class="NLM_def"><p class="first last">atomic mass units</p></td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">autism spectrum disorder</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term"><i>B</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum amount of radioligand which can bind specifically to the receptors in a membrane preparation</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">CL<sub>HEP</sub></td><td class="NLM_def"><p class="first last">predicted hepatic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>INT</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>p</sub></td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">concentration response curve</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">the concentration of agonist that affords a half-maximal response</p></td></tr><tr><td class="NLM_term">Et</td><td class="NLM_def"><p class="first last">ethyl</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FPEB</td><td class="NLM_def"><p class="first last">3-fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile</p></td></tr><tr><td class="NLM_term">FST</td><td class="NLM_def"><p class="first last">forced swim test</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">FXS</td><td class="NLM_def"><p class="first last">fragile X syndrome</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">glutamate</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptors</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hours</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">the concentration of antagonist at which 50% of receptor function or radioligand binding is inhibited</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">the concentration of compound that will bind half of the binding sites at equilibrium</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>p</sub></td><td class="NLM_def"><p class="first last">brain to plasma ratio</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>p,uu</sub></td><td class="NLM_def"><p class="first last">unbound brain to unbound plasma ratio</p></td></tr><tr><td class="NLM_term">L</td><td class="NLM_def"><p class="first last">liters</p></td></tr><tr><td class="NLM_term">LID</td><td class="NLM_def"><p class="first last">levodopa-induced dyskinesia</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">MadinâDarby canine kidney</p></td></tr><tr><td class="NLM_term">MDD</td><td class="NLM_def"><p class="first last">major depressive disorder</p></td></tr><tr><td class="NLM_term">Me</td><td class="NLM_def"><p class="first last">methyl</p></td></tr><tr><td class="NLM_term">mGlu</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor</p></td></tr><tr><td class="NLM_term">MPEP</td><td class="NLM_def"><p class="first last">methyl-6-(phenylethynyl)-pyridine</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minutes</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term">MTEP</td><td class="NLM_def"><p class="first last">3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate (reduced form)</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">negative allosteric modulator</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">NHP</td><td class="NLM_def"><p class="first last">nonhuman primate</p></td></tr><tr><td class="NLM_term">Occ<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration of drug that produces 50% receptor brain occupancy</p></td></tr><tr><td class="NLM_term">OCD</td><td class="NLM_def"><p class="first last">obsessive-compulsive disorder</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinsonâs disease</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">RO</td><td class="NLM_def"><p class="first last">receptor occupancy</p></td></tr><tr><td class="NLM_term">RO<sub>50</sub></td><td class="NLM_def"><p class="first last">dose of compound that results in 50% receptor occupancy</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">seconds</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TRD</td><td class="NLM_def"><p class="first last">treatment-resistant depression</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time at which maximum concentration of test compound occurs</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>SS</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady-state</p></td></tr><tr><td class="NLM_term">VFT</td><td class="NLM_def"><p class="first last">venus fly trap</p></td></tr><tr><td class="NLM_term">7TM</td><td class="NLM_def"><p class="first last">seven transmembrane</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 65 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golubeva, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moloney, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâConnor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinan, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryan, J. F.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptors in central nervous system disease</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">538</span>â <span class="NLM_lpage">616</span>, <span class="refDoi">Â DOI: 10.2174/1389450116666150316224011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2174%2F1389450116666150316224011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25777273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCkt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=538-616&author=A.+V.+Golubevaauthor=R.+D.+Moloneyauthor=R.+M.+O%E2%80%99Connorauthor=T.+G.+Dinanauthor=J.+F.+Cryan&title=Metabotropic+glutamate+receptors+in+central+nervous+system+disease&doi=10.2174%2F1389450116666150316224011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic Glutamate Receptors in Central Nervous System Diseases</span></div><div class="casAuthors">Golubeva, Anna V.; Moloney, Rachel D.; O'Connor, Richard M.; Dinan, Timothy G.; Cryan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-616</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Extensive research over the past thirty years has demonstrated a vital role for metabotropic glutamate (mGlu) receptors in the major functions of the central nervous system (CNS).  A wealth of preclin. studies provide evidence that pharmacol. targeting of mGlu receptors can effectively attenuate the development of symptoms and progression of many CNS disorders in animal models.  In this review we summarize the current knowledge on the involvement of mGlu receptors in the pathophysiol. of neuropsychiatric disorders (schizophrenia, depression, anxiety and cognitive disorders, pain perception and addiction), as well as neurodegenerative (Alzheimer's, Huntington's and Parkinson's diseases) and neurodevelopmental (fragile X syndrome and autism spectrum disorders) diseases.  We further emphasize the therapeutic potential of mGlu receptors' pharmacol. modulators in these diseases, describe the results of clin. trials with these compds. and discuss the potential sources of translational difficulties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi8y35VRCCS7Vg90H21EOLACvtfcHk0limT-wySRVCtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCkt7c%253D&md5=c708232b06c6329cbc7dea983bf0070b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150316224011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150316224011%26sid%3Dliteratum%253Aachs%26aulast%3DGolubeva%26aufirst%3DA.%2BV.%26aulast%3DMoloney%26aufirst%3DR.%2BD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BM.%26aulast%3DDinan%26aufirst%3DT.%2BG.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520in%2520central%2520nervous%2520system%2520disease%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2016%26volume%3D17%26spage%3D538%26epage%3D616%26doi%3D10.2174%2F1389450116666150316224011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noetzel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">860</span>â <span class="NLM_lpage">875</span>, <span class="refDoi">Â DOI: 10.1124/mol.112.080531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.112.080531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22863693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktLvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=860-875&author=K.+J.+Gregoryauthor=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=S.+R.+Staufferauthor=A.+L.+Rodriguezauthor=K.+A.+Emmitteauthor=Y.+Zhouauthor=A.+C.+Chunauthor=A.+S.+Feltsauthor=B.+A.+Chauderauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Investigating+metabotropic+glutamate+receptor+5+allosteric+modulator+cooperativity%2C+affinity%2C+and+agonism%3A+enriching+structure-function+studies+and+structure-activity+relationships&doi=10.1124%2Fmol.112.080531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships</span></div><div class="casAuthors">Gregory, Karen J.; Noetzel, Meredith J.; Rook, Jerri M.; Vinson, Paige N.; Stauffer, Shaun R.; Rodriguez, Alice L.; Emmitte, Kyle A.; Zhou, Ya; Chun, Aspen C.; Felts, Andrew S.; Chauder, Brian A.; Lindsley, Craig W.; Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">860-875</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Drug discovery programs increasingly are focusing on allosteric modulators as a means to modify the activity of G protein-coupled receptor (GPCR) targets.  Allosteric binding sites are topog. distinct from the endogenous ligand (orthosteric) binding site, which allows for co-occupation of a single receptor with the endogenous ligand and an allosteric modulator that can alter receptor pharmacol. characteristics.  Neg. allosteric modulators (NAMs) inhibit and pos. allosteric modulators (PAMs) enhance the affinity and/or efficacy of orthosteric agonists.  Established approaches for estn. of affinity and efficacy values for orthosteric ligands are not appropriate for allosteric modulators, and this presents challenges for fully understanding the actions of novel modulators of GPCRs.  Metabotropic glutamate receptor 5 (mGlu5) is a family C GPCR for which a large array of allosteric modulators have been identified.  We took advantage of the many tools for probing allosteric sites on mGlu5 to validate an operational model of allosterism that allows quant. estn. of modulator affinity and cooperativity values.  Affinity ests. derived from functional assays fit well with affinities measured in radioligand binding expts. for both PAMs and NAMs with diverse chem. scaffolds and varying degrees of cooperativity.  We obsd. modulation bias for PAMs when we compared mGlu5-mediated Ca2+ mobilization and extracellular signal-regulated kinase 1/2 phosphorylation data.  Furthermore, we used this model to quantify the effects of mutations that reduce binding or potentiation by PAMs.  This model can be applied to PAM and NAM potency curves in combination with maximal fold-shift data to derive reliable ests. of modulator affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczOVRJNi-orVg90H21EOLACvtfcHk0lj8sdUyVmGVVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktLvF&md5=ca035d4e987783c9cf51e0fa12c4f761</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.080531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.080531%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DA.%2BC.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DInvestigating%2520metabotropic%2520glutamate%2520receptor%25205%2520allosteric%2520modulator%2520cooperativity%252C%2520affinity%252C%2520and%2520agonism%253A%2520enriching%2520structure-function%2520studies%2520and%2520structure-activity%2520relationships%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D860%26epage%3D875%26doi%3D10.1124%2Fmol.112.080531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Practical strategies and concepts in GPCR allosteric modulator discovery: recent advances with metabotropic glutamate receptors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">6707</span>â <span class="NLM_lpage">6741</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrev.5b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=6707-6741&author=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=C.+R.+Hopkinsauthor=T.+M.+Bridgesauthor=K.+J.+Gregoryauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Practical+strategies+and+concepts+in+GPCR+allosteric+modulator+discovery%3A+recent+advances+with+metabotropic+glutamate+receptors&doi=10.1021%2Facs.chemrev.5b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors</span></div><div class="casAuthors">Lindsley, Craig W.; Emmitte, Kyle A.; Hopkins, Corey R.; Bridges, Thomas M.; Gregory, Karen J.; Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6707-6741</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats.  Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacol., unprecedented subtype selectivity, and unique signal bias.  This review provides a comprehensive overview of the basics of GPCR allosteric pharmacol., medicinal chem., drug metab., and validated approaches to address each of the major challenges and caveats.  Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("mol. switches", signal bias, heterodimers) and practical solns. to enable the development of tool compds. and clin. candidates.  The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq18XJrjVel-7Vg90H21EOLACvtfcHk0lhzfkN3a4_P9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D&md5=c12704b6602b6c50add92e7fd9350382</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DPractical%2520strategies%2520and%2520concepts%2520in%2520GPCR%2520allosteric%2520modulator%2520discovery%253A%2520recent%2520advances%2520with%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D6707%26epage%3D6741%26doi%3D10.1021%2Facs.chemrev.5b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">mGlu<sub>5</sub> negative allosteric modulators: a patent review (2013â2016)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">691</span>â <span class="NLM_lpage">706</span>, <span class="refDoi">Â DOI: 10.1080/13543776.2017.1280466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1080%2F13543776.2017.1280466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=28067079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlemsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=691-706&author=K.+A.+Emmitte&title=mGlu5+negative+allosteric+modulators%3A+a+patent+review+%282013%E2%80%932016%29&doi=10.1080%2F13543776.2017.1280466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">mGlu5 negative allosteric modulators: a patent review (2013 - 2016)</span></div><div class="casAuthors">Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">691-706</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Introduction: The pursuit of small mol. mGlu5 NAMs as treatments for a variety of psychiatric and neurodegenerative disorders has developed into a mature field.  In addn. to extensive preclin. studies, multiple compds. have advanced into clin. trials with the most advanced studies occurring in patients with FXS, PD-LID, and MDD.  Areas Covered: This review begins with an update of the clin. activity with mGlu5 NAMs, and then moves into a summary of patent applications filed since 2013.  The summaries are organized into three sep. sections: (1) inventions centered on improvements to existing clin. compds.; (2) new small mols. that maintain the prototypical disubstituted alkyne chemotype found in many mGlu5 NAM compds.; and (3) new small mols. that are not from a disubstituted alkyne chemotype.  Expert Opinion: It is a crit. moment for mGlu5 NAM research as recent reports from clin. trials have included some significant disappointments that have blunted prior optimism.  Still, research in this area remains active, and recent years have added several more attractive small mols. to this field.  There is now an arsenal of diverse chemotypes available to continue to probe this target in the hopes that a drug may yet emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWQ94UvPC2ALVg90H21EOLACvtfcHk0lhzfkN3a4_P9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlemsb0%253D&md5=f2c86384dc509c8677e4c94ec2bfabb9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1280466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1280466%26sid%3Dliteratum%253Aachs%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DmGlu5%2520negative%2520allosteric%2520modulators%253A%2520a%2520patent%2520review%2520%25282013%25E2%2580%25932016%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D691%26epage%3D706%26doi%3D10.1080%2F13543776.2017.1280466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rocher, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BolÃ©a, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¼tjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Poul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epping-Jordan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutel, V.</span></span> <span> </span><span class="NLM_article-title">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutics</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">680</span>â <span class="NLM_lpage">695</span>, <span class="refDoi">Â DOI: 10.2174/1568026611109060680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2174%2F1568026611109060680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=21261592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=680-695&author=J.+P.+Rocherauthor=B.+Bonnetauthor=C.+Bol%C3%A9aauthor=R.+L%C3%BCtjensauthor=E.+Le+Poulauthor=S.+Poliauthor=M.+Epping-Jordanauthor=A.+S.+Bessisauthor=B.+Ludwigauthor=V.+Mutel&title=mGluR5+negative+allosteric+modulators+overview%3A+a+medicinal+chemistry+approach+towards+a+series+of+novel+therapeutics&doi=10.2174%2F1568026611109060680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents</span></div><div class="casAuthors">Rocher, Jean-Philippe; Bonnet, Beatrice; Bolea, Christelle; Lutjens, Robert; Le Poul, Emmanuel; Poli, Sonia; Epping-Jordan, Mark; Bessis, Anne-Sophie; Ludwig, Bernard; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">680-695</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Allosteric modulators of metabotropic glutamate receptors (mGluRs) subtypes 1-8 have been shown to offer a valid way to develop small mol. non aminoacid-like therapeutics that can be administered orally and that readily cross the blood-brain barrier.  Allosteric modulators of glutamatergic receptors and in particular mGluR5 have emerged as a novel and highly desirable class of compds. for the treatment of central nervous system (CNS) disorders and peripheral disorders.  This article provides medicinal chem. highlights around the chem. classes of potent and highly selective mGluR5 neg. allosteric modulators (NAMs) and their therapeutic potential.  In addn., it describes the medicinal chem. approach from the discovery to the clin. candidate selection of a new series of heteroaryl-butynylpyridines targeting mGluR5.  The multiparametric optimization of the initial starting point which ended in the selection of potential clin. candidates combining the best pharmacophoric features is presented.  The pharmacol. properties are reported and support the interest of these agents for new therapeutic approaches.  Furthermore, a summary of the diverse mGluR5 Positron Emission Tomog. (PET) radioligands is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeXrv5HnHG77Vg90H21EOLACvtfcHk0lhzfkN3a4_P9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D&md5=aab29725fa93c1895f32f7dbe93a16f1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060680%26sid%3Dliteratum%253Aachs%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DBonnet%26aufirst%3DB.%26aulast%3DBol%25C3%25A9a%26aufirst%3DC.%26aulast%3DL%25C3%25BCtjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DBessis%26aufirst%3DA.%2BS.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DmGluR5%2520negative%2520allosteric%2520modulators%2520overview%253A%2520a%2520medicinal%2520chemistry%2520approach%2520towards%2520a%2520series%2520of%2520novel%2520therapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D680%26epage%3D695%26doi%3D10.2174%2F1568026611109060680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mihov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, G.</span></span> <span> </span><span class="NLM_article-title">Negative allosteric modulators of metabotropic glutamate receptors subtype 5 in addiction: a therapeutic window</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">pyw002</span>, <span class="refDoi">Â DOI: 10.1093/ijnp/pyw002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1093%2Fijnp%2Fpyw002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26802568" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=pyw002&author=Y.+Mihovauthor=G.+Hasler&title=Negative+allosteric+modulators+of+metabotropic+glutamate+receptors+subtype+5+in+addiction%3A+a+therapeutic+window&doi=10.1093%2Fijnp%2Fpyw002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyw002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyw002%26sid%3Dliteratum%253Aachs%26aulast%3DMihov%26aufirst%3DY.%26aulast%3DHasler%26aufirst%3DG.%26atitle%3DNegative%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptors%2520subtype%25205%2520in%2520addiction%253A%2520a%2520therapeutic%2520window%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2016%26volume%3D19%26spage%3Dpyw002%26doi%3D10.1093%2Fijnp%2Fpyw002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmo, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptors and neurodegenerative diseases</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">191</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2016.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.phrs.2016.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=27872019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOgt7zM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2017&pages=179-191&author=F.+M.+Ribeiroauthor=L.+B.+Vieiraauthor=R.+G.+Piresauthor=R.+P.+Olmoauthor=S.+S.+Ferguson&title=Metabotropic+glutamate+receptors+and+neurodegenerative+diseases&doi=10.1016%2Fj.phrs.2016.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors and neurodegenerative diseases</span></div><div class="casAuthors">Ribeiro, Fabiola M.; Vieira, Luciene B.; Pires, Rita G. W.; Olmo, Roenick P.; Ferguson, Stephen S. G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-191</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Glutamate is the most important excitatory neurotransmitter of the mammalian central nervous system (CNS), playing an important role in memory, synaptic plasticity and neuronal development.  However, glutamate overstimulation is also implicated in neuronal cell death.  There are two major types of glutamate receptors: ionotropic and metabotropic.  Thus far, eight metabotropic glutamate receptors (mGluRs) subtypes have been characterized and are divided into three subgroups based on sequence homol. and cell signaling activation. mGluRs activate a wide variety of cell signaling pathways by G protein-coupled pathways or via G protein-independent cell signaling activation.  Moreover, these receptors exhibit widespread distribution in the CNS and are implicated in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).  This review aims to discuss the latest updates concerning mGluRs and their role in neurodegenerative diseases. mGluRs agonists and antagonists as well as pos. and neg. allosteric modulators have been tested in several animal models of neurodegenerative diseases.  Furthermore, mGluR knockout mouse models have been crossed to mouse models of AD and HD, providing important data about mGluRs role in neurodegenerative disease progression.  Thus, mGluRs constitute potential therapeutic targets for the development of therapies to treat neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ohpCmghKrrVg90H21EOLACvtfcHk0lifbG-VJ4u41g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOgt7zM&md5=dd9b8b140e8b0094c62005eccffd923c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DF.%2BM.%26aulast%3DVieira%26aufirst%3DL.%2BB.%26aulast%3DPires%26aufirst%3DR.%2BG.%26aulast%3DOlmo%26aufirst%3DR.%2BP.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520and%2520neurodegenerative%2520diseases%26jtitle%3DPharmacol.%2520Res.%26date%3D2017%26volume%3D115%26spage%3D179%26epage%3D191%26doi%3D10.1016%2Fj.phrs.2016.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busse, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattersall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D. P.</span></span> <span> </span><span class="NLM_article-title">The behavioral profile of the potent and selective mGlu<sub>5</sub> receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) in rodent models of anxiety</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1971</span>â <span class="NLM_lpage">1979</span>, <span class="refDoi">Â DOI: 10.1038/sj.npp.1300540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fsj.npp.1300540" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1971-1979&author=C.+S.+Busseauthor=J.+Brodkinauthor=D.+Tattersallauthor=J.+J.+Andersonauthor=N.+Warrenauthor=L.+Tehraniauthor=L.+J.+Bristowauthor=M.+A.+Varneyauthor=N.+D.+P.+Cosford&title=The+behavioral+profile+of+the+potent+and+selective+mGlu5+receptor+antagonist+3-%5B%282-methyl-1%2C3-thiazol-4-yl%29ethynyl%5D-pyridine+%28MTEP%29+in+rodent+models+of+anxiety&doi=10.1038%2Fsj.npp.1300540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300540%26sid%3Dliteratum%253Aachs%26aulast%3DBusse%26aufirst%3DC.%2BS.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DTattersall%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DJ.%2BJ.%26aulast%3DWarren%26aufirst%3DN.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DThe%2520behavioral%2520profile%2520of%2520the%2520potent%2520and%2520selective%2520mGlu5%2520receptor%2520antagonist%25203-%255B%25282-methyl-1%252C3-thiazol-4-yl%2529ethynyl%255D-pyridine%2520%2528MTEP%2529%2520in%2520rodent%2520models%2520of%2520anxiety%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1971%26epage%3D1979%26doi%3D10.1038%2Fsj.npp.1300540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karras, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, J. N.</span></span> <span> </span><span class="NLM_article-title">Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">131ra51</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.3003501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1126%2Fscitranslmed.3003501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22539775" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=131ra51&author=J.+L.+Silvermanauthor=D.+G.+Smithauthor=S.+J.+Rizzoauthor=M.+N.+Karrasauthor=S.+M.+Turnerauthor=S.+S.+Toluauthor=D.+K.+Bryceauthor=D.+L.+Smithauthor=K.+Fonsecaauthor=R.+H.+Ringauthor=J.+N.+Crawley&title=Negative+allosteric+modulation+of+the+mGluR5+receptor+reduces+repetitive+behaviors+and+rescues+social+deficits+in+mouse+models+of+autism&doi=10.1126%2Fscitranslmed.3003501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003501%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DRizzo%26aufirst%3DS.%2BJ.%26aulast%3DKarras%26aufirst%3DM.%2BN.%26aulast%3DTurner%26aufirst%3DS.%2BM.%26aulast%3DTolu%26aufirst%3DS.%2BS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26atitle%3DNegative%2520allosteric%2520modulation%2520of%2520the%2520mGluR5%2520receptor%2520reduces%2520repetitive%2520behaviors%2520and%2520rescues%2520social%2520deficits%2520in%2520mouse%2520models%2520of%2520autism%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D131ra51%26doi%3D10.1126%2Fscitranslmed.3003501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pop, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span> <span> </span><span class="NLM_article-title">Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development</span>. <i>Psychopharmacology (Berl)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>231</i></span>,  <span class="NLM_fpage">1217</span>â <span class="NLM_lpage">1226</span>, <span class="refDoi">Â DOI: 10.1007/s00213-013-3330-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1007%2Fs00213-013-3330-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24232444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ms1WksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=1217-1226&author=A.+S.+Popauthor=B.+Gomez-Mancillaauthor=G.+Neriauthor=R.+Willemsenauthor=F.+Gasparini&title=Fragile+X+syndrome%3A+a+preclinical+review+on+metabotropic+glutamate+receptor+5+%28mGluR5%29+antagonists+and+drug+development&doi=10.1007%2Fs00213-013-3330-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development</span></div><div class="casAuthors">Pop Andreea S; Gomez-Mancilla Baltazar; Neri Giovanni; Willemsen Rob; Gasparini Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1217-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Fragile X syndrome (FXS) is considered the leading inherited cause of intellectual disability and autism.  In FXS, the fragile X mental retardation 1 (FMR1) gene is silenced and the fragile X mental retardation protein (FMRP) is not expressed, resulting in the characteristic features of the syndrome.  Despite recent advances in understanding the pathophysiology of FXS, there is still no cure for this condition; current treatment is symptomatic.  Preclinical research is essential in the development of potential therapeutic agents.  OBJECTIVES:  This review provides an overview of the preclinical evidence supporting metabotropic glutamate receptor 5 (mGluR5) antagonists as therapeutic agents for FXS.  RESULTS:  According to the mGluR theory of FXS, the absence of FMRP leads to enhanced glutamatergic signaling via mGluR5, which leads to increased protein synthesis and defects in synaptic plasticity including enhanced long-term depression.  As such, efforts to develop agents that target the underlying pathophysiology of FXS have focused on mGluR5 modulation.  Animal models, particularly the Fmr1 knockout mouse model, have become invaluable in exploring therapeutic approaches on an electrophysiological, behavioral, biochemical, and neuroanatomical level.  Two direct approaches are currently being investigated for FXS treatment: reactivating the FMR1 gene and compensating for the lack of FMRP.  The latter approach has yielded promising results, with mGluR5 antagonists showing efficacy in clinical trials.  CONCLUSIONS:  Targeting mGluR5 is a valid approach for the development of therapeutic agents that target the underlying pathophysiology of FXS.  Several compounds are currently in development, with encouraging results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpayJ8_eLcGekdrW1FkXG-fW6udTcc2ea4N0EITuy20bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ms1WksA%253D%253D&md5=4cc3fa76ed54a0a52c624a90ac92a985</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3330-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3330-3%26sid%3Dliteratum%253Aachs%26aulast%3DPop%26aufirst%3DA.%2BS.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26aulast%3DNeri%26aufirst%3DG.%26aulast%3DWillemsen%26aufirst%3DR.%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DFragile%2520X%2520syndrome%253A%2520a%2520preclinical%2520review%2520on%2520metabotropic%2520glutamate%2520receptor%25205%2520%2528mGluR5%2529%2520antagonists%2520and%2520drug%2520development%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2014%26volume%3D231%26spage%3D1217%26epage%3D1226%26doi%3D10.1007%2Fs00213-013-3330-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Litim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, T.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as therapeutic targets in Parkinsonâs disease: an update from the last 5 years of research</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">166</span>â <span class="NLM_lpage">179</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2016.03.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.neuropharm.2016.03.036" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2017&pages=166-179&author=N.+Litimauthor=M.+Morissetteauthor=T.+Di+Paolo&title=Metabotropic+glutamate+receptors+as+therapeutic+targets+in+Parkinson%E2%80%99s+disease%3A+an+update+from+the+last+5+years+of+research&doi=10.1016%2Fj.neuropharm.2016.03.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.03.036%26sid%3Dliteratum%253Aachs%26aulast%3DLitim%26aufirst%3DN.%26aulast%3DMorissette%26aufirst%3DM.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520therapeutic%2520targets%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520an%2520update%2520from%2520the%2520last%25205%2520years%2520of%2520research%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D115%26spage%3D166%26epage%3D179%26doi%3D10.1016%2Fj.neuropharm.2016.03.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span> <span> </span><span class="NLM_article-title">Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias</span>. <i>Parkinsonism Relat. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">947</span>â <span class="NLM_lpage">956</span>, <span class="refDoi">Â DOI: 10.1016/j.parkreldis.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.parkreldis.2014.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24951359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADC%252BC2cfksFWgtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=947-956&author=O.+Rascolauthor=S.+Foxauthor=F.+Gaspariniauthor=C.+Kenneyauthor=T.+Di+Paoloauthor=B.+Gomez-Mancilla&title=Use+of+metabotropic+glutamate+5-receptor+antagonists+for+treatment+of+levodopa-induced+dyskinesias&doi=10.1016%2Fj.parkreldis.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias</span></div><div class="casAuthors">Rascol Olivier; Fox Susan; Gasparini Fabrizio; Kenney Christopher; Di Paolo Therese; Gomez-Mancilla Baltazar</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">947-56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Modulation of metabotropic glutamate receptors may be a novel therapeutic approach to manage L-Dopa-induced dyskinesias in patients with Parkinson's disease.  This article reviews the rationale for use of metabotropic glutamate 5-receptor antagonists in experimental and clinical L-Dopa-induced dyskinesias.  METHODS:  Systematic literature searches were performed (between May 2012-March 2014) for relevant English language articles using PubMed.  Additional articles of interest were identified from reference lists of included publications.  Relevant clinical abstracts from Movement Disorder Society meetings were included.  RESULTS:  16 preclinical studies of metabotropic glutamate 5-receptor antagonists in animal models of L-Dopa-induced dyskinesias and 7 clinical studies in patients with Parkinson's disease and L-Dopa-induced dyskinesias were included.  Anti-dyskinetic effects of metabotropic glutamate 5-receptor blockade (MPEP, MTEP, fenobam, or MRZ-8676) were reported in dyskinetic 6-hydroxydopamine-lesioned rats.  Studies in MPTP-lesioned non-human primates reported anti-dyskinetic effects of MPEP, MTEP, fenobam and mavoglurant (AFQ056).  Three randomized, double-blind clinical trials reported anti-dyskinetic efficacy of mavoglurant, without effects on anti-parkinsonian therapy, with dizziness the most common adverse event.  However, two further studies failed to demonstrate significant anti-dyskinetic efficacy.  A randomized, double-blind, placebo-controlled safety study of dipraglurant (ADX48621) demonstrated tolerability and positive exploratory secondary outcomes of reduced dyskinesia.  CONCLUSIONS:  Animal model studies provide evidence for anti-dyskinetic efficacy of metabotropic glutamate 5-receptor antagonists.  Initial proof-of-concept clinical trials of mavoglurant and dipraglurant showed positive results; anti-dyskinetic efficacy was not supported by two recent mavoglurant trials.  Further evaluations of optimal dosage and long-term efficacy and safety of metabotropic glutamate 5-receptor antagonists for management of L-Dopa-induced dyskinesias in Parkinson's disease are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqMEpWKJUcNC86Js-BCLiifW6udTcc2eblKxR8OB9Z2bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfksFWgtA%253D%253D&md5=c68e2b9580c0d0b360db519ef4718f31</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.parkreldis.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parkreldis.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DFox%26aufirst%3DS.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26atitle%3DUse%2520of%2520metabotropic%2520glutamate%25205-receptor%2520antagonists%2520for%2520treatment%2520of%2520levodopa-induced%2520dyskinesias%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2014%26volume%3D20%26spage%3D947%26epage%3D956%26doi%3D10.1016%2Fj.parkreldis.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaso, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niciu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iadarola, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lally, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado-Vieira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic modulation of glutamate receptors in major depressive disorder</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">70</span>, <span class="refDoi">Â DOI: 10.2174/1570159X14666160321123221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2174%2F1570159X14666160321123221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26997505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1WlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=57-70&author=B.+A.+Jasoauthor=M.+J.+Niciuauthor=N.+D.+Iadarolaauthor=N.+Lallyauthor=E.+M.+Richardsauthor=M.+Parkauthor=E.+D.+Ballardauthor=A.+C.+Nugentauthor=R.+Machado-Vieiraauthor=C.+A.+Zarate&title=Therapeutic+modulation+of+glutamate+receptors+in+major+depressive+disorder&doi=10.2174%2F1570159X14666160321123221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder</span></div><div class="casAuthors">Jaso, Brittany A.; Niciu, Mark J.; Iadarola, Nicolas D.; Lally, Niall; Richards, Erica M.; Park, Minkyung; Ballard, Elizabeth D.; Nugent, Allison C.; Machado-Vieira, Rodrigo; Zarate, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and impairment for patients, and real world effectiveness trials further suggest that antidepressant efficacy is limited in many patients.  All currently approved antidepressant medications for MDD act primarily through monoaminergic mechanisms, e.g., receptor/reuptake agonists or antagonists with varying affinities for serotonin, norepinephrine, or dopamine.  Glutamate is the major excitatory neurotransmitter in the central nervous system, and glutamate and its cognate receptors are implicated in the pathophysiol. of MDD, as well as in the development of novel therapeutics for this disorder.  Since the rapid and robust antidepressant effects of the N-methyl-D-aspartate (NMDA) antagonist ketamine were first obsd. in 2000, other NMDA receptor antagonists have been studied in MDD.  These have been assocd. with relatively modest antidepressant effects compared to ketamine, but some have shown more favorable characteristics with increased potential in clin. practice (for instance, oral administration, decreased dissociative and/or psychotomimetic effects, and reduced abuse/diversion liability).  This article reviews the clin. evidence supporting the use of glutamate receptor modulators with direct affinity for cognate receptors: 1) non-competitive NMDA receptor antagonists (ketamine, memantine, dextromethorphan, AZD6765); 2) subunit (NR2B)-specific NMDA receptor antagonists (CP- 101,606/traxoprodil, MK-0657); 3) NMDA receptor glycine-site partial agonists (D-cycloserine, GLYX- 13); and 4) metabotropic glutamate receptor (mGluR) modulators (AZD2066, RO4917523/basimglurant).  Several other theor. glutamate receptor targets with preclin. antidepressant-like efficacy, but that have yet to be studied clin., are also briefly discussed; these include -amino-3-hydroxyl-5-methyl-4- isoxazoleproprionic acid (AMPA) agonists, mGluR2/3 neg. allosteric modulators, and mGluR7 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9HWcN60qpHrVg90H21EOLACvtfcHk0ljcgAZf8XDGDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1WlsQ%253D%253D&md5=180a395edc9d7dd01db713c249039783</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1570159X14666160321123221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X14666160321123221%26sid%3Dliteratum%253Aachs%26aulast%3DJaso%26aufirst%3DB.%2BA.%26aulast%3DNiciu%26aufirst%3DM.%2BJ.%26aulast%3DIadarola%26aufirst%3DN.%2BD.%26aulast%3DLally%26aufirst%3DN.%26aulast%3DRichards%26aufirst%3DE.%2BM.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DE.%2BD.%26aulast%3DNugent%26aufirst%3DA.%2BC.%26aulast%3DMachado-Vieira%26aufirst%3DR.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26atitle%3DTherapeutic%2520modulation%2520of%2520glutamate%2520receptors%2520in%2520major%2520depressive%2520disorder%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2017%26volume%3D15%26spage%3D57%26epage%3D70%26doi%3D10.2174%2F1570159X14666160321123221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutrick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donchev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocwieja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span> <span> </span><span class="NLM_article-title">Mavoglurant augmentation in OCD patients resistant to selective serotonin reuptake inhibitors: a proof-of-concept, randomized, placebo-controlled, phase 2 study</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">524</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1007/s12325-016-0468-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1007%2Fs12325-016-0468-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=524-541&author=D.+Rutrickauthor=D.+J.+Steinauthor=G.+Subramanianauthor=B.+Smithauthor=M.+Favaauthor=G.+Haslerauthor=J.+Chaauthor=F.+Gaspariniauthor=T.+Donchevauthor=M.+Ocwiejaauthor=D.+Johnsauthor=B.+Gomez-Mancilla&title=Mavoglurant+augmentation+in+OCD+patients+resistant+to+selective+serotonin+reuptake+inhibitors%3A+a+proof-of-concept%2C+randomized%2C+placebo-controlled%2C+phase+2+study&doi=10.1007%2Fs12325-016-0468-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs12325-016-0468-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12325-016-0468-5%26sid%3Dliteratum%253Aachs%26aulast%3DRutrick%26aufirst%3DD.%26aulast%3DStein%26aufirst%3DD.%2BJ.%26aulast%3DSubramanian%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DFava%26aufirst%3DM.%26aulast%3DHasler%26aufirst%3DG.%26aulast%3DCha%26aufirst%3DJ.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DDonchev%26aufirst%3DT.%26aulast%3DOcwieja%26aufirst%3DM.%26aulast%3DJohns%26aufirst%3DD.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26atitle%3DMavoglurant%2520augmentation%2520in%2520OCD%2520patients%2520resistant%2520to%2520selective%2520serotonin%2520reuptake%2520inhibitors%253A%2520a%2520proof-of-concept%252C%2520randomized%252C%2520placebo-controlled%252C%2520phase%25202%2520study%26jtitle%3DAdv.%2520Ther.%26date%3D2017%26volume%3D34%26spage%3D524%26epage%3D541%26doi%3D10.1007%2Fs12325-016-0468-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LingenhÃ¶hl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoehr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flor, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranesic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biollaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgeier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckendorn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urwyler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacaan, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santori, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veliocelebi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span> <span> </span><span class="NLM_article-title">Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systematically active mGlu<sub>5</sub> receptor antagonist</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1493</span>â <span class="NLM_lpage">1503</span>, <span class="refDoi">Â DOI: 10.1016/S0028-3908(99)00082-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2FS0028-3908%2899%2900082-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1493-1503&author=F.+Gaspariniauthor=K.+Lingenh%C3%B6hlauthor=N.+Stoehrauthor=P.+J.+Florauthor=M.+Heinrichauthor=I.+Vranesicauthor=M.+Biollazauthor=H.+Allgeierauthor=R.+Heckendornauthor=S.+Urwylerauthor=M.+A.+Varneyauthor=E.+C.+Johnsonauthor=S.+D.+Hessauthor=S.+P.+Raoauthor=A.+I.+Sacaanauthor=E.+M.+Santoriauthor=G.+Veliocelebiauthor=R.+Kuhn&title=Methyl-6-%28phenylethynyl%29-pyridine+%28MPEP%29%2C+a+potent%2C+selective+and+systematically+active+mGlu5+receptor+antagonist&doi=10.1016%2FS0028-3908%2899%2900082-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900082-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900082-9%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DLingenh%25C3%25B6hl%26aufirst%3DK.%26aulast%3DStoehr%26aufirst%3DN.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DBiollaz%26aufirst%3DM.%26aulast%3DAllgeier%26aufirst%3DH.%26aulast%3DHeckendorn%26aufirst%3DR.%26aulast%3DUrwyler%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DE.%2BC.%26aulast%3DHess%26aufirst%3DS.%2BD.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DSacaan%26aufirst%3DA.%2BI.%26aulast%3DSantori%26aufirst%3DE.%2BM.%26aulast%3DVeliocelebi%26aufirst%3DG.%26aulast%3DKuhn%26aufirst%3DR.%26atitle%3DMethyl-6-%2528phenylethynyl%2529-pyridine%2520%2528MPEP%2529%252C%2520a%2520potent%252C%2520selective%2520and%2520systematically%2520active%2520mGlu5%2520receptor%2520antagonist%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1493%26epage%3D1503%26doi%3D10.1016%2FS0028-3908%2899%2900082-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roppe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span> <span> </span><span class="NLM_article-title">3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">204</span>â <span class="NLM_lpage">206</span>, <span class="refDoi">Â DOI: 10.1021/jm025570j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025570j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=204-206&author=N.+D.+Cosfordauthor=L.+Tehraniauthor=J.+Roppeauthor=E.+Schweigerauthor=N.+D.+Smithauthor=J.+Andersonauthor=L.+Bristowauthor=J.+Brodkinauthor=X.+Jiangauthor=I.+McDonaldauthor=S.+Raoauthor=M.+Washburnauthor=M.+A.+Varney&title=3-%5B%282-Methyl-1%2C3-thiazol-4-yl%29ethynyl%5D-pyridine%3A+a+potent+and+highly+selective+metabotropic+glutamate+subtype+5+receptor+antagonist+with+anxiolytic+activity&doi=10.1021%2Fjm025570j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm025570j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025570j%26sid%3Dliteratum%253Aachs%26aulast%3DCosford%26aufirst%3DN.%2BD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DSchweiger%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMcDonald%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DM.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26atitle%3D3-%255B%25282-Methyl-1%252C3-thiazol-4-yl%2529ethynyl%255D-pyridine%253A%2520a%2520potent%2520and%2520highly%2520selective%2520metabotropic%2520glutamate%2520subtype%25205%2520receptor%2520antagonist%2520with%2520anxiolytic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D204%26epage%3D206%26doi%3D10.1021%2Fjm025570j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R.
H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼ttelmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolczewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼hlemann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malherbe, P.</span></span> <span> </span><span class="NLM_article-title">Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu<sub>5</sub> receptor antagonist with inverse agonist activity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>315</i></span>,  <span class="NLM_fpage">711</span>â <span class="NLM_lpage">721</span>, <span class="refDoi">Â DOI: 10.1124/jpet.105.089839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fjpet.105.089839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16040814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=711-721&author=R.%0AH.+P.+Porterauthor=G.+Jaeschkeauthor=W.+Spoorenauthor=T.+M.+Ballardauthor=B.+B%C3%BCttelmannauthor=S.+Kolczewskiauthor=J.+U.+Petersauthor=E.+Prinssenauthor=J.+Wichmannauthor=E.+Vieiraauthor=A.+M%C3%BChlemannauthor=S.+Gattiauthor=V.+Mutelauthor=P.+Malherbe&title=Fenobam%3A+a+clinically+validated+nonbenzodiazepine+anxiolytic+is+a+potent%2C+selective%2C+and+noncompetitive+mGlu5+receptor+antagonist+with+inverse+agonist+activity&doi=10.1124%2Fjpet.105.089839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fenobam: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity</span></div><div class="casAuthors">Porter, Richard H. P.; Jaeschke, Georg; Spooren, Will; Ballard, Theresa M.; Buttelmann, Bernd; Kolczewski, Sabine; Peters, Jens-Uwe; Prinseen, Eric; Wichmann, Jurgen; Vieira, Eric; Muhlemann, Andreas; Gatti, Silvia; Mutel, Vincent; Malherbe, Pari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">711-721</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea] is an atypical anxiolytic agent with unknown mol. target that has previously been demonstrated both in rodents and human to exert anxiolytic activity.  Here, we report that fenobam is a selective and potent metabotropic glutamate (mGlu)5 receptor antagonist acting at an allosteric modulatory site shared with 2-methyl-6-phenylethynyl-pyridine (MPEP), the protypical selective mGlu5 receptor antagonist.  Fenobam inhibited quisqualate-evoked intracellular calcium response mediated by human mGlu5 receptor with IC50 = 58Â±2 nM.  It acted in a noncompetitive manner, similar to MPEP and demonstrated inverse agonist properties, blocking 66% of the mGlu5 receptor basal activity (in an over expressed cell line) with an IC50 = 84Â±13 nM.  [3H]Fenobam bound to rat and human recombinant receptors with Kd values of 54Â±6 and 31Â±4 nM, resp.  MPEP inhibited [3H]fenobam binding to human mGlu5 receptors with a Ki value of 6.7Â±0.7 nM, indicating a common binding site shared by both allosteric antagonists.  Fenobam exhibits anxiolytic activity in the stress-induced hyperthermia model, Vogel conflict test, Geller-Seifter conflict test, and conditioned emotional response with a min. ED of 10 to 30 mg/kg p.o.  Furthermore, fenobam is devoid of GABAergic activity, confirming previous reports that fenobam acts by a mechanism distinct from benzodiazepines.  The non-GABAergic activity of fenobam, coupled with its robust anxiolytic activity and reported efficacy in human in a double blind placebo-controlled trial, supports the potential of developing mGlu5 receptor antagonists with an improved therapeutic window over benzodiazepines as novel anxiolytic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQg1qRiOD0cLVg90H21EOLACvtfcHk0lhB6oOHYVtd3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F&md5=8d08eb1e3f777231204024da12301a2e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089839%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DBallard%26aufirst%3DT.%2BM.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DM%25C3%25BChlemann%26aufirst%3DA.%26aulast%3DGatti%26aufirst%3DS.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DMalherbe%26aufirst%3DP.%26atitle%3DFenobam%253A%2520a%2520clinically%2520validated%2520nonbenzodiazepine%2520anxiolytic%2520is%2520a%2520potent%252C%2520selective%252C%2520and%2520noncompetitive%2520mGlu5%2520receptor%2520antagonist%2520with%2520inverse%2520agonist%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D711%26epage%3D721%26doi%3D10.1124%2Fjpet.105.089839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berry-Kravis, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuhas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snape, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranfaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagerman, R.</span></span> <span> </span><span class="NLM_article-title">A pilot open label, single dose trial of fenobam in adults with fragile X syndrome</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">266</span>â <span class="NLM_lpage">271</span>, <span class="refDoi">Â DOI: 10.1136/jmg.2008.063701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1136%2Fjmg.2008.063701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=19126569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Git7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2009&pages=266-271&author=E.+M.+Berry-Kravisauthor=D.+Hesslauthor=S.+Coffeyauthor=C.+Herveyauthor=A.+Schneiderauthor=J.+Yuhasauthor=J.+Hutchinsonauthor=M.+Snapeauthor=M.+Tranfagliaauthor=D.+V.+Nguyenauthor=R.+Hagerman&title=A+pilot+open+label%2C+single+dose+trial+of+fenobam+in+adults+with+fragile+X+syndrome&doi=10.1136%2Fjmg.2008.063701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A pilot open label, single dose trial of fenobam in adults with fragile X syndrome</span></div><div class="casAuthors">Berry-Kravis, E.; Hessl, D.; Coffey, S.; Hervey, C.; Schneider, A.; Yuhas, J.; Hutchison, J.; Snape, M.; Tranfaglia, M.; Nguyen, D. V.; Hagerman, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">266-271</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective: A pilot open label, single dose trial of fenobam, an mGluR5 antagonist, was conducted to provide an initial evaluation of safety and pharmacokinetics in adult males and females with fragile X syndrome (FXS).  Methods: Twelve subjects, recruited from two fragile X clinics, received a single oral dose of 50-150 mg of fenobam.  Blood for pharmacokinetic testing, vital signs and side effect screening was obtained at baseline and numerous time points for 6 h after dosing.  Outcome measures included prepulse inhibition (PPI) and a continuous performance test (CPT) obtained before and after dosing to explore the effects of fenobam on core phenotypic measures of sensory gating, attention and inhibition.  Results: There were no significant adverse reactions to fenobam administration.  Pharmacokinetic anal. showed that fenobam concns. were dose dependent but variable, with mean (SEM) peak values of 39.7 (18.4) ng/mL at 180 min after the 150 mg dose.  PPI met a response criterion of an improvement of at least 20% over baseline in 6 of 12 individuals (4/6 males and 2/6 females).  The CPT did not display improvement with treatment due to ceiling effects.  Conclusions: Clin. significant adverse effects were not identified in this study of single dose fenobam across the range of dosages utilized.  The pos. effects seen in animal models of FXS treated with fenobam or other mGluR5 antagonists, the apparent lack of clin. significant adverse effects, and the potential beneficial clin. effects seen in this pilot trial support further study of the compd. in adults with FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99DijLUqcQLVg90H21EOLACvtfcHk0lhB6oOHYVtd3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Git7c%253D&md5=956667f6a057902de18996447ef27400</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2008.063701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2008.063701%26sid%3Dliteratum%253Aachs%26aulast%3DBerry-Kravis%26aufirst%3DE.%2BM.%26aulast%3DHessl%26aufirst%3DD.%26aulast%3DCoffey%26aufirst%3DS.%26aulast%3DHervey%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DYuhas%26aufirst%3DJ.%26aulast%3DHutchinson%26aufirst%3DJ.%26aulast%3DSnape%26aufirst%3DM.%26aulast%3DTranfaglia%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DD.%2BV.%26aulast%3DHagerman%26aufirst%3DR.%26atitle%3DA%2520pilot%2520open%2520label%252C%2520single%2520dose%2520trial%2520of%2520fenobam%2520in%2520adults%2520with%2520fragile%2520X%2520syndrome%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2009%26volume%3D46%26spage%3D266%26epage%3D271%26doi%3D10.1136%2Fjmg.2008.063701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swedberg, M. D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span> <span> </span><span class="NLM_article-title">AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">212</span>â <span class="NLM_lpage">222</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.215137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fjpet.114.215137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24876235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=212-222&author=M.+D.+B.+Swedbergauthor=P.+Raboisson&title=AZD9272+and+AZD2066%3A+selective+and+highly+central+nervous+system+penetrant+mGluR5+antagonists+characterized+by+their+discriminative+effects&doi=10.1124%2Fjpet.114.215137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects</span></div><div class="casAuthors">Swedberg, Michael D. B.; Raboisson, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-222, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metabotropic glutamate receptor 5 (mGluR5) antagonists fenobam, MPEP (2-methyl-6-(phenylethynyl)pyridine), and MTEP (3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine) were previously shown to not cause N-methyl-d-aspartate antagonist-like psychoactive effects in phencyclidine (PCP) drug discrimination studies, but to cause MTEP-like discrimination in rats, suggesting that the psychoactive and psychotomimetic effects reported with fenobam in humans were likely mediated by mGluR5 antagonist mechanisms.  The present study was designed to characterize AZD9272 (3-fluoro-5-(3-(5-fluoropyridin-2-yl)-1,2,4-oxadiazol5-yl)benzonitrile) and AZD2066 [4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine], two mGluR5 antagonists taken to clin. development for analgesia.  AZD9272 was evaluated in several groups of rats trained to discriminate cocaine, PCP, chlordiazepoxide, (-)-Î9-tetrahydrocannabinol [(-)-Î9-THC], or MTEP from no drug.  AZD9272 shared discriminative properties with MTEP only.  The discriminative half-life was 3.23 h for MTEP and 21.93 h for AZD9272 in rats trained to discriminate MTEP from no drug.  Other rats were successfully trained to discriminate AZD9272 from no drug.  Due to the long duration of action of AZD9272, discrimination training was conducted every other day.  AZD9272 caused a dose-dependent increase in AZD9272-appropriate responding.  PCP did not cause AZD9272-appropriate responding, whereas MTEP, fenobam, and the mGluR5 antagonist AZD2066 did.  The discriminative half-life of AZD9272 was 24.3 h in rats trained to discriminate AZD9272 from no drug.  It is concluded that the discriminative effects of AZD9272 and AZD2066 are similar to those of previously investigated mGluR5 antagonists and dissimilar to those of cocaine, PCP, chlordiazepoxide, and (-)-Î9-THC.  The discriminative half-life of AZD9272 is approx. 7-fold longer than for MTEP.  These data support and extend previous findings suggesting that mGluR5 antagonism causes psychoactive effects selectively mediated by mGluR5 mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWgs3LGXT2QbVg90H21EOLACvtfcHk0lhB6oOHYVtd3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7nL&md5=814d1e196e926aaf96fd64e575207922</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.215137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.215137%26sid%3Dliteratum%253Aachs%26aulast%3DSwedberg%26aufirst%3DM.%2BD.%2BB.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DAZD9272%2520and%2520AZD2066%253A%2520selective%2520and%2520highly%2520central%2520nervous%2520system%2520penetrant%2520mGluR5%2520antagonists%2520characterized%2520by%2520their%2520discriminative%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D212%26epage%3D222%26doi%3D10.1124%2Fjpet.114.215137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">StÃ¥hle, L.</span>; <span class="NLM_string-name">Karlsten, R.</span>; <span class="NLM_string-name">Jonzon, B.</span>; <span class="NLM_string-name">Eriksson, B.</span>; <span class="NLM_string-name">KÃ¥gedal, M.</span>; <span class="NLM_string-name">Dominicus, A.</span></span> Safety evaluation of the mGluR5 antagonists AZD9272, AZD2066, and AZD2516 in healthy volunteers and patients with neuropathic pain or major depressive disorders. Abstract PT444. Proceedings of the  <i>14th World Congress on Pain</i>,  Milan, Italy, August 28, 2012; <span class="NLM_publisher-name">International Association for the Study of Pain</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=L.+St%C3%A5hle&author=R.+Karlsten&author=B.+Jonzon&author=B.+Eriksson&author=M.+K%C3%A5gedal&author=A.+Dominicus&title=14th+World+Congress+on+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSt%25C3%25A5hle%26aufirst%3DL.%26jtitle%3D14th%2520World%2520Congress%2520on%2520Pain%26pub%3DInternational%2520Association%2520for%2520the%2520Study%2520of%2520Pain%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vranesic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flor, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhelal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrayaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span> <span> </span><span class="NLM_article-title">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5790</span>â <span class="NLM_lpage">5803</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2014.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.bmc.2014.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25316499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5790-5803&author=I.+Vranesicauthor=S.+Ofnerauthor=P.+J.+Florauthor=G.+Bilbeauthor=R.+Bouhelalauthor=A.+Enzauthor=S.+Desrayaudauthor=K.+McAllisterauthor=R.+Kuhnauthor=F.+Gasparini&title=AFQ056%2Fmavoglurant%2C+a+novel+clinically+effective+mGluR5+antagonist%3A+identification%2C+SAR+and+pharmacological+characterization&doi=10.1016%2Fj.bmc.2014.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization</span></div><div class="casAuthors">Vranesic, Ivo; Ofner, Silvio; Flor, Peter Josef; Bilbe, Graeme; Bouhelal, Rochdi; Enz, Albert; Desrayaud, Sandrine; McAllister, Kevin; Kuhn, Rainer; Gasparini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5790-5803</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the identification, structure-activity relation and the initial pharmacol. characterization of AFQ056/mavoglurant, a structurally novel, non-competitive mGlu5 receptor antagonist.  AFQ056/mavoglurant was identified by chem. derivatization of a lead compd. discovered in a HTS campaign.  In vitro, AFQ056/mavoglurant had an IC50 of 30 nM in a functional assay with human mGluR5 and was selective over the other mGluR subtypes, iGluRs and a panel of 238 CNS relevant receptors, transporter or enzymes.  In vivo, AFQ056/mavoglurant showed an improved pharmacokinetic profile in rat and efficacy in the stress-induced hyperthermia test in mice as compared to the prototypic mGluR5 antagonist MPEP.  The efficacy of AFQ056/mavoglurant in humans has been assessed in L-dopa induced dyskinesia in Parkinson's disease and Fragile X syndrome in proof of principle clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomfnTAWNW_RbVg90H21EOLACvtfcHk0liNDUBsjtNAVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ&md5=a34ab6585a186730f2fbf09d8c97180c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DMcAllister%26aufirst%3DK.%26aulast%3DKuhn%26aufirst%3DR.%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DAFQ056%252Fmavoglurant%252C%2520a%2520novel%2520clinically%2520effective%2520mGluR5%2520antagonist%253A%2520identification%252C%2520SAR%2520and%2520pharmacological%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5790%26epage%3D5803%26doi%3D10.1016%2Fj.bmc.2014.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berry-Kravis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Portes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagerman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquemont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visootsak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rerat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumaras, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaecklin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Raison, F.</span></span> <span> </span><span class="NLM_article-title">Mavoglurant in fragile X syndrome: results of two randomized, double-blind, placebo-controlled trials</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">321ra5</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.aab4109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1126%2Fscitranslmed.aab4109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26764156" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=321ra5&author=E.+Berry-Kravisauthor=V.+Des+Portesauthor=R.+Hagermanauthor=S.+Jacquemontauthor=P.+Charlesauthor=J.+Visootsakauthor=M.+Brinkmanauthor=K.+Reratauthor=B.+Koumarasauthor=L.+Zhuauthor=G.+M.+Barthauthor=T.+Jaecklinauthor=G.+Apostolauthor=F.+von+Raison&title=Mavoglurant+in+fragile+X+syndrome%3A+results+of+two+randomized%2C+double-blind%2C+placebo-controlled+trials&doi=10.1126%2Fscitranslmed.aab4109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aab4109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aab4109%26sid%3Dliteratum%253Aachs%26aulast%3DBerry-Kravis%26aufirst%3DE.%26aulast%3DDes%2BPortes%26aufirst%3DV.%26aulast%3DHagerman%26aufirst%3DR.%26aulast%3DJacquemont%26aufirst%3DS.%26aulast%3DCharles%26aufirst%3DP.%26aulast%3DVisootsak%26aufirst%3DJ.%26aulast%3DBrinkman%26aufirst%3DM.%26aulast%3DRerat%26aufirst%3DK.%26aulast%3DKoumaras%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBarth%26aufirst%3DG.%2BM.%26aulast%3DJaecklin%26aufirst%3DT.%26aulast%3DApostol%26aufirst%3DG.%26aulast%3Dvon%2BRaison%26aufirst%3DF.%26atitle%3DMavoglurant%2520in%2520fragile%2520X%2520syndrome%253A%2520results%2520of%2520two%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trials%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D321ra5%26doi%3D10.1126%2Fscitranslmed.aab4109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trenkwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poewe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dronamraju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Raison, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span> <span> </span><span class="NLM_article-title">Mavoglurant in Parkinsonâs patients with l-Dopa-induced dyskinesias: two randomized phase 2 studies</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1054</span>â <span class="NLM_lpage">1058</span>, <span class="refDoi">Â DOI: 10.1002/mds.26585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.26585" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=1054-1058&author=C.+Trenkwalderauthor=F.+Stocchiauthor=W.+Poeweauthor=N.+Dronamrajuauthor=C.+Kenneyauthor=A.+Shahauthor=F.+von+Raisonauthor=A.+Graf&title=Mavoglurant+in+Parkinson%E2%80%99s+patients+with+l-Dopa-induced+dyskinesias%3A+two+randomized+phase+2+studies&doi=10.1002%2Fmds.26585"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fmds.26585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.26585%26sid%3Dliteratum%253Aachs%26aulast%3DTrenkwalder%26aufirst%3DC.%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DPoewe%26aufirst%3DW.%26aulast%3DDronamraju%26aufirst%3DN.%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DA.%26aulast%3Dvon%2BRaison%26aufirst%3DF.%26aulast%3DGraf%26aufirst%3DA.%26atitle%3DMavoglurant%2520in%2520Parkinson%25E2%2580%2599s%2520patients%2520with%2520l-Dopa-induced%2520dyskinesias%253A%2520two%2520randomized%2520phase%25202%2520studies%26jtitle%3DMov.%2520Disord.%26date%3D2016%26volume%3D31%26spage%3D1054%26epage%3D1058%26doi%3D10.1002%2Fmds.26585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stocchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poewe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolosa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merschhemke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenkwalder, C.</span></span> <span> </span><span class="NLM_article-title">AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1838</span>â <span class="NLM_lpage">1846</span>, <span class="refDoi">Â DOI: 10.1002/mds.25561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.25561" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=1838-1846&author=F.+Stocchiauthor=O.+Rascolauthor=A.+Desteeauthor=N.+Hattoriauthor=R.+A.+Hauserauthor=A.+E.+Langauthor=W.+Poeweauthor=M.+Stacyauthor=E.+Tolosaauthor=H.+Gaoauthor=J.+Nagelauthor=M.+Merschhemkeauthor=A.+Grafauthor=C.+Kenneyauthor=C.+Trenkwalder&title=AFQ056+in+Parkinson+patients+with+levodopa-induced+dyskinesia%3A+13-week%2C+randomized%2C+dose-finding+study&doi=10.1002%2Fmds.25561"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmds.25561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25561%26sid%3Dliteratum%253Aachs%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DDestee%26aufirst%3DA.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DPoewe%26aufirst%3DW.%26aulast%3DStacy%26aufirst%3DM.%26aulast%3DTolosa%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DMerschhemke%26aufirst%3DM.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DTrenkwalder%26aufirst%3DC.%26atitle%3DAFQ056%2520in%2520Parkinson%2520patients%2520with%2520levodopa-induced%2520dyskinesia%253A%252013-week%252C%2520randomized%252C%2520dose-finding%2520study%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D1838%26epage%3D1846%26doi%3D10.1002%2Fmds.25561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gschwind, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittelmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocwieja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woessner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, P.</span></span> <span> </span><span class="NLM_article-title">Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1626</span>â <span class="NLM_lpage">1641</span>, <span class="refDoi">Â DOI: 10.1124/dmd.112.050716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.112.050716" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1626-1641&author=M.+Wallesauthor=T.+Wolfauthor=Y.+Jinauthor=M.+Ritzauauthor=L.+A.+Leutholdauthor=J.+Krauserauthor=H.+P.+Gschwindauthor=D.+Carcacheauthor=M.+Kittelmannauthor=M.+Ocwiejaauthor=M.+Uferauthor=R.+Woessnerauthor=A.+Chakrabortyauthor=P.+Swart&title=Metabolism+and+disposition+of+the+metabotropic+glutamate+receptor+5+antagonist+%28mGluR5%29+mavoglurant+%28AFQ056%29+in+healthy+subjects&doi=10.1124%2Fdmd.112.050716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.050716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.050716%26sid%3Dliteratum%253Aachs%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DRitzau%26aufirst%3DM.%26aulast%3DLeuthold%26aufirst%3DL.%2BA.%26aulast%3DKrauser%26aufirst%3DJ.%26aulast%3DGschwind%26aufirst%3DH.%2BP.%26aulast%3DCarcache%26aufirst%3DD.%26aulast%3DKittelmann%26aufirst%3DM.%26aulast%3DOcwieja%26aufirst%3DM.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DWoessner%26aufirst%3DR.%26aulast%3DChakraborty%26aufirst%3DA.%26aulast%3DSwart%26aufirst%3DP.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25205%2520antagonist%2520%2528mGluR5%2529%2520mavoglurant%2520%2528AFQ056%2529%2520in%2520healthy%2520subjects%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1626%26epage%3D1641%26doi%3D10.1124%2Fdmd.112.050716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolczewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitter-Stoll, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boissin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼ttelmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huwyler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuratli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhauser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¤hler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TÃ¤nnler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, L.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1358</span>â <span class="NLM_lpage">1371</span>, <span class="refDoi">Â DOI: 10.1021/jm501642c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501642c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1358-1371&author=G.+Jaeschkeauthor=S.+Kolczewskiauthor=W.+Spoorenauthor=E.+Vieiraauthor=N.+Bitter-Stollauthor=P.+Boissinauthor=E.+Borroniauthor=B.+B%C3%BCttelmannauthor=S.+Ceccarelliauthor=N.+Clemannauthor=B.+Davidauthor=C.+Funkauthor=W.+Gubaauthor=A.+Harrisonauthor=T.+Hartungauthor=M.+Honerauthor=J.+Huwylerauthor=M.+Kuratliauthor=U.+Niederhauserauthor=A.+P%C3%A4hlerauthor=J.+U.+Petersauthor=A.+Petersenauthor=E.+Prinssenauthor=A.+Ricciauthor=D.+Rueherauthor=M.+Rueherauthor=M.+Schneiderauthor=P.+Spurrauthor=T.+Stollauthor=D.+T%C3%A4nnlerauthor=J.+Wichmannauthor=R.+H.+Porterauthor=J.+G.+Wettsteinauthor=L.+Lindemann&title=Metabotropic+glutamate+receptor+5+negative+allosteric+modulators%3A+discovery+of+2-chloro-4-%5B1-%284-fluorophenyl%29-2%2C5-dimethyl-1H-imidazol-4-ylethynyl%5Dpyridine+%28basimglurant%2C+RO4917523%29%2C+a+promising+novel+medicine+for+psychiatric+diseases&doi=10.1021%2Fjm501642c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501642c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501642c%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DBitter-Stoll%26aufirst%3DN.%26aulast%3DBoissin%26aufirst%3DP.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DCeccarelli%26aufirst%3DS.%26aulast%3DClemann%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DB.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DHarrison%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DKuratli%26aufirst%3DM.%26aulast%3DNiederhauser%26aufirst%3DU.%26aulast%3DP%25C3%25A4hler%26aufirst%3DA.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DRueher%26aufirst%3DD.%26aulast%3DRueher%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSpurr%26aufirst%3DP.%26aulast%3DStoll%26aufirst%3DT.%26aulast%3DT%25C3%25A4nnler%26aufirst%3DD.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DLindemann%26aufirst%3DL.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulators%253A%2520discovery%2520of%25202-chloro-4-%255B1-%25284-fluorophenyl%2529-2%252C5-dimethyl-1H-imidazol-4-ylethynyl%255Dpyridine%2520%2528basimglurant%252C%2520RO4917523%2529%252C%2520a%2520promising%2520novel%2520medicine%2520for%2520psychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1358%26epage%3D1371%26doi%3D10.1021%2Fjm501642c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schadt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallalieu, N. L.</span></span> <span> </span><span class="NLM_article-title">A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [<sup>14</sup>C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [<sup>13</sup>C6]-labeled basimglurant in humans</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">144</span>â <span class="NLM_lpage">153</span>, <span class="refDoi">Â DOI: 10.3109/00498254.2016.1169334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.3109%2F00498254.2016.1169334" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=144-153&author=E.+Gueriniauthor=S.+Schadtauthor=G.+Greigauthor=R.+Haasauthor=C.+Husserauthor=M.+Zellauthor=C.+Funkauthor=T.+Hartungauthor=A.+Glogeauthor=N.+L.+Mallalieu&title=A+double-tracer+technique+to+characterize+absorption%2C+distribution%2C+metabolism+and+excretion+%28ADME%29+of+%5B14C%5D-basimglurant+and+absolute+bioavailability+after+oral+administration+and+concomitant+intravenous+microdose+administration+of+%5B13C6%5D-labeled+basimglurant+in+humans&doi=10.3109%2F00498254.2016.1169334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3109%2F00498254.2016.1169334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2016.1169334%26sid%3Dliteratum%253Aachs%26aulast%3DGuerini%26aufirst%3DE.%26aulast%3DSchadt%26aufirst%3DS.%26aulast%3DGreig%26aufirst%3DG.%26aulast%3DHaas%26aufirst%3DR.%26aulast%3DHusser%26aufirst%3DC.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DGloge%26aufirst%3DA.%26aulast%3DMallalieu%26aufirst%3DN.%2BL.%26atitle%3DA%2520double-tracer%2520technique%2520to%2520characterize%2520absorption%252C%2520distribution%252C%2520metabolism%2520and%2520excretion%2520%2528ADME%2529%2520of%2520%255B14C%255D-basimglurant%2520and%2520absolute%2520bioavailability%2520after%2520oral%2520administration%2520and%2520concomitant%2520intravenous%2520microdose%2520administration%2520of%2520%255B13C6%255D-labeled%2520basimglurant%2520in%2520humans%26jtitle%3DXenobiotica%26date%3D2017%26volume%3D47%26spage%3D144%26epage%3D153%26doi%3D10.3109%2F00498254.2016.1169334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quiroz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deptula, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontoura, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, L.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of basimglurant as adjunctive therapy for major depression: a randomized clinical trial</span>. <i>JAMA Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">675</span>â <span class="NLM_lpage">684</span>, <span class="refDoi">Â DOI: 10.1001/jamapsychiatry.2016.0838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1001%2Fjamapsychiatry.2016.0838" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=675-684&author=J.+A.+Quirozauthor=P.+Tamburriauthor=D.+Deptulaauthor=L.+Bankenauthor=U.+Beyerauthor=M.+Rabbiaauthor=N.+Parkarauthor=P.+Fontouraauthor=L.+Santarelli&title=Efficacy+and+safety+of+basimglurant+as+adjunctive+therapy+for+major+depression%3A+a+randomized+clinical+trial&doi=10.1001%2Fjamapsychiatry.2016.0838"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2016.0838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2016.0838%26sid%3Dliteratum%253Aachs%26aulast%3DQuiroz%26aufirst%3DJ.%2BA.%26aulast%3DTamburri%26aufirst%3DP.%26aulast%3DDeptula%26aufirst%3DD.%26aulast%3DBanken%26aufirst%3DL.%26aulast%3DBeyer%26aufirst%3DU.%26aulast%3DRabbia%26aufirst%3DM.%26aulast%3DParkar%26aufirst%3DN.%26aulast%3DFontoura%26aufirst%3DP.%26aulast%3DSantarelli%26aufirst%3DL.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520basimglurant%2520as%2520adjunctive%2520therapy%2520for%2520major%2520depression%253A%2520a%2520randomized%2520clinical%2520trial%26jtitle%3DJAMA%2520Psychiatry%26date%3D2016%26volume%3D73%26spage%3D675%26epage%3D684%26doi%3D10.1001%2Fjamapsychiatry.2016.0838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuxe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroto-Escuela, D. O.</span></span> <span> </span><span class="NLM_article-title">Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1247</span>â <span class="NLM_lpage">1260</span>, <span class="refDoi">Â DOI: 10.1517/13543784.2015.1074175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1517%2F13543784.2015.1074175" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1247-1260&author=K.+Fuxeauthor=D.+O.+Borroto-Escuela&title=Basimglurant+for+treatment+of+major+depressive+disorder%3A+a+novel+negative+allosteric+modulator+of+metabotropic+glutamate+receptor+5&doi=10.1517%2F13543784.2015.1074175"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1074175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1074175%26sid%3Dliteratum%253Aachs%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DBorroto-Escuela%26aufirst%3DD.%2BO.%26atitle%3DBasimglurant%2520for%2520treatment%2520of%2520major%2520depressive%2520disorder%253A%2520a%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%25205%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D1247%26epage%3D1260%26doi%3D10.1517%2F13543784.2015.1074175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pioli, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keywood, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tison, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, S. M.</span></span> <span> </span><span class="NLM_article-title">The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1074</span>â <span class="NLM_lpage">1079</span>, <span class="refDoi">Â DOI: 10.1002/mds.25920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.25920" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=1074-1079&author=E.+Bezardauthor=E.+Y.+Pioliauthor=Q.+Liauthor=F.+Girardauthor=V.+Mutelauthor=C.+Keywoodauthor=F.+Tisonauthor=O.+Rascolauthor=S.+M.+Poli&title=The+mGluR5+negative+allosteric+modulator+dipraglurant+reduces+dyskinesia+in+the+MPTP+macaque+model&doi=10.1002%2Fmds.25920"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fmds.25920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25920%26sid%3Dliteratum%253Aachs%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DPioli%26aufirst%3DE.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DKeywood%26aufirst%3DC.%26aulast%3DTison%26aufirst%3DF.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26atitle%3DThe%2520mGluR5%2520negative%2520allosteric%2520modulator%2520dipraglurant%2520reduces%2520dyskinesia%2520in%2520the%2520MPTP%2520macaque%2520model%26jtitle%3DMov.%2520Disord.%26date%3D2014%26volume%3D29%26spage%3D1074%26epage%3D1079%26doi%3D10.1002%2Fmds.25920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tison, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keywood, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakefield, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durif, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenkwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span> <span> </span><span class="NLM_article-title">A phase 2A trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in Parkinsonâs disease</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1373</span>â <span class="NLM_lpage">1380</span>, <span class="refDoi">Â DOI: 10.1002/mds.26659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.26659" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=1373-1380&author=F.+Tisonauthor=C.+Keywoodauthor=M.+Wakefieldauthor=F.+Durifauthor=J.+C.+Corvolauthor=K.+Eggertauthor=M.+Lewauthor=S.+Isaacsonauthor=E.+Bezardauthor=S.+M.+Poliauthor=C.+G.+Goetzauthor=C.+Trenkwalderauthor=O.+Rascol&title=A+phase+2A+trial+of+the+novel+mGluR5-negative+allosteric+modulator+dipraglurant+for+levodopa-induced+dyskinesia+in+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.26659"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fmds.26659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.26659%26sid%3Dliteratum%253Aachs%26aulast%3DTison%26aufirst%3DF.%26aulast%3DKeywood%26aufirst%3DC.%26aulast%3DWakefield%26aufirst%3DM.%26aulast%3DDurif%26aufirst%3DF.%26aulast%3DCorvol%26aufirst%3DJ.%2BC.%26aulast%3DEggert%26aufirst%3DK.%26aulast%3DLew%26aufirst%3DM.%26aulast%3DIsaacson%26aufirst%3DS.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DTrenkwalder%26aufirst%3DC.%26aulast%3DRascol%26aufirst%3DO.%26atitle%3DA%2520phase%25202A%2520trial%2520of%2520the%2520novel%2520mGluR5-negative%2520allosteric%2520modulator%2520dipraglurant%2520for%2520levodopa-induced%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2016%26volume%3D31%26spage%3D1373%26epage%3D1380%26doi%3D10.1002%2Fmds.26659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palanisamy, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcek, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappon, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whritenour, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span> <span> </span><span class="NLM_article-title">Drug-induced skin lesions in cynomolgus macaques treated with metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">995</span>â <span class="NLM_lpage">1003</span>, <span class="refDoi">Â DOI: 10.1177/0192623315588114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1177%2F0192623315588114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26059827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Wqsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=995-1003&author=G.+S.+Palanisamyauthor=J.+M.+Marcekauthor=G.+D.+Capponauthor=J.+Whritenourauthor=C.+L.+Shafferauthor=J.+T.+Bradyauthor=C.+Houle&title=Drug-induced+skin+lesions+in+cynomolgus+macaques+treated+with+metabotropic+glutamate+receptor+5+%28mGluR5%29+negative+allosteric+modulators&doi=10.1177%2F0192623315588114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced skin lesions in cynomolgus macaques treated with metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators</span></div><div class="casAuthors">Palanisamy, Gopinath S.; Marcek, John M.; Cappon, Gregg D.; Whritenour, Jessica; Shaffer, Christopher L.; Brady, Joseph T.; Houle, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-1003</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Three orally administered metabotropic glutamate receptor 5 (mGluR5) neg. allosteric modulators caused skin lesions consistent with delayed type-IV hypersensitivity in cynomolgus macaques in 2- and 12-wk toxicity studies.  Several monkeys developed macroscopic skin lesions in multiple locations after 8 to 9 days of dosing; the most prominent effects involved the genital region of males and generalized erythema occurred in both sexes.  Microscopic lesions occurred in both clin. affected and unaffected areas and were characterized by lymphocytic interface inflammation, subepidermal bullae, and individual keratinocyte vacuolation/necrosis.  In the 12-wk study, clin. effects in 2 animals resolved with continued dosing, whereas in others the inflammatory process progressed with 1 female exhibiting systemic lymphocytic inflammation in multiple tissues.  The inflammatory infiltrate consisted of CD3 and CD4 pos. T lymphocytes with minimal CD68 pos. macrophages and only rare CD8 pos. T lymphocytes.  A subset of animals given a dosing holiday was subsequently rechallenged with similar lesions developing but with a more rapid clin. onset.  These skin lesions were consistent with type-IV delayed hypersensitivity with some features comparable to bullous drug eruptions in humans.  A relationship between these findings and the intended mode of action for these compds. could not be ruled out, given the occurrence across different chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS0b8GvuCkpLVg90H21EOLACvtfcHk0ljILTquyyqD8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Wqsbo%253D&md5=99ad96bc755c182aca73a1d14dc1d614</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F0192623315588114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623315588114%26sid%3Dliteratum%253Aachs%26aulast%3DPalanisamy%26aufirst%3DG.%2BS.%26aulast%3DMarcek%26aufirst%3DJ.%2BM.%26aulast%3DCappon%26aufirst%3DG.%2BD.%26aulast%3DWhritenour%26aufirst%3DJ.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DBrady%26aufirst%3DJ.%2BT.%26aulast%3DHoule%26aufirst%3DC.%26atitle%3DDrug-induced%2520skin%2520lesions%2520in%2520cynomolgus%2520macaques%2520treated%2520with%2520metabotropic%2520glutamate%2520receptor%25205%2520%2528mGluR5%2529%2520negative%2520allosteric%2520modulators%26jtitle%3DToxicol.%2520Pathol.%26date%3D2015%26volume%3D43%26spage%3D995%26epage%3D1003%26doi%3D10.1177%2F0192623315588114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GrÃ©goire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, T.</span></span> <span> </span><span class="NLM_article-title">Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">216</span>â <span class="NLM_lpage">231</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2013.05.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.neuropharm.2013.05.028" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=216-231&author=N.+Morinauthor=M.+Morissetteauthor=L.+Gr%C3%A9goireauthor=B.+Gomez-Mancillaauthor=F.+Gaspariniauthor=T.+Di+Paolo&title=Chronic+treatment+with+MPEP%2C+an+mGlu5+receptor+antagonist%2C+normalizes+basal+ganglia+glutamate+neurotransmission+in+L-DOPA-treated+parkinsonian+monkeys&doi=10.1016%2Fj.neuropharm.2013.05.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.05.028%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DN.%26aulast%3DMorissette%26aufirst%3DM.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DL.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26atitle%3DChronic%2520treatment%2520with%2520MPEP%252C%2520an%2520mGlu5%2520receptor%2520antagonist%252C%2520normalizes%2520basal%2520ganglia%2520glutamate%2520neurotransmission%2520in%2520L-DOPA-treated%2520parkinsonian%2520monkeys%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D73%26spage%3D216%26epage%3D231%26doi%3D10.1016%2Fj.neuropharm.2013.05.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masilamoni, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogenpohl, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delevich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votaw, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">2057</span>â <span class="NLM_lpage">2073</span>, <span class="refDoi">Â DOI: 10.1093/brain/awr137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1093%2Fbrain%2Fawr137" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=2057-2073&author=G.+J.+Masilamoniauthor=J.+W.+Bogenpohlauthor=D.+Alagilleauthor=K.+Delevichauthor=G.+Tamagnanauthor=J.+R.+Votawauthor=T.+Wichmannauthor=Y.+Smith&title=Metabotropic+glutamate+receptor+5+antagonist+protects+dopaminergic+and+noradrenergic+neurons+from+degeneration+in+MPTP-treated+monkeys&doi=10.1093%2Fbrain%2Fawr137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawr137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawr137%26sid%3Dliteratum%253Aachs%26aulast%3DMasilamoni%26aufirst%3DG.%2BJ.%26aulast%3DBogenpohl%26aufirst%3DJ.%2BW.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DDelevich%26aufirst%3DK.%26aulast%3DTamagnan%26aufirst%3DG.%26aulast%3DVotaw%26aufirst%3DJ.%2BR.%26aulast%3DWichmann%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DY.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520antagonist%2520protects%2520dopaminergic%2520and%2520noradrenergic%2520neurons%2520from%2520degeneration%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D2057%26epage%3D2073%26doi%3D10.1093%2Fbrain%2Fawr137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span> See page 862 of:<span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenard, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunetz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galatsis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reese, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleska, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1<i>H</i>-pyrazolo-[3,4-<i>b</i>]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">861</span>â <span class="NLM_lpage">877</span>, <span class="refDoi">Â DOI: 10.1021/jm401622k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401622k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtFansw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=861-877&author=L.+Zhangauthor=G.+Balanauthor=G.+Barreiroauthor=B.+P.+Boscoeauthor=L.+K.+Chenardauthor=J.+Cianfrognaauthor=M.+M.+Claffeyauthor=L.+Chenauthor=K.+J.+Coffmanauthor=S.+E.+Drozdaauthor=J.+R.+Dunetzauthor=K.+R.+Fonsecaauthor=P.+Galatsisauthor=S.+Grimwoodauthor=J.+T.+Lazzaroauthor=J.+Y.+Mancusoauthor=E.+L.+Millerauthor=M.+R.+Reeseauthor=B.+N.+Rogersauthor=I.+Sakuradaauthor=M.+Skaddanauthor=D.+L.+Smithauthor=A.+F.+Stepanauthor=P.+Trapaauthor=J.+B.+Tuttleauthor=P.+R.+Verhoestauthor=D.+P.+Walkerauthor=A.+S.+Wrightauthor=M.+M.+Zaleskaauthor=K.+Zasadnyauthor=C.+L.+Shaffer&title=Discovery+and+preclinical+characterization+of+1-methyl-3-%284-methylpyridin-3-yl%29-6-%28pyridin-2-ylmethoxy%29-1H-pyrazolo-%5B3%2C4-b%5Dpyrazine+%28PF470%29%3A+a+highly+potent%2C+selective%2C+and+efficacious+metabotropic+glutamate+receptor+5+%28mGluR5%29+negative+allosteric+modulator&doi=10.1021%2Fjm401622k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 1-Methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]-pyrazine (PF470): A Highly Potent, Selective, and Efficacious Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator</span></div><div class="casAuthors">Zhang, Lei; Balan, Gayatri; Barreiro, Gabriela; Boscoe, Brian P.; Chenard, Lois K.; Cianfrogna, Julie; Claffey, Michelle M.; Chen, Laigao; Coffman, Karen J.; Drozda, Susan E.; Dunetz, Joshua R.; Fonseca, Kari R.; Galatsis, Paul; Grimwood, Sarah; Lazzaro, John T.; Mancuso, Jessica Y.; Miller, Emily L.; Reese, Matthew R.; Rogers, Bruce N.; Sakurada, Isao; Skaddan, Marc; Smith, Deborah L.; Stepan, Antonia F.; Trapa, Patrick; Tuttle, Jamison B.; Verhoest, Patrick R.; Walker, Daniel P.; Wright, Ann S.; Zaleska, Margaret M.; Zasadny, Kenneth; Shaffer, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">861-877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of pyrazolopyrazines is herein disclosed as mGluR5 neg. allosteric modulators (NAMs).  Starting from a high-throughput screen (HTS) hit (1), a systematic structure-activity relationship (SAR) study was conducted with a specific focus on balancing pharmacol. potency with physicochem. and pharmacokinetic (PK) properties.  This effort led to the discovery of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]-pyrazine (PF470, 14) as a highly potent, selective, and orally bioavailable mGluR5 NAM.  Compd. 14 demonstrated robust efficacy in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-rendered Parkinsonian nonhuman primate model of l-DOPA-induced dyskinesia (PD-LID).  However, the progression of 14 to the clinic was terminated because of a potentially mechanism-mediated finding consistent with a delayed-type immune-mediated type IV hypersensitivity in a 90-day NHP regulatory toxicol. study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Qvow6xYg4LVg90H21EOLACvtfcHk0liRM_prNFctag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtFansw%253D%253D&md5=d0185d833cbc1f82e287df0ff8dcb323</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm401622k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401622k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DChenard%26aufirst%3DL.%2BK.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DMiller%26aufirst%3DE.%2BL.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSakurada%26aufirst%3DI.%26aulast%3DSkaddan%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25201-methyl-3-%25284-methylpyridin-3-yl%2529-6-%2528pyridin-2-ylmethoxy%2529-1H-pyrazolo-%255B3%252C4-b%255Dpyrazine%2520%2528PF470%2529%253A%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520metabotropic%2520glutamate%2520receptor%25205%2520%2528mGluR5%2529%2520negative%2520allosteric%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D861%26epage%3D877%26doi%3D10.1021%2Fjm401622k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of VU0431316: a negative allosteric modulator of mGlu<sub>5</sub> with activity in a mouse model of anxiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3307</span>â <span class="NLM_lpage">3314</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.bmcl.2014.06.003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3307-3314&author=B.+S.+Batesauthor=A.+L.+Rodriguezauthor=A.+S.+Feltsauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=K.+P.+Lawsonauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+VU0431316%3A+a+negative+allosteric+modulator+of+mGlu5+with+activity+in+a+mouse+model+of+anxiety&doi=10.1016%2Fj.bmcl.2014.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DLawson%26aufirst%3DK.%2BP.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520VU0431316%253A%2520a%2520negative%2520allosteric%2520modulator%2520of%2520mGlu5%2520with%2520activity%2520in%2520a%2520mouse%2520model%2520of%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3307%26epage%3D3314%26doi%3D10.1016%2Fj.bmcl.2014.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of VU0409106: a negative allosteric modulator of mGlu<sub>5</sub> with activity in a mouse model of anxiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5779</span>â <span class="NLM_lpage">5785</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.bmcl.2013.09.001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5779-5785&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=J.+T.+Mankaauthor=B.+S.+Batesauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+VU0409106%3A+a+negative+allosteric+modulator+of+mGlu5+with+activity+in+a+mouse+model+of+anxiety&doi=10.1016%2Fj.bmcl.2013.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520VU0409106%253A%2520a%2520negative%2520allosteric%2520modulator%2520of%2520mGlu5%2520with%2520activity%2520in%2520a%2520mouse%2520model%2520of%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5779%26epage%3D5785%26doi%3D10.1016%2Fj.bmcl.2013.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">Evaluating the disposition of a mixed aldehyde oxidase/cytochrome P450 substrate in rats with attenuated P450 activity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1296</span>â <span class="NLM_lpage">1303</span>, <span class="refDoi">Â DOI: 10.1124/dmd.115.068338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.115.068338" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1296-1303&author=R.+D.+Crouchauthor=R.+D.+Morrisonauthor=F.+W.+Byersauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=Evaluating+the+disposition+of+a+mixed+aldehyde+oxidase%2Fcytochrome+P450+substrate+in+rats+with+attenuated+P450+activity&doi=10.1124%2Fdmd.115.068338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068338%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DEvaluating%2520the%2520disposition%2520of%2520a%2520mixed%2520aldehyde%2520oxidase%252Fcytochrome%2520P450%2520substrate%2520in%2520rats%2520with%2520attenuated%2520P450%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D1296%26epage%3D1303%26doi%3D10.1124%2Fdmd.115.068338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantawy, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">755</span>â <span class="NLM_lpage">765</span>, <span class="refDoi">Â DOI: 10.1038/npp.2014.245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fnpp.2014.245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25241804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWntbjP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=755-765&author=J.+M.+Rookauthor=M.+N.+Tantawyauthor=M.+S.+Ansariauthor=A.+S.+Feltsauthor=S.+R.+Staufferauthor=K.+A.+Emmitteauthor=R.+M.+Kesslerauthor=C.+M.+Niswenderauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Relationship+between+in+vivo+receptor+occupancy+and+efficacy+of+metabotropic+glutamate+receptor+subtype+5+allosteric+modulators+with+different+in+vitro+binding+profiles&doi=10.1038%2Fnpp.2014.245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles</span></div><div class="casAuthors">Rook, Jerri M.; Tantawy, Mohammed N.; Ansari, Mohammad S.; Felts, Andrew S.; Stauffer, Shaun R.; Emmitte, Kyle A.; Kessler, Robert M.; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">755-765</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu5) have exciting potential as therapeutic agents for multiple brain disorders.  Translational studies with mGlu5 modulators have relied on mGlu5 allosteric site positron emission tomog. (PET) radioligands to assess receptor occupancy in the brain.  However, recent structural and modeling studies suggest that closely related mGlu5 allosteric modulators can bind to overlapping but not identical sites, which could complicate interpretation of in vivo occupancy data, even when PET ligands and drug leads are developed from the same chem. scaffold.  We now report that systemic administration of the novel mGlu5 pos. allosteric modulator VU0092273 displaced the structurally related mGlu5 PET ligand, [18F]FPEB, with measures of in vivo occupancy that closely aligned with its in vivo efficacy.  In contrast, a close analog of VU0092273 and [18F]FPEB, VU0360172, provided robust efficacy in rodent models in the absence of detectable occupancy.  Furthermore, a structurally unrelated mGlu5 neg. allosteric modulator, VU0409106, displayed measures of in vivo occupancy that correlated well with behavioral effects, despite the fact that VU0409106 is structurally unrelated to [18F]FPEB.  Interestingly, all three compds. inhibit radioligand binding to the prototypical MPEP/FPEB allosteric site in vitro.  However, VU0092273 and VU0409106 bind to this site in a fully competitive manner, whereas the interaction of VU0360172 is noncompetitive.  Thus, while close structural similarity between PET ligands and drug leads does not circumvent issues assocd. with differential binding to a given target, detailed mol. pharmacol. anal. accurately predicts utility of ligand pairs for in vivo occupancy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo519UTnt7mFLVg90H21EOLACvtfcHk0liMhSRBM3-EgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWntbjP&md5=1b83f3d15347d176c2504b618fc9af25</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.245%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DRelationship%2520between%2520in%2520vivo%2520receptor%2520occupancy%2520and%2520efficacy%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520allosteric%2520modulators%2520with%2520different%2520in%2520vitro%2520binding%2520profiles%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26volume%3D40%26spage%3D755%26epage%3D765%26doi%3D10.1038%2Fnpp.2014.245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santomango, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Ponce, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corlew, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1834</span>â <span class="NLM_lpage">1845</span>, <span class="refDoi">Â DOI: 10.1124/dmd.112.046136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.112.046136" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1834-1845&author=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=T.+S.+Santomangoauthor=T.+M.+Bridgesauthor=D.+Stecauthor=K.+A.+Brewerauthor=R.+Sanchez-Ponceauthor=M.+M.+Corlewauthor=R.+Rushauthor=A.+S.+Feltsauthor=J.+Mankaauthor=B.+S.+Batesauthor=D.+F.+Venableauthor=A.+L.+Rodriguezauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=The+role+of+aldehyde+oxidase+and+xanthine+oxidase+in+the+biotransformation+of+a+novel+negative+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5&doi=10.1124%2Fdmd.112.046136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046136%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DSantomango%26aufirst%3DT.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DStec%26aufirst%3DD.%26aulast%3DBrewer%26aufirst%3DK.%2BA.%26aulast%3DSanchez-Ponce%26aufirst%3DR.%26aulast%3DCorlew%26aufirst%3DM.%2BM.%26aulast%3DRush%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DManka%26aufirst%3DJ.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520role%2520of%2520aldehyde%2520oxidase%2520and%2520xanthine%2520oxidase%2520in%2520the%2520biotransformation%2520of%2520a%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1834%26epage%3D1845%26doi%3D10.1124%2Fdmd.112.046136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunklee, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahmi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, D.</span></span> <span> </span><span class="NLM_article-title">Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">206</span>â <span class="NLM_lpage">214</span>, <span class="refDoi">Â DOI: 10.1016/j.vascn.2008.05.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.vascn.2008.05.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=18634893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGls7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=206-214&author=M.+Zientekauthor=H.+Millerauthor=D.+Smithauthor=M.+B.+Dunkleeauthor=L.+Heinleauthor=A.+Thurstonauthor=C.+Leeauthor=R.+Hylandauthor=O.+Fahmiauthor=D.+Burdette&title=Development+of+an+in+vitro+drug-drug+interaction+assay+to+simultaneously+monitor+five+cytochrome+P450+isoforms+and+performance+assessment+using+drug+library+compounds&doi=10.1016%2Fj.vascn.2008.05.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds</span></div><div class="casAuthors">Zientek, Michael; Miller, Howard; Smith, Danielle; Dunklee, Mary Beth; Heinle, Lance; Thurston, Archie; Lee, Caroline; Hyland, Ruth; Fahmi, Odette; Burdette, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-214</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibition of cytochrome P 450 (CYP) is a principal mechanism for metab.-based drug-drug interactions (DDIs).  This article describes a robust, high-throughput CYP-mediated DDI assay using a cocktail of 5 clin. relevant probe substrates with quantification by liq. chromatog./tandem mass spectrometry (LC/MS-MS).  The assay consisted of human liver microsomes and a cocktail of probe substrates metabolized by the five major CYP isoforms (tacrine for CYP1A2, diclofenac for CYP2C9, (S)-mephenytoin for CYP2C19, dextromethorphan for CYP2D6 and midazolam for CYP3A4).  The assay was fully automated in both 96- and 384-well formats.  A series of expts. were conducted to define the optimal kinetic parameters and solvent concns., as well as, to assess potential reactant and product interference.  The assay was validated against known CYP inhibitors (miconazole, sulfaphenazole, ticlopidine, quinidine, ketoconazole, itraconazole, fluoxetine) and evaluated in a screening environment by testing 9494 compds.  Our findings show that this assay has application in early stage drug discovery to economically, reliably and accurately assess compds. for DDIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr26mBaPKv-bLVg90H21EOLACvtfcHk0lhXt0rLONhVDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGls7rP&md5=f8d2b450d3821b859d0830a96b968ec2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2008.05.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2008.05.131%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DDunklee%26aufirst%3DM.%2BB.%26aulast%3DHeinle%26aufirst%3DL.%26aulast%3DThurston%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DFahmi%26aufirst%3DO.%26aulast%3DBurdette%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520an%2520in%2520vitro%2520drug-drug%2520interaction%2520assay%2520to%2520simultaneously%2520monitor%2520five%2520cytochrome%2520P450%2520isoforms%2520and%2520performance%2520assessment%2520using%2520drug%2520library%2520compounds%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2008%26volume%3D58%26spage%3D206%26epage%3D214%26doi%3D10.1016%2Fj.vascn.2008.05.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, T.</span></span> <span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1093</span>â <span class="NLM_lpage">1095</span>, <span class="refDoi">Â DOI: 10.1023/A:1018943613122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans&doi=10.1023%2FA%3A1018943613122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2ebvVr9-nbgKvbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095%26doi%3D10.1023%2FA%3A1018943613122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2</span>â <span class="NLM_lpage">12</span>, <span class="refDoi">Â DOI: 10.1021/jm301297f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery&doi=10.1021%2Fjm301297f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lgMa-qF9q8mew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2%26epage%3D12%26doi%3D10.1021%2Fjm301297f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Drug-metabolizing ability of molybdenum hydroxylases</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">83</span>â <span class="NLM_lpage">98</span>, <span class="refDoi">Â DOI: 10.2133/dmpk.21.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2133%2Fdmpk.21.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16702728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=83-98&author=S.+Kitamuraauthor=K.+Sugiharaauthor=S.+Ohta&title=Drug-metabolizing+ability+of+molybdenum+hydroxylases&doi=10.2133%2Fdmpk.21.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-metabolizing ability of molybdenum hydroxylases</span></div><div class="casAuthors">Kitamura, Shigeyuki; Sugihara, Kazumi; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-98</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  Molybdenum hydroxylases, which include aldehyde oxidase and xanthine oxidoreductase, are involved in the metab. of some medicines in humans.  They exhibit oxidase activity toward various heterocyclic compds. and aldehydes.  The liver cytosol of various mammals also exhibits a significant reductase activity toward nitro, sulfoxide, N-oxide, and other moieties, catalyzed by aldehyde oxidase.  There is considerable variability of aldehyde oxidase activity in liver cytosol of mammals: humans show the highest activity, rats and mice show low activity, and dogs have no detectable activity.  On the other hand, xanthine oxidoreductase activity is present widely among species.  Interindividual variation of aldehyde oxidase activity is present in humans.  Drug-drug interactions assocd. with aldehyde oxidase and xanthine oxidoreductase are of potential clin. significance.  The drug-metabolizing ability of molybdenum hydroxylases and variation of the activity are described here by the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIDBvL67GcbVg90H21EOLACvtfcHk0lgMa-qF9q8mew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D&md5=0698f203efaf5b2cf20f373af3cd4f28</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.83%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DDrug-metabolizing%2520ability%2520of%2520molybdenum%2520hydroxylases%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D83%26epage%3D98%26doi%3D10.2133%2Fdmpk.21.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noetzel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Days, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavreysen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">120</span>â <span class="NLM_lpage">133</span>, <span class="refDoi">Â DOI: 10.1124/mol.111.075184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.111.075184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22021324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSkt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=120-133&author=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=H.+Choauthor=E.+Daysauthor=Y.+Zhouauthor=A.+L.+Rodriguezauthor=H.+Lavreysenauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+W.+Lindsleyauthor=C.+D.+Weaverauthor=P.+J.+Conn&title=Functional+impact+of+allosteric+agonist+activity+of+selective+positive+allosteric+modulators+of+metabotropic+glutamate+receptor+subtype+5+in+regulating+central+nervous+system+function&doi=10.1124%2Fmol.111.075184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function</span></div><div class="casAuthors">Noetzel, Meredith J.; Rook, Jerri M.; Vinson, Paige N.; Cho, Hyekyung P.; Days, Emily; Zhou, Y.; Rodriguez, Alice L.; Lavreysen, Hilde; Stauffer, Shaun R.; Niswender, Colleen M.; Xiang, Zixiu; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Weaver, C. David; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-133</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) have emerged as an exciting new approach for the treatment of schizophrenia and other central nervous system (CNS) disorders.  Of interest, some mGlu5 PAMs act as pure PAMs, only potentiating mGlu5 responses to glutamate whereas others [allosteric agonists coupled with PAM activity (ago-PAMs)] potentiate responses to glutamate and have intrinsic allosteric agonist activity in mGlu5-expressing cell lines.  All mGlu5 PAMs previously shown to have efficacy in animal models act as ago-PAMs in cell lines, raising the possibility that allosteric agonist activity is crit. for in vivo efficacy.  We have now optimized novel mGlu5 pure PAMs that are devoid of detectable agonist activity and structurally related mGlu5 ago-PAMs that activate mGlu5 alone in cell lines.  Studies of mGlu5 PAMs in cell lines revealed that ago-PAM activity is dependent on levels of mGlu5 receptor expression in human embryonic kidney 293 cells, whereas PAM potency is relatively unaffected by levels of receptor expression.  Furthermore, ago-PAMs have no agonist activity in the native systems tested, including cortical astrocytes and subthalamic nucleus neurons and in measures of long-term depression at the hippocampal Schaffer collateral-CA1 synapse.  Finally, studies with pure PAMs and ago-PAMs chem. optimized to provide comparable CNS exposure revealed that both classes of mGlu5 PAMs have similar efficacy in a rodent model predictive of antipsychotic activity.  These data suggest that the level of receptor expression influences the ability of mGlu5 PAMs to act as allosteric agonists in vitro and that ago-PAM activity obsd. in cell-based assays may not be important for in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgBNVLHUParVg90H21EOLACvtfcHk0ljtnI-iE-KT-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSkt7s%253D&md5=a3b948ee64cd97a9046ab91004549ca1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.075184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.075184%26sid%3Dliteratum%253Aachs%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DFunctional%2520impact%2520of%2520allosteric%2520agonist%2520activity%2520of%2520selective%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520in%2520regulating%2520central%2520nervous%2520system%2520function%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D120%26epage%3D133%26doi%3D10.1124%2Fmol.111.075184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. D.</span></span> <span> </span><span class="NLM_article-title">A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1213</span>â <span class="NLM_lpage">1224</span>, <span class="refDoi">Â DOI: 10.1124/mol.107.041053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.107.041053" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1213-1224&author=C.+M.+Niswenderauthor=K.+A.+Johnsonauthor=Q.+Luoauthor=J.+E.+Ayalaauthor=C.+Kimauthor=P.+J.+Connauthor=C.+D.+Weaver&title=A+novel+assay+of+Gi%2Fo-linked+G+protein-coupled+receptor+coupling+to+potassium+channels+provides+new+insights+into+the+pharmacology+of+the+group+III+metabotropic+glutamate+receptors&doi=10.1124%2Fmol.107.041053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.041053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.041053%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520assay%2520of%2520Gi%252Fo-linked%2520G%2520protein-coupled%2520receptor%2520coupling%2520to%2520potassium%2520channels%2520provides%2520new%2520insights%2520into%2520the%2520pharmacology%2520of%2520the%2520group%2520III%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1213%26epage%3D1224%26doi%3D10.1124%2Fmol.107.041053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span> <i>LeadProfilingScreen</i> (catalog #68); <span class="NLM_publisher-name">Eurofins
Panlabs, Inc.</span>: <span class="NLM_publisher-loc">St. Charles, MO</span>. <a href="https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0aCrd3Mu4RA%3d&amp;path=128&amp;leaf=128&amp;track=Add%2f2%2fPackages%2fMolecular+Packages" class="extLink">https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0aCrd3Mu4RA%3d&path=128&leaf=128&track=Add%2f2%2fPackages%2fMolecular+Packages</a> (accessed April 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LeadProfilingScreen+%28catalog+%2368%29%3B+Eurofins%0APanlabs%2C+Inc.%3A+St.+Charles%2C+MO.+https%3A%2F%2Fwww.eurofinspanlabs.com%2FCatalog%2FProducts%2FProductDetails.aspx%3FprodId%3D0aCrd3Mu4RA%253d%26path%3D128%26leaf%3D128%26track%3DAdd%252f2%252fPackages%252fMolecular%2BPackages+%28accessed+April+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DLeadProfilingScreen%26pub%3DEurofins%250APanlabs%252C%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zahniser, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorkin, A.</span></span> <span> </span><span class="NLM_article-title">Rapid regulation of the dopamine transporter: role in stimulant addiction?</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">S1</span>),  <span class="NLM_fpage">80</span>â <span class="NLM_lpage">91</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2004.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.neuropharm.2004.07.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=80-91&issue=S1&author=N.+R.+Zahniserauthor=A.+Sorkin&title=Rapid+regulation+of+the+dopamine+transporter%3A+role+in+stimulant+addiction%3F&doi=10.1016%2Fj.neuropharm.2004.07.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DZahniser%26aufirst%3DN.%2BR.%26aulast%3DSorkin%26aufirst%3DA.%26atitle%3DRapid%2520regulation%2520of%2520the%2520dopamine%2520transporter%253A%2520role%2520in%2520stimulant%2520addiction%253F%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26issue%3DS1%26spage%3D80%26epage%3D91%26doi%3D10.1016%2Fj.neuropharm.2004.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span> <i>Dopamine
uptake</i> (catalog #316010); <span class="NLM_publisher-name">Eurofins
Panlabs, Inc.</span>: <span class="NLM_publisher-loc">St. Charles, MO</span>. <a href="https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0WVKOLUf1Bw%3d" class="extLink">https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0WVKOLUf1Bw%3d</a> (accessed April 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Dopamine%0Auptake+%28catalog+%23316010%29%3B+Eurofins%0APanlabs%2C+Inc.%3A+St.+Charles%2C+MO.+https%3A%2F%2Fwww.eurofinspanlabs.com%2FCatalog%2FProducts%2FProductDetails.aspx%3FprodId%3D0WVKOLUf1Bw%253d+%28accessed+April+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DDopamine%250Auptake%26pub%3DEurofins%250APanlabs%252C%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roppe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiders, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span> <span> </span><span class="NLM_article-title">[<sup>3</sup>H]-Methoxymethyl-MTEP and [<sup>3</sup>H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">351</span>â <span class="NLM_lpage">354</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(02)00997-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2FS0960-894X%2802%2900997-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=351-354&author=N.+D.+P.+Cosfordauthor=J.+Roppeauthor=L.+Tehraniauthor=E.+J.+Schweigerauthor=T.+J.+Seidersauthor=A.+Chaudaryauthor=S.+Raoauthor=M.+A.+Varney&title=%5B3H%5D-Methoxymethyl-MTEP+and+%5B3H%5D-methoxy-PEPy%3A+potent+and+selective+radioligands+for+the+metabotropic+glutamate+subtype+5+%28mGlu5%29+receptor&doi=10.1016%2FS0960-894X%2802%2900997-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900997-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900997-6%26sid%3Dliteratum%253Aachs%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DSchweiger%26aufirst%3DE.%2BJ.%26aulast%3DSeiders%26aufirst%3DT.%2BJ.%26aulast%3DChaudary%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26atitle%3D%255B3H%255D-Methoxymethyl-MTEP%2520and%2520%255B3H%255D-methoxy-PEPy%253A%2520potent%2520and%2520selective%2520radioligands%2520for%2520the%2520metabotropic%2520glutamate%2520subtype%25205%2520%2528mGlu5%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D351%26epage%3D354%26doi%3D10.1016%2FS0960-894X%2802%2900997-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekaran, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1793</span>â <span class="NLM_lpage">1802</span>, <span class="refDoi">Â DOI: 10.1124/mol.105.016139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.105.016139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16155210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktr7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1793-1802&author=A.+L.+Rodriguezauthor=Y.+Nongauthor=N.+K.+Sekaranauthor=D.+Alagilleauthor=G.+D.+Tamagnanauthor=P.+J.+Conn&title=A+close+structural+analog+of+2-methyl-6-%28phenylethynyl%29-pyridine+acts+as+a+neutral+allosteric+site+ligand+on+metabotropic+glutamate+receptor+subtype+5+and+blocks+the+effects+of+multiple+allosteric+modulators&doi=10.1124%2Fmol.105.016139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A close structural analog of 2-methyl-6-(phenylethynyl)pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators</span></div><div class="casAuthors">Rodriguez, Alice L.; Nong, Yi; Sekaran, Nishant K.; Alagille, David; Tamagnan, Gilles D.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1793-1802</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metabotropic glutamate receptor subtype 5 (mGlu5) activates calcium mobilization via binding of glutamate, the major excitatory neurotransmitter in the central nervous system.  Allosteric modulation of the receptor has recently emerged as a promising alternative method of regulation to traditional regulation through orthosteric ligands.  We now report three novel compds. that bind to the allosteric 2-methyl-6-(phenylethynyl)-pyridine (MPEP) site on mGlu5 but have only partial inhibition or no functional effects on the mGlu5 response.  Two of these compds., 2-(2-(3-methoxyphenyl)ethynyl)-5-methylpyridine (M-5MPEP) and 2-(2-(5-bromopyridin-3-yl)ethynyl)-5-methylpyridine (Br-5MPEPy), act as partial antagonists of mGlu5 in that they only partially inhibit the response of this receptor to glutamate.  The third compd., 5-methyl-6-(phenylethynyl)-pyridine (5MPEP), acts as a neutral allosteric site ligand that binds to the MPEP site and has no effects alone.  However, 5MPEP blocks the effects of both the allosteric antagonist MPEP and potentiators 3,3'-difluorobenzaldazine and 3-cyanol-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB).  This compd. also blocks depolarization effects of both MPEP and CDPPB in neurons in the subthalamic nucleus.  These novel compds. provide valuable new insight into the pharmacol. of allosteric sites on G protein-coupled receptors and provide valuable new tools for detg. the effects of allosteric site ligands in native systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19VhRAjS5FLVg90H21EOLACvtfcHk0lib6enjMLAPtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktr7M&md5=c89d04464e403e6c0b044f09f94fec89</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.016139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.016139%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DNong%26aufirst%3DY.%26aulast%3DSekaran%26aufirst%3DN.%2BK.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520close%2520structural%2520analog%2520of%25202-methyl-6-%2528phenylethynyl%2529-pyridine%2520acts%2520as%2520a%2520neutral%2520allosteric%2520site%2520ligand%2520on%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520and%2520blocks%2520the%2520effects%2520of%2520multiple%2520allosteric%2520modulators%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1793%26epage%3D1802%26doi%3D10.1124%2Fmol.105.016139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rager, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardos, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the MDR-MDCK cell line as a permeability screen for the bloodâbrain barrier</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">349</span>â <span class="NLM_lpage">359</span>, <span class="refDoi">Â DOI: 10.1016/j.ijpharm.2004.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.ijpharm.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=15620875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=349-359&author=Q.+Wangauthor=J.+D.+Ragerauthor=K.+Weinsteinauthor=P.+S.+Kardosauthor=G.+L.+Dobsonauthor=J.+Liauthor=I.+J.+Hidalgo&title=Evaluation+of+the+MDR-MDCK+cell+line+as+a+permeability+screen+for+the+blood%E2%80%93brain+barrier&doi=10.1016%2Fj.ijpharm.2004.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Wang, Qing; Rager, Joseph D.; Weinstein, Kathryn; Kardos, Paula S.; Dobson, Glenn L.; Li, Jibin; Hidalgo, Ismael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objectives of this study were to (1) characterize MDR-MDCK monolayers as an in vitro model to predict brain uptake potential; (2) examine the ability of MDR-MDCK monolayers to identify the brain uptake potential of compds. that interact with P-glycoprotein (P-gp).  The study measured the bi-directional transport of 28 compds. across MDR-MDCK monolayers.  The brain uptake of a subset of the compds. was detd. in the rat brain perfusion model.  Drug concns. were analyzed by LC-MS-MS.  CNS-pos. drugs exhibited absorptive permeability coeffs. (Papp, A-B) values ranging from 3.4 Ã 10-6 to 20.2 Ã 10-6 cm/s; whereas CNS-neg. drugs showed Papp (A-B) ranging from 0.03 Ã 10-6 to 0.83 Ã 10-6 cm/s.  Inhibition of P-gp by cyclosporin A (CsA) significantly reduced secretory flux of compds. known to be P-pg substrates, but only enhanced the absorptive flux of compds. with high efflux ratio (>100).  In vitro results were confirmed by brain perfusion studies on selected compds.  MDR-MDCK monolayers can be used to classify compds. into CNS-pos. or CNS-neg. based on the permeability coeffs. (Papp, A-B).  Under the authors' exptl. conditions, compds. with Papp (A-B) >3 Ã 10-6 cm/s have high brain uptake potential; compds. with Papp (A-B) < 1 Ã 10-6 cm/s are unable to penetrate the blood-brain barrier (BBB); the brain uptake of compds. with Papp (A-B) < 1 Ã 10-6 cm/s and a P-gp-mediated efflux ratio of >100 may be enhanced by inhibiting P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvF-zoLte8trVg90H21EOLACvtfcHk0lib6enjMLAPtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE&md5=7d2cb9e13b2767b337bf808e73141ae1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRager%26aufirst%3DJ.%2BD.%26aulast%3DWeinstein%26aufirst%3DK.%26aulast%3DKardos%26aufirst%3DP.%2BS.%26aulast%3DDobson%26aufirst%3DG.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520MDR-MDCK%2520cell%2520line%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D288%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.ijpharm.2004.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, J.</span></span> <span> </span><span class="NLM_article-title">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">880</span>â <span class="NLM_lpage">885</span>, <span class="refDoi">Â DOI: 10.1016/0006-291X(91)91647-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2F0006-291X%2891%2991647-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1673839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1991&pages=880-885&author=P.+Arturssonauthor=J.+Karlsson&title=Correlation+between+oral+drug+absorption+in+humans+and+apparent+drug+permeability+coefficients+in+human+intestinal+epithelial+%28Caco-2%29+cells&doi=10.1016%2F0006-291X%2891%2991647-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span></div><div class="casAuthors">Artursson, P.; Karlsson, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium.  Absorption rate consts. (expressed as apparent permeability coeffs.) were detd. for 20 drugs and peptides with different structural properties.  The permeability coeffs. ranged from approx. 5 Ã 10-8 to 5 Ã 10-5 cm/s.  A good correlation was obtained between data on oral absorption in humans and the results in the Caco-2 model.  Drugs that are completely absorbed in humans had permeability coeffs. >1 Ã 10-6 cm/s.  Drugs that are absorbed to >1% but <100% had permeability coeffs. of 0.1-1.0 Ã 10-6 cm/s while drugs and peptides that are absorbed to <1% had permeability coeffs. of â¤1 Ã 10-7 cm/s.  The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvsEluSXCILVg90H21EOLACvtfcHk0ljYeO9puvPUsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D&md5=3b1e14cae3beb0345014284e3aa6a7c0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991647-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991647-U%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCorrelation%2520between%2520oral%2520drug%2520absorption%2520in%2520humans%2520and%2520apparent%2520drug%2520permeability%2520coefficients%2520in%2520human%2520intestinal%2520epithelial%2520%2528Caco-2%2529%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D175%26spage%3D880%26epage%3D885%26doi%3D10.1016%2F0006-291X%2891%2991647-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullenwider, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmenk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepaotcytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">267</span>â <span class="NLM_lpage">275</span>, <span class="refDoi">Â DOI: 10.1124/dmd.111.042861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.111.042861" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=267-275&author=J.+M.+Hutzlerauthor=Y.-S.+Yangauthor=D.+Albaughauthor=C.+L.+Fullenwiderauthor=J.+Schmenkauthor=M.+B.+Fisher&title=Characterization+of+aldehyde+oxidase+enzyme+activity+in+cryopreserved+human+hepaotcytes&doi=10.1124%2Fdmd.111.042861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042861%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DY.-S.%26aulast%3DAlbaugh%26aufirst%3DD.%26aulast%3DFullenwider%26aufirst%3DC.%2BL.%26aulast%3DSchmenk%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26atitle%3DCharacterization%2520of%2520aldehyde%2520oxidase%2520enzyme%2520activity%2520in%2520cryopreserved%2520human%2520hepaotcytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D267%26epage%3D275%26doi%3D10.1124%2Fdmd.111.042861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span> <i>ChanTest Cardiac Channel Panel</i>; <span class="NLM_publisher-name">Charles
River Laboratories International, Inc.</span>: <span class="NLM_publisher-loc">Wilmington, MA</span>. <a href="http://www.criver.com/products-services/drug-discovery/therapeutic-areas/oncology/safety-assessment/cardiac-risk/cardiac-ion-channel-panel" class="extLink">http://www.criver.com/products-services/drug-discovery/therapeutic-areas/oncology/safety-assessment/cardiac-risk/cardiac-ion-channel-panel</a> (accessed April 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ChanTest+Cardiac+Channel+Panel%3B+Charles%0ARiver+Laboratories+International%2C+Inc.%3A+Wilmington%2C+MA.+http%3A%2F%2Fwww.criver.com%2Fproducts-services%2Fdrug-discovery%2Ftherapeutic-areas%2Foncology%2Fsafety-assessment%2Fcardiac-risk%2Fcardiac-ion-channel-panel+%28accessed+April+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DChanTest%2520Cardiac%2520Channel%2520Panel%26pub%3DCharles%250ARiver%2520Laboratories%2520International%252C%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">5135</span>â <span class="NLM_lpage">5139</span>, <span class="refDoi">Â DOI: 10.1073/pnas.72.12.5135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1073%2Fpnas.72.12.5135" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1975&pages=5135-5139&author=J.+McCannauthor=E.+Choiauthor=E.+Yamasakiauthor=B.+N.+Ames&title=Detection+of+carcinogens+as+mutagens+in+the+Salmonella%2Fmicrosome+test%3A+assay+of+300+chemicals&doi=10.1073%2Fpnas.72.12.5135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.72.12.5135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.72.12.5135%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%26aulast%3DYamasaki%26aufirst%3DE.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DDetection%2520of%2520carcinogens%2520as%2520mutagens%2520in%2520the%2520Salmonella%252Fmicrosome%2520test%253A%2520assay%2520of%2520300%2520chemicals%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1975%26volume%3D72%26spage%3D5135%26epage%3D5139%26doi%3D10.1073%2Fpnas.72.12.5135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E. P. M.</span></span> <span> </span><span class="NLM_article-title">A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>547</i></span>,  <span class="NLM_fpage">106</span>â <span class="NLM_lpage">115</span>, <span class="refDoi">Â DOI: 10.1016/j.ejphar.2006.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.ejphar.2006.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16934246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1OmtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2006&pages=106-115&author=L.+B.+Nicolasauthor=Y.+Kolbauthor=E.+P.+M.+Prinssen&title=A+combined+marble+burying-locomotor+activity+test+in+mice%3A+a+practical+screening+test+with+sensitivity+to+different+classes+of+anxiolytics+and+antidepressants&doi=10.1016%2Fj.ejphar.2006.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A combined marble burying-locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants</span></div><div class="casAuthors">Nicolas, Laurent B.; Kolb, Yeter; Prinssen, Eric P. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the last decades, the inhibition of spontaneous burying of glass marbles by mice has been used as an index of anxiolytic drug action in the so-called marble burying test.  Indeed, acute administration of rapid-onset (e.g. diazepam) and slow-onset (e.g. fluoxetine) anxiolytics inhibit marble burying.  However, non-anxiolytic compds. such as classical antipsychotics also reduce marble burying thus suggesting that the predictive validity of this procedure for anxiety may be limited.  In the present study, after having selected a strain of mice (C57BL/6J) that showed spontaneous avoidance of glass marbles, we tried to improve the predictive validity of the marble burying test for anxiety by measuring locomotor activity during the marble burying test and - if needed - in control expts. by using a videotracking system.  Twenty-four ref. compds. were tested including anxiolytics, anxiogenics, antidepressants, antipsychotics and other classes.  By comparing marble burying scores with locomotor measures, we found that, based on our criteria, most of the anxiolytics and antidepressants selectively inhibited marble burying in contrast to most of the other compds. (e.g. haloperidol, morphine).  Two putative anxiolytics, i.e. the nociceptin orphanin FQ peptide receptor agonist Ro 64-6198 and the metabotropic glutamate 5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine, also showed a selective profile.  We propose this modified procedure, requiring only a limited no. of animals, as a valuable screening test for the detection of compds. having anxiolytic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwO1R3IOmPbVg90H21EOLACvtfcHk0ljq4NIP_YFc9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1OmtLo%253D&md5=459a1e0324f23fe9437f95dee46d350c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DNicolas%26aufirst%3DL.%2BB.%26aulast%3DKolb%26aufirst%3DY.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%2BM.%26atitle%3DA%2520combined%2520marble%2520burying-locomotor%2520activity%2520test%2520in%2520mice%253A%2520a%2520practical%2520screening%2520test%2520with%2520sensitivity%2520to%2520different%2520classes%2520of%2520anxiolytics%2520and%2520antidepressants%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D547%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.ejphar.2006.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burant, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuva-Paylor, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paylor, R.</span></span> <span> </span><span class="NLM_article-title">Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">361</span>â <span class="NLM_lpage">373</span>, <span class="refDoi">Â DOI: 10.1007/s00213-009-1466-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1007%2Fs00213-009-1466-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=19189082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyhsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2009&pages=361-373&author=A.+Thomasauthor=A.+Burantauthor=N.+Buiauthor=D.+Grahamauthor=L.+A.+Yuva-Paylorauthor=R.+Paylor&title=Marble+burying+reflects+a+repetitive+and+perseverative+behavior+more+than+novelty-induced+anxiety&doi=10.1007%2Fs00213-009-1466-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety</span></div><div class="casAuthors">Thomas, Alexia; Burant, April; Bui, Nghiem; Graham, Deanna; Yuva-Paylor, Lisa A.; Paylor, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-373</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale An increasing no. of investigators utilize the marble-burying assay despite the paucity of information available regarding what underlies the behavior.  Objectives We tested the possibility that a genetic component underlies marble burying in mice and if there is a genetic correlation with other anxiety-like traits.  Since findings reported in the literature indicate that marble-burying behavior reflects an anxiety-like response, we explored the assumption that the novel nature of a marble induces this anxiety.  Finally, we investigated how the natural response of a mouse to dig relates to the marble-burying phenomenon.  Methods We examd. ten different inbred mouse strains to det. if marble-burying behavior is genetically regulated and correlated with anxiety-like traits in two other assays.  We employed multiple variants of the "traditional" marble-burying assay to address how issues such as the novelty of marbles and digging behavior contribute to marble burying.  Results Marble-burying behavior varied across strain and did not correlate with anxiety measures in other assays.  Multiple tests conducted to reduce the novelty of marbles failed to alter burying behavior.  Addnl., digging behavior correlated with marble burying, and the presence of marbles did not significantly impact the digging response.  Conclusions Our results indicate that mouse marble burying is genetically regulated, not correlated with other anxiety-like traits, not stimulated by novelty, and is a repetitive behavior that persists/perseveres with little change across multiple exposures.  Marble burying is related to digging behavior and may in fact be more appropriately considered as an indicative measure of repetitive digging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfiaqRWC5NHLVg90H21EOLACvtfcHk0ljq4NIP_YFc9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyhsrk%253D&md5=50c19b59c7493766238cab5a68ffcedf</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1466-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1466-y%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DBurant%26aufirst%3DA.%26aulast%3DBui%26aufirst%3DN.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DYuva-Paylor%26aufirst%3DL.%2BA.%26aulast%3DPaylor%26aufirst%3DR.%26atitle%3DMarble%2520burying%2520reflects%2520a%2520repetitive%2520and%2520perseverative%2520behavior%2520more%2520than%2520novelty-induced%2520anxiety%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D204%26spage%3D361%26epage%3D373%26doi%3D10.1007%2Fs00213-009-1466-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slattery, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryan, J. F.</span></span> <span> </span><span class="NLM_article-title">Using the rat forced swim test to assess antidepressant-like activity in rodents</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1009</span>â <span class="NLM_lpage">1014</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2012.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fnprot.2012.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22555240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFClsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1009-1014&author=D.+A.+Slatteryauthor=J.+F.+Cryan&title=Using+the+rat+forced+swim+test+to+assess+antidepressant-like+activity+in+rodents&doi=10.1038%2Fnprot.2012.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Using the rat forced swim test to assess antidepressant-like activity in rodents</span></div><div class="casAuthors">Slattery, David A.; Cryan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1009-1014</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The forced swim test (FST) is one of the most commonly used animal models for assessing antidepressant-like behavior.  This protocol details using the FST in rats, which takes place over 48 h and is followed by the video anal. of the behavior.  The swim test involves the scoring of active (swimming and climbing) or passive (immobility) behavior when rodents are forced to swim in a cylinder from which there is no escape.  There are two versions that are used, namely the traditional and modified FSTs, which differ in their exptl. setup.  For both versions, a pretest of 15 min (although a no. of labs. have used a 10-min pretest with success) is included, as this accentuates the different behaviors in the 5-min swim test following drug treatment.  Redn. in passive behavior is interpreted as an antidepressant-like effect of the manipulation, provided it does not increase general locomotor activity, which could provide a false pos. result in the FST.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYcYTFaBQwLVg90H21EOLACvtfcHk0ljq4NIP_YFc9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFClsLg%253D&md5=233fde8d745f3edacb78d2a38b6249f9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2012.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2012.044%26sid%3Dliteratum%253Aachs%26aulast%3DSlattery%26aufirst%3DD.%2BA.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26atitle%3DUsing%2520the%2520rat%2520forced%2520swim%2520test%2520to%2520assess%2520antidepressant-like%2520activity%2520in%2520rodents%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1009%26epage%3D1014%26doi%3D10.1038%2Fnprot.2012.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharf, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuennecke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kienlin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paehler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrott, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhauser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morairty, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilduff, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolczewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">233</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.222463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fjpet.114.222463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25665805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvV2gtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=213-233&author=L.+Lindemannauthor=R.+H.+Porterauthor=S.+H.+Scharfauthor=B.+Kuenneckeauthor=A.+Brunsauthor=M.+von+Kienlinauthor=A.+C.+Harrisonauthor=A.+Paehlerauthor=C.+Funkauthor=A.+Glogeauthor=M.+Schneiderauthor=N.+J.+Parrottauthor=L.+Polonchukauthor=U.+Niederhauserauthor=S.+R.+Morairtyauthor=T.+S.+Kilduffauthor=E.+Vieiraauthor=S.+Kolczewskiauthor=J.+Wichmannauthor=T.+Hartungauthor=M.+Honerauthor=E.+Borroniauthor=J.+L.+Moreauauthor=E.+Prinssenauthor=W.+Spoorenauthor=J.+G.+Wettsteinauthor=G.+Jaeschke&title=Pharmacology+of+basimglurant+%28RO4917523%2C+RG7090%29%2C+a+unique+metabotropic+glutamate+receptor+5+negative+allosteric+modulator+in+clinical+development+for+depression&doi=10.1124%2Fjpet.114.222463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression</span></div><div class="casAuthors">Lindemann, Lothar; Porter, Richard H.; Scharf, Sebastian H.; Kuennecke, Basil; Bruns, Andreas; von Kienlin, Markus; Harrison, Anthony C.; Paehler, Axel; Funk, Christoph; Gloge, Andreas; Schneider, Manfred; Parrott, Neil J.; Polonchuk, Liudmila; Niederhauser, Urs; Morairty, Stephen R.; Kilduff, Thomas S.; Vieira, Eric; Kolczewski, Sabine; Wichmann, Juergen; Hartung, Thomas; Honer, Michael; Borroni, Edilio; Moreau, Jean-Luc; Prinssen, Eric; Spooren, Will; Wettstein, Joseph G.; Jaeschke, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-233</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability.  Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics.  Recently, glutamatergic approaches for the treatment of MDD have increasingly received attention, and preclin. research suggests that metabotropic glutamate receptor 5 (mGlu5) inhibitors have antidepressant-like properties.  Basimglurant (2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine) is a novel mGlu5 neg. allosteric modulator currently in phase 2 clin. development for MDD and fragile X syndrome.  Here, the comprehensive preclin. pharmacol. profile of basimglurant is presented with a focus on its therapeutic potential for MDD and drug-like properties.  Basimglurant is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency.  It has antidepressant properties that are corroborated by its functional magnetic imaging profile as well as anxiolytic-like and antinociceptive features.  In electroencephalog. recordings, basimglurant shows wake-promoting effects followed by increased delta power during subsequent non-rapid eye movement sleep.  In microdialysis studies, basimglurant had no effect on monoamine transmitter levels in the frontal cortex or nucleus accumbens except for a moderate increase of accumbal dopamine, which is in line with its lack of pharmacol. activity on monoamine reuptake transporters.  These data taken together, basimglurant has favorable drug-like properties, a differentiated mol. mechanism of action, and antidepressant-like features that suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphweERNWGN57Vg90H21EOLACvtfcHk0ljttkFOmSs2eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvV2gtL8%253D&md5=a9cb923e5f3704ebb4835684e962fb9f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.222463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.222463%26sid%3Dliteratum%253Aachs%26aulast%3DLindemann%26aufirst%3DL.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DScharf%26aufirst%3DS.%2BH.%26aulast%3DKuennecke%26aufirst%3DB.%26aulast%3DBruns%26aufirst%3DA.%26aulast%3Dvon%2BKienlin%26aufirst%3DM.%26aulast%3DHarrison%26aufirst%3DA.%2BC.%26aulast%3DPaehler%26aufirst%3DA.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGloge%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DParrott%26aufirst%3DN.%2BJ.%26aulast%3DPolonchuk%26aufirst%3DL.%26aulast%3DNiederhauser%26aufirst%3DU.%26aulast%3DMorairty%26aufirst%3DS.%2BR.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DJaeschke%26aufirst%3DG.%26atitle%3DPharmacology%2520of%2520basimglurant%2520%2528RO4917523%252C%2520RG7090%2529%252C%2520a%2520unique%2520metabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulator%2520in%2520clinical%2520development%2520for%2520depression%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D213%26epage%3D233%26doi%3D10.1124%2Fjpet.114.222463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Browne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucki, I.</span></span> <span> </span><span class="NLM_article-title">Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>, <span class="refDoi">Â DOI: 10.3389/fphar.2013.00161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.3389%2Ffphar.2013.00161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24409146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADC%252BC2cflsFWguw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=161&author=C.+A.+Browneauthor=I.+Lucki&title=Antidepressant+effects+of+ketamine%3A+mechanisms+underlying+fast-acting+novel+antidepressants&doi=10.3389%2Ffphar.2013.00161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants</span></div><div class="casAuthors">Browne Caroline A; Lucki Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Newer antidepressants are needed for the many individuals with major depressive disorder (MDD) that do not respond adequately to treatment and because of a delay of weeks before the emergence of therapeutic effects.  Recent evidence from clinical trials shows that the NMDA antagonist ketamine is a revolutionary novel antidepressant because it acts rapidly and is effective for treatment-resistant patients.  A single infusion of ketamine alleviates depressive symptoms in treatment-resistant depressed patients within hours and these effects may be sustained for up to 2 weeks.  Although the discovery of ketamine's effects has reshaped drug discovery for antidepressants, the psychotomimetic properties of this compound limit the use of this therapy to the most severely ill patients.  In order to develop additional antidepressants like ketamine, adequate preclinical behavioral screening paradigms for fast-acting antidepressants need to be established and used to identify the underlying neural mechanisms.  This review examines the preclinical literature attempting to model the antidepressant-like effects of ketamine.  Acute administration of ketamine has produced effects in behavioral screens for antidepressants like the forced swim test, novelty suppression of feeding and in rodent models for depression.  Protracted behavioral effects of ketamine have been reported to appear after a single treatment that last for days.  This temporal pattern is similar to its clinical effects and may serve as a new animal paradigm for rapid antidepressant effects in humans.  In addition, protracted changes in molecules mediating synaptic plasticity have been implicated in mediating the antidepressant-like behavioral effects of ketamine.  Current preclinical studies are examining compounds with more specific pharmacological effects at glutamate receptors and synapses in order to develop additional rapidly acting antidepressants without the hallucinogenic side effects or abuse potential of ketamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuDJ7Ng-_tWZPq5LRczm8ffW6udTcc2eYrztbFUZ5uMbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflsFWguw%253D%253D&md5=12ece8b57b8dd91cac6ece8313c77239</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00161%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DC.%2BA.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAntidepressant%2520effects%2520of%2520ketamine%253A%2520mechanisms%2520underlying%2520fast-acting%2520novel%2520antidepressants%26jtitle%3DFront.%2520Pharmacol.%26date%3D2013%26volume%3D4%26spage%3D161%26doi%3D10.3389%2Ffphar.2013.00161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moaddel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkondon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribut, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossou, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainer, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T. D.</span></span> <span> </span><span class="NLM_article-title">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>533</i></span>,  <span class="NLM_fpage">481</span>â <span class="NLM_lpage">486</span>, <span class="refDoi">Â DOI: 10.1038/nature17998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fnature17998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=27144355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=481-486&author=P.+Zanosauthor=R.+Moaddelauthor=P.+J.+Morrisauthor=P.+Georgiouauthor=J.+Fischellauthor=G.+I.+Elmerauthor=M.+Alkondonauthor=P.+Yuanauthor=H.+J.+Pributauthor=N.+S.+Singhauthor=K.+S.+Dossouauthor=Y.+Fangauthor=X.+P.+Huangauthor=C.+L.+Mayoauthor=I.+W.+Wainerauthor=E.+X.+Albuquerqueauthor=S.+M.+Thompsonauthor=C.+J.+Thomasauthor=C.+A.+Zarateauthor=T.+D.+Gould&title=NMDAR+inhibition-independent+antidepressant+actions+of+ketamine+metabolites&doi=10.1038%2Fnature17998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span></div><div class="casAuthors">Zanos, Panos; Moaddel, Ruin; Morris, Patrick J.; Georgiou, Polymnia; Fischell, Jonathan; Elmer, Greg I.; Alkondon, Manickavasagom; Yuan, Peixiong; Pribut, Heather J.; Singh, Nagendra S.; Dossou, Katina S. S.; Fang, Yuhong; Huang, Xi-Ping; Mayo, Cheryl L.; Wainer, Irving W.; Albuquerque, Edson X.; Thompson, Scott M.; Thomas, Craig J.; Zarate, Carlos A., Jr; Gould, Todd D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7604</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Major depressive disorder affects around 16% of the world population at some point in their lives.  Despite the availability of numerous monoaminergic-based antidepressants, most patients require several weeks, if not months, to respond to these treatments, and many patients never attain sustained remission of their symptoms.  The noncompetitive, glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist (R,S)-ketamine exerts rapid and sustained antidepressant effects after a single dose in patients with depression, but its use is assocd. with undesirable side effects.  Here the authors show that the metab. of (R,S)-ketamine to (2S,6S;2R,6R)-hydroxynorketamine (HNK) is essential for its antidepressant effects, and that the (2R,6R)-HNK enantiomer exerts behavioral, electroencephalog., electrophysiol. and cellular antidepressant-related actions in mice.  These antidepressant actions are independent of NMDAR inhibition but involve early and sustained activation of AMPARs (Î±-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors).  The authors also establish that (2R,6R)-HNK lacks ketamine-related side effects.  The data implicate a novel mechanism underlying the antidepressant properties of (R,S)-ketamine and have relevance for the development of next-generation, rapid-acting antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzu3ydujHJ37Vg90H21EOLACvtfcHk0lilSAW3JeTc6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D&md5=fcb8479079696cf3dc0ee89f5fadd72a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature17998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17998%26sid%3Dliteratum%253Aachs%26aulast%3DZanos%26aufirst%3DP.%26aulast%3DMoaddel%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DP.%2BJ.%26aulast%3DGeorgiou%26aufirst%3DP.%26aulast%3DFischell%26aufirst%3DJ.%26aulast%3DElmer%26aufirst%3DG.%2BI.%26aulast%3DAlkondon%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DPribut%26aufirst%3DH.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%2BS.%26aulast%3DDossou%26aufirst%3DK.%2BS.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMayo%26aufirst%3DC.%2BL.%26aulast%3DWainer%26aufirst%3DI.%2BW.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DThompson%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26aulast%3DGould%26aufirst%3DT.%2BD.%26atitle%3DNMDAR%2520inhibition-independent%2520antidepressant%2520actions%2520of%2520ketamine%2520metabolites%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature17998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pomierny-ChamioÅo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poleszak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, G.</span></span> <span> </span><span class="NLM_article-title">NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1186</span>â <span class="NLM_lpage">1190</span>, <span class="refDoi">Â DOI: 10.1016/S1734-1140(10)70381-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2FS1734-1140%2810%2970381-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=21273676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlCjsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1186-1190&author=L.+Pomierny-Chamio%C5%82oauthor=E.+Poleszakauthor=A.+Pilcauthor=G.+Nowak&title=NMDA+but+not+AMPA+glutamatergic+receptors+are+involved+in+the+antidepressant-like+activity+of+MTEP+during+the+forced+swim+test+in+mice&doi=10.1016%2FS1734-1140%2810%2970381-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice</span></div><div class="casAuthors">Pomierny-Chamiolo, Lucyna; Poleszak, Ewa; Pilc, Andrzej; Nowak, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1186-1190</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">Several lines of evidence suggest an antidepressant-like activity for 3-[(methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP), a highly selective, non-competitive antagonist of metabotropic glutamate receptors subtype 5 (mGluR5).  This effect has been obsd. following both acute and chronic MTEP treatments in behavioral tests and exptl. models of depression, such as the forced swim test (FST), the tail suspension test, and the olfactory bulbectomy model of depression.  However, the mechanism of action for mGluR5 antagonists remains unclear.  The aim of this study was to investigate whether the antidepressant-like action of MTEP is dependent on ionotropic glutamatergic receptors.  Male Albino Swiss mice were used, and antidepressant-like activity was evaluated using the FST.  The antidepressant-like effect of MTEP (0.3 mg/kg) was significantly antagonized by pre-treatment with the NMDA receptor agonist N-methyl-D-aspartic acid (NMDA, 75 mg/kg, i.p.).  The AMPA receptor antagonist NBQX (10 mg/kg, i.p.) did not affect the MTEP activity.  Our results indicate that the antidepressant-like activity of MTEP in the FST involves NMDA but not AMPA receptors and suggest that the interaction between mGluR5 and NMDA receptors plays an important role in the underlying antidepressant mechanism(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvGosZc_aGmrVg90H21EOLACvtfcHk0lhMojTuJpbbTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlCjsrs%253D&md5=ff430c21cc5a56049bca53d69c66773e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2810%2970381-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252810%252970381-9%26sid%3Dliteratum%253Aachs%26aulast%3DPomierny-Chamio%25C5%2582o%26aufirst%3DL.%26aulast%3DPoleszak%26aufirst%3DE.%26aulast%3DPilc%26aufirst%3DA.%26aulast%3DNowak%26aufirst%3DG.%26atitle%3DNMDA%2520but%2520not%2520AMPA%2520glutamatergic%2520receptors%2520are%2520involved%2520in%2520the%2520antidepressant-like%2520activity%2520of%2520MTEP%2520during%2520the%2520forced%2520swim%2520test%2520in%2520mice%26jtitle%3DPharmacol.%2520Rep.%26date%3D2010%26volume%3D62%26spage%3D1186%26epage%3D1190%26doi%3D10.1016%2FS1734-1140%2810%2970381-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BraÅ¡iÄ, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamroonrat, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stabins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dannals, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamill, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, P. D.</span></span> <span> </span><span class="NLM_article-title"><sup>18</sup>F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">388</span>â <span class="NLM_lpage">396</span>, <span class="refDoi">Â DOI: 10.2967/jnumed.112.107995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2967%2Fjnumed.112.107995" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=388-396&author=D.+F.+Wongauthor=R.+Waterhouseauthor=H.+Kuwabaraauthor=J.+Kimauthor=J.+R.+Bra%C5%A1i%C4%87author=W.+Chamroonratauthor=M.+Stabinsauthor=D.+P.+Holtauthor=R.+F.+Dannalsauthor=T.+G.+Hamillauthor=P.+D.+Mozley&title=18F-FPEB%2C+a+PET+radiopharmaceutical+for+quantifying+metabotropic+glutamate+5+receptors%3A+a+first-in-human+study+of+radiochemical+safety%2C+biokinetics%2C+and+radiation+dosimetry&doi=10.2967%2Fjnumed.112.107995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.107995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.107995%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DWaterhouse%26aufirst%3DR.%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DBra%25C5%25A1i%25C4%2587%26aufirst%3DJ.%2BR.%26aulast%3DChamroonrat%26aufirst%3DW.%26aulast%3DStabins%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DMozley%26aufirst%3DP.%2BD.%26atitle%3D18F-FPEB%252C%2520a%2520PET%2520radiopharmaceutical%2520for%2520quantifying%2520metabotropic%2520glutamate%25205%2520receptors%253A%2520a%2520first-in-human%2520study%2520of%2520radiochemical%2520safety%252C%2520biokinetics%252C%2520and%2520radiation%2520dosimetry%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D388%26epage%3D396%26doi%3D10.2967%2Fjnumed.112.107995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span>; <span class="NLM_string-name">Lindsley, C. W.</span>; <span class="NLM_string-name">Emmitte</span>; , <span class="NLM_string-name">Kyle, A.</span>; <span class="NLM_string-name">Rodriguez, A. L.</span>; <span class="NLM_string-name">Felts, A. S.</span>; <span class="NLM_string-name">Jones, C. K.</span>; <span class="NLM_string-name">Bates, B. S.</span>; <span class="NLM_string-name">Chauder, B. A.</span></span> <span> </span><span class="NLM_article-title">6-Alkyl-<i>N</i>-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same</span>. U.S. Patent <span class="NLM_patent">9085562</span>, July 21, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+J.+Conn&author=C.+W.+Lindsley&author=+Emmitte&author=A.+Kyle&author=A.+L.+Rodriguez&author=A.+S.+Felts&author=C.+K.+Jones&author=B.+S.+Bates&author=B.+A.+Chauder&title=6-Alkyl-N-%28pyridin-2-yl%29-4-aryloxypicolinamide+analogs+as+mGluR5+negative+allosteric+modulators+and+methods+of+making+and+using+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3D6-Alkyl-N-%2528pyridin-2-yl%2529-4-aryloxypicolinamide%2520analogs%2520as%2520mGluR5%2520negative%2520allosteric%2520modulators%2520and%2520methods%2520of%2520making%2520and%2520using%2520the%2520same%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jeffrey N. Levy, Juan V. Alegre-Requena, Renrong Liu, Robert S. Paton, <span class="NLM_string-name hlFld-ContribAuthor">Andrew McNally</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Halogenation of Pyridines Using Designed Phosphine Reagents. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (25)
                                     , 11295-11305. <a href="https://doi.org/10.1021/jacs.0c04674" title="DOI URL">https://doi.org/10.1021/jacs.0c04674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c04674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c04674%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSelective%252BHalogenation%252Bof%252BPyridines%252BUsing%252BDesigned%252BPhosphine%252BReagents%26aulast%3DLevy%26aufirst%3DJeffrey%2BN.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03052020%26date%3D10062020%26date%3D29052020%26volume%3D142%26issue%3D25%26spage%3D11295%26epage%3D11305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Davide Graziani, Silvia Caligari, Elisa Callegari, Carlo De Toma, Matteo Longhi, Fabio Frigerio, Roberto Dilernia, Sergio Menegon, Luca Pinzi, Lorenza Pirona, Valerio Tazzari, Anna Elisa Valsecchi, Giulio Vistoli, Giulio Rastelli, <span class="NLM_string-name hlFld-ContribAuthor">Carlo Riva</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1246-1273. <a href="https://doi.org/10.1021/acs.jmedchem.8b01226" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01226%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252BAmides%25252C%252BCarbamates%25252C%252BSulfonamides%25252C%252Band%252BUreas%252Bof%252B4-Prop-2-ynylidenecycloalkylamine%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BBioavailable%252BNegative%252BAllosteric%252BModulators%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252B5%26aulast%3DGraziani%26aufirst%3DDavide%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29082018%26date%3D28012019%26date%3D09012019%26volume%3D62%26issue%3D3%26spage%3D1246%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhigao Shen, Huawen Huang, Cuiju Zhu, Svenja Warratz, <span class="NLM_string-name hlFld-ContribAuthor">Lutz Ackermann</span>. </span><span class="cited-content_cbyCitation_article-title">MnCl2-Catalyzed CâH Alkylation on Azine Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (2)
                                     , 571-574. <a href="https://doi.org/10.1021/acs.orglett.8b03924" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b03924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b03924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b03924%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DMnCl2-Catalyzed%252BC%2525E2%252580%252593H%252BAlkylation%252Bon%252BAzine%252BHeterocycles%26aulast%3DShen%26aufirst%3DZhigao%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D08122018%26date%3D03012019%26volume%3D21%26issue%3D2%26spage%3D571%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaoyong Lu, <span class="NLM_string-name hlFld-ContribAuthor">Jian Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: DrugâTarget Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 24-45. <a href="https://doi.org/10.1021/acs.jmedchem.7b01844" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01844%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BAllosteric%252BModulators%252Bof%252BG-Protein-Coupled%252BReceptors%25253A%252BDrug%2525E2%252580%252593Target%252BInteractions%26aulast%3DLu%26aufirst%3DShaoyong%26date%3D2019%26date%3D2018%26date%3D2017%26date%3D14122017%26date%3D26022018%26date%3D19022018%26volume%3D62%26issue%3D1%26spage%3D24%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas BostrÃ¶m</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tingting Fu, Guoxun Zheng, Gao Tu, Fengyuan Yang, Yuzong Chen, Xiaojun Yao, Xiaofeng Li, Weiwei Xue, <span class="NLM_string-name hlFld-ContribAuthor">Feng Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (6)
                                     , 1492-1502. <a href="https://doi.org/10.1021/acschemneuro.8b00059" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00059%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DExploring%252Bthe%252BBinding%252BMechanism%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252B5%252BNegative%252BAllosteric%252BModulators%252Bin%252BClinical%252BTrials%252Bby%252BMolecular%252BDynamics%252BSimulations%26aulast%3DFu%26aufirst%3DTingting%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08022018%26date%3D09032018%26date%3D16032018%26date%3D09032018%26volume%3D9%26issue%3D6%26spage%3D1492%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Somaieh  Soltani</span>, <span class="hlFld-ContribAuthor ">Somayeh  Hallaj-Nezhadi</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Rashidi</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review of in silico approaches for the prediction and modulation of aldehyde oxidase-mediated drug metabolism: The current features, challenges and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113559. <a href="https://doi.org/10.1016/j.ejmech.2021.113559" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113559%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bof%252Bin%252Bsilico%252Bapproaches%252Bfor%252Bthe%252Bprediction%252Band%252Bmodulation%252Bof%252Baldehyde%252Boxidase-mediated%252Bdrug%252Bmetabolism%25253A%252BThe%252Bcurrent%252Bfeatures%25252C%252Bchallenges%252Band%252Bfuture%252Bperspectives%26aulast%3DSoltani%26aufirst%3DSomaieh%26date%3D2021%26volume%3D222%26spage%3D113559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael C.  Salling</span>, <span class="hlFld-ContribAuthor ">Alexander  Grassetti</span>, <span class="hlFld-ContribAuthor ">Vincent P.  Ferrera</span>, <span class="hlFld-ContribAuthor ">Diana  Martinez</span>, <span class="hlFld-ContribAuthor ">Richard W.  Foltin</span>. </span><span class="cited-content_cbyCitation_article-title">Negative allosteric modulation of metabotropic glutamate receptor 5 attenuates alcohol self-administration in baboons. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2021,</strong> <em>208 </em>, 173227. <a href="https://doi.org/10.1016/j.pbb.2021.173227" title="DOI URL">https://doi.org/10.1016/j.pbb.2021.173227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2021.173227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2021.173227%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DNegative%252Ballosteric%252Bmodulation%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252B5%252Battenuates%252Balcohol%252Bself-administration%252Bin%252Bbaboons%26aulast%3DSalling%26aufirst%3DMichael%2BC.%26date%3D2021%26volume%3D208%26spage%3D173227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-ting  Fu</span>, <span class="hlFld-ContribAuthor ">Gao  Tu</span>, <span class="hlFld-ContribAuthor ">Meng  Ping</span>, <span class="hlFld-ContribAuthor ">Guo-xun  Zheng</span>, <span class="hlFld-ContribAuthor ">Feng-yuan  Yang</span>, <span class="hlFld-ContribAuthor ">Jing-yi  Yang</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-jun  Yao</span>, <span class="hlFld-ContribAuthor ">Wei-wei  Xue</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>42 </em>
                                    (8)
                                     , 1354-1367. <a href="https://doi.org/10.1038/s41401-020-00541-z" title="DOI URL">https://doi.org/10.1038/s41401-020-00541-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-00541-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-00541-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DSubtype-selective%252Bmechanisms%252Bof%252Bnegative%252Ballosteric%252Bmodulators%252Bbinding%252Bto%252Bgroup%252BI%252Bmetabotropic%252Bglutamate%252Breceptors%26aulast%3DFu%26aufirst%3DTing-ting%26date%3D2021%26date%3D2020%26volume%3D42%26issue%3D8%26spage%3D1354%26epage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimberly M.  Holter</span>, <span class="hlFld-ContribAuthor ">Alex D.  Lekander</span>, <span class="hlFld-ContribAuthor ">Christina M.  LaValley</span>, <span class="hlFld-ContribAuthor ">Elizabeth G.  Bedingham</span>, <span class="hlFld-ContribAuthor ">Bethany E.  Pierce</span>, <span class="hlFld-ContribAuthor ">L. Paul  Sands</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Robert W.  Gould</span>. </span><span class="cited-content_cbyCitation_article-title">Partial mGlu5 Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.3389/fnins.2021.700822" title="DOI URL">https://doi.org/10.3389/fnins.2021.700822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2021.700822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2021.700822%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DPartial%252BmGlu5%252BNegative%252BAllosteric%252BModulator%252BM-5MPEP%252BDemonstrates%252BAntidepressant-Like%252BEffects%252Bon%252BSleep%252BWithout%252BAffecting%252BCognition%252Bor%252BQuantitative%252BEEG%26aulast%3DHolter%26aufirst%3DKimberly%2BM.%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1007/s11030-020-10165-4" title="DOI URL">https://doi.org/10.1007/s11030-020-10165-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10165-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DClassification%252Bmodels%252Band%252BSAR%252Banalysis%252Bon%252BCysLT1%252Breceptor%252Bantagonists%252Busing%252Bmachine%252Blearning%252Balgorithms%26aulast%3DWang%26aufirst%3DHongzhao%26date%3D2021%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>. </span><span class="cited-content_cbyCitation_article-title">Technologies for Screening of mGlu Receptor Allosteric Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-22. <a href="https://doi.org/10.1007/978-1-0716-1107-4_1" title="DOI URL">https://doi.org/10.1007/978-1-0716-1107-4_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-0716-1107-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-0716-1107-4_1%26sid%3Dliteratum%253Aachs%26atitle%3DTechnologies%252Bfor%252BScreening%252Bof%252BmGlu%252BReceptor%252BAllosteric%252BModulators%26aulast%3DRodriguez%26aufirst%3DAlice%2BL.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D22%26pub%3DSpringer%2520US%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252BTechnologies%26aulast%3DOlive%26aufirst%3DM%2BFoster%26date%3D2021%26volume%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baohui  Qi</span>, <span class="hlFld-ContribAuthor ">Xingwei  Xu</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Huan  He</span>, <span class="hlFld-ContribAuthor ">Xupeng  Yue</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and biological evaluation of nicotinamide derivatives as Aurora kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (17)
                                     , 3825-3835. <a href="https://doi.org/10.1016/j.bmc.2019.07.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Bnicotinamide%252Bderivatives%252Bas%252BAurora%252Bkinase%252Binhibitors%26aulast%3DQi%26aufirst%3DBaohui%26date%3D2019%26volume%3D27%26issue%3D17%26spage%3D3825%26epage%3D3835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trevor C.  Chopko</span>, <span class="hlFld-ContribAuthor ">Changho  Han</span>, <span class="hlFld-ContribAuthor ">Alison R.  Gregro</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Mike S.  Poslusney</span>, <span class="hlFld-ContribAuthor ">Katrina A.  Bollinger</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Morrison</span>, <span class="hlFld-ContribAuthor ">Michael  Bubser</span>, <span class="hlFld-ContribAuthor ">Atin  Lamsal</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Nathalie C.  Schnetz-Boutaud</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Sichen  Chang</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Donald F.  Stec</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wood</span>, <span class="hlFld-ContribAuthor ">Michael W.  Wood</span>, <span class="hlFld-ContribAuthor ">Mark E.  Duggan</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Brandon</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Melancon</span>. </span><span class="cited-content_cbyCitation_article-title">SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M4 PAMs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2224-2228. <a href="https://doi.org/10.1016/j.bmcl.2019.06.032" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Binspired%252Bby%252Baldehyde%252Boxidase%252B%252528AO%252529%252Bmetabolism%25253A%252BDiscovery%252Bof%252Bnovel%25252C%252BCNS%252Bpenetrant%252Btricyclic%252BM4%252BPAMs%26aulast%3DChopko%26aufirst%3DTrevor%2BC.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2224%26epage%3D2228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Melancon</span>, <span class="hlFld-ContribAuthor ">Allison R.  Gregro</span>, <span class="hlFld-ContribAuthor ">Jeanette L.  Bertron</span>, <span class="hlFld-ContribAuthor ">Sean R.  Bollinger</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Leah C.  Konkol</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wood</span>, <span class="hlFld-ContribAuthor ">Katrina A.  Bollinger</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Michael  Bubser</span>, <span class="hlFld-ContribAuthor ">Samantha E.  Yohn</span>, <span class="hlFld-ContribAuthor ">Michael W.  Wood</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Brandon</span>, <span class="hlFld-ContribAuthor ">Mark E.  Dugan</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">VU6005806/AZN-00016130, an advanced M4 positive allosteric modulator (PAM) profiled as a potential preclinical development candidate. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (14)
                                     , 1714-1718. <a href="https://doi.org/10.1016/j.bmcl.2019.05.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.05.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.05.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVU6005806%25252FAZN-00016130%25252C%252Ban%252Badvanced%252BM4%252Bpositive%252Ballosteric%252Bmodulator%252B%252528PAM%252529%252Bprofiled%252Bas%252Ba%252Bpotential%252Bpreclinical%252Bdevelopment%252Bcandidate%26aulast%3DEngers%26aufirst%3DDarren%2BW.%26date%3D2019%26volume%3D29%26issue%3D14%26spage%3D1714%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Katrina A.  Bollinger</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Brassard</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Morrison</span>, <span class="hlFld-ContribAuthor ">J.  Scott Daniels</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">P.  Jeffrey Conn</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (1)
                                     , 47-50. <a href="https://doi.org/10.1016/j.bmcl.2018.11.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B4-alkoxy-6-methylpicolinamide%252Bnegative%252Ballosteric%252Bmodulators%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsubtype%252B5%26aulast%3DFelts%26aufirst%3DAndrew%2BS.%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D47%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Morrison</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Frank W.  Byers</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1679-1685. <a href="https://doi.org/10.1016/j.bmcl.2018.04.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B6-%252528pyrimidin-5-ylmethyl%252529quinoline-8-carboxamide%252Bnegative%252Ballosteric%252Bmodulators%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsubtype%252B5%26aulast%3DFelts%26aufirst%3DAndrew%2BS.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1679%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel D.  Crouch</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu
              5
              -Negative Allosteric Modulator VU0424238 (Auglurant). </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2017,</strong> <em>45 </em>
                                    (12)
                                     , 1245-1259. <a href="https://doi.org/10.1124/dmd.117.077552" title="DOI URL">https://doi.org/10.1124/dmd.117.077552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.117.077552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.117.077552%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DSpecies-Specific%252BInvolvement%252Bof%252BAldehyde%252BOxidase%252Band%252BXanthine%252BOxidase%252Bin%252Bthe%252BMetabolism%252Bof%252Bthe%252BPyrimidine-Containing%252BmGlu%252B5%252B-Negative%252BAllosteric%252BModulator%252BVU0424238%252B%252528Auglurant%252529%26aulast%3DCrouch%26aufirst%3DRachel%2BD.%26date%3D2017%26date%3D2017%26volume%3D45%26issue%3D12%26spage%3D1245%26epage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Morrison</span>, <span class="hlFld-ContribAuthor ">Katrina A.  Bollinger</span>, <span class="hlFld-ContribAuthor ">Daryl F.  Venable</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Frank W.  Byers</span>, <span class="hlFld-ContribAuthor ">Analisa  Thompson Gray</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (21)
                                     , 4858-4866. <a href="https://doi.org/10.1016/j.bmcl.2017.09.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bimidazo%25255B1%25252C2-a%25255D-%25252C%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255D-%25252C%252Band%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridine-8-carboxamide%252Bnegative%252Ballosteric%252Bmodulators%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsubtype%252B5%26aulast%3DFelts%26aufirst%3DAndrew%2BS.%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4858%26epage%3D4866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas K.  David</span>, <span class="hlFld-ContribAuthor ">Nayak K.  Prashanth</span>, <span class="hlFld-ContribAuthor ">M.  Rajendraswami</span>, <span class="hlFld-ContribAuthor ">Devendrareddy  Pallalu</span>, <span class="hlFld-ContribAuthor ">Arlindo L.  Castelhano</span>, <span class="hlFld-ContribAuthor ">Michael J.  Kates</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Development and kilogram-scale synthesis of mGlu5 negative allosteric modulator VU0424238 (auglurant). </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (36)
                                     , 3554-3558. <a href="https://doi.org/10.1016/j.tetlet.2017.07.100" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.07.100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.07.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.07.100%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDevelopment%252Band%252Bkilogram-scale%252Bsynthesis%252Bof%252BmGlu5%252Bnegative%252Ballosteric%252Bmodulator%252BVU0424238%252B%252528auglurant%252529%26aulast%3DDavid%26aufirst%3DThomas%2BK.%26date%3D2017%26volume%3D58%26issue%3D36%26spage%3D3554%26epage%3D3558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Prototypical mGlu<sub>5</sub> NAM preclinical tools <b>1</b> and <b>2</b> and clinically investigated mGlu<sub>5</sub> NAMs <b>3</b>â<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Picolinamide Analogs <b>10</b>â<b>13</b> and <b>21</b>â<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: R<sup>1</sup> = H, Me, CHF<sub>2</sub>; R<sup>2</sup> = H, Me, C<sub>3</sub>H<sub>5</sub>; A = N, CH, CF, CCl; R<sup>4</sup> = 4-methylthiazol-2-yl or substituted pyridin-2-yl; (a) conc. HCl, reflux, 53â75%; (b) H<sub>2</sub>O<sub>2</sub>Â·urea, (F<sub>3</sub>CCO)<sub>2</sub>O, THF, 0 Â°C to rt, 44â99%; (c) Me<sub>3</sub>SiCN, CH<sub>2</sub>Cl<sub>2</sub>, Me<sub>2</sub>NCOCl, 75â86%; (d) <b>18</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 Â°C, 45â77%; (e) 2 N aq. NaOH, dioxane, reflux, 82â99%; (f) H<sub>2</sub>NR<sup>4</sup>, POCl<sub>3</sub>, pyridine, â15 Â°C, 22â81%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolite (<b>38</b>) of <b>27</b> identified in rat, cynomolgus monkey, and human hepatic S9 fractions that is produced predominately by AO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Ca<sup>2+</sup> mobilization assay CRC for <b>27</b> in HEK293A cells expressing human mGlu<sub>5</sub>. (B) Effects of <b>27</b> on glutamate CRC in rat cortical astrocytes. (C) Competition radioligand binding CRC with <b>27</b> and [<sup>3</sup>H]-3-methoxy-5-(pyridin-2-ylethynyl)pyridine (<b>39</b>). (D) Saturation binding experiment: increasing concentrations of [<sup>3</sup>H]-<b>39</b> in the presence and absence of multiple concentrations of <b>27</b>. (E) Saturation binding experiment: Scatchard analysis of bound/free versus bound ligand. (F) Effects of the neutral mGlu<sub>5</sub> site ligand 5-methyl-6-(phenylethynyl)-pyridine (<b>40</b>) on the functional inhibition of glutamate responses induced by <b>27</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Dose-dependent inhibition of marble burying with <b>27</b>; vehicle = 10% polysorbate 80 (IP); male CD-1 mice; <i>n</i> = 10 per treatment group; 15 min pretreatment; 30 min burying time; *, <i>p</i> < 0.05 versus vehicle control group, Dunnettâs test; bars denote marbles buried. (<b>B</b>) Dose-dependent inhibition of immobility in rats with <b>27</b>; vehicle = 10% polysorbate 80 (<b>27</b>, intraperitoneal) and sterile saline (ketamine, subcutaneous); male SpragueâDawley rats; <i>n</i> = 8â10 per treatment group; 30 min pretreatment; 6 min testing session; *, <i>p</i> < 0.05 versus vehicle control group, Dunnettâs test; bars denote duration of immobility in s.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Imaging studies in rodents; <i>n</i> = 4â8 SpragueâDawley rats; <b>27</b> vehicle = 10% polysorbate 80 in 0.5% methyl cellulose; <b>27</b> dosed 30 min prior to [<sup>18</sup>F]-<b>41</b> (IV). (A) Representative images of [<sup>18</sup>F]-<b>41</b> by increasing oral doses of <b>27</b>. (B) mGlu<sub>5</sub> RO obtained with [<sup>18</sup>F]-<b>41</b> and increasing oral doses of <b>27</b>. (C) Unbound maximum plasma concentration of <b>27</b> versus mGlu<sub>5</sub> RO. (D) Dose of <b>27</b> versus mGlu<sub>5</sub> RO; *normalized to the maximum displacement of [<sup>18</sup>F]-<b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/medium/jm-2017-00410d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Imaging studies in female baboons: subject A received three doses (0.01, 0.1, and 0.18 mg/kg); subject B received two doses (0.03 and 0.56 mg/kg); <b>27</b> vehicle = 10% ethanol, 30% PEG 400, 20% hydroxypropyl-Î²-cyclodextrin in water; <b>27</b> dosed over 20 min, 30 min prior to [<sup>18</sup>F]-<b>41</b> (IV, 3 min bolus) for all doses except the 0.18 mg/kg dose, which was dosed over 2 min, 50 min prior to [<sup>18</sup>F]-<b>41</b>. (A) mGlu<sub>5</sub> RO obtained in two female baboons with [<sup>18</sup>F]-<b>41</b> and increasing IV doses of <b>27</b>. (B) Total maximum plasma concentration of <b>27</b> versus mGlu<sub>5</sub> RO. (C) Dose of <b>27</b> versus mGlu<sub>5</sub> RO. (D) Images for subject A averaged from 0 to 150 min. (E) Images for subject B averaged from 0 to 180 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.7b00410/20180522/images/large/jm-2017-00410d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00410&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 65 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golubeva, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moloney, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâConnor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinan, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryan, J. F.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptors in central nervous system disease</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">538</span>â <span class="NLM_lpage">616</span>, <span class="refDoi">Â DOI: 10.2174/1389450116666150316224011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2174%2F1389450116666150316224011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25777273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCkt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=538-616&author=A.+V.+Golubevaauthor=R.+D.+Moloneyauthor=R.+M.+O%E2%80%99Connorauthor=T.+G.+Dinanauthor=J.+F.+Cryan&title=Metabotropic+glutamate+receptors+in+central+nervous+system+disease&doi=10.2174%2F1389450116666150316224011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic Glutamate Receptors in Central Nervous System Diseases</span></div><div class="casAuthors">Golubeva, Anna V.; Moloney, Rachel D.; O'Connor, Richard M.; Dinan, Timothy G.; Cryan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-616</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Extensive research over the past thirty years has demonstrated a vital role for metabotropic glutamate (mGlu) receptors in the major functions of the central nervous system (CNS).  A wealth of preclin. studies provide evidence that pharmacol. targeting of mGlu receptors can effectively attenuate the development of symptoms and progression of many CNS disorders in animal models.  In this review we summarize the current knowledge on the involvement of mGlu receptors in the pathophysiol. of neuropsychiatric disorders (schizophrenia, depression, anxiety and cognitive disorders, pain perception and addiction), as well as neurodegenerative (Alzheimer's, Huntington's and Parkinson's diseases) and neurodevelopmental (fragile X syndrome and autism spectrum disorders) diseases.  We further emphasize the therapeutic potential of mGlu receptors' pharmacol. modulators in these diseases, describe the results of clin. trials with these compds. and discuss the potential sources of translational difficulties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi8y35VRCCS7Vg90H21EOLACvtfcHk0lgys-0TC1Rp2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCkt7c%253D&md5=c708232b06c6329cbc7dea983bf0070b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150316224011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150316224011%26sid%3Dliteratum%253Aachs%26aulast%3DGolubeva%26aufirst%3DA.%2BV.%26aulast%3DMoloney%26aufirst%3DR.%2BD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BM.%26aulast%3DDinan%26aufirst%3DT.%2BG.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520in%2520central%2520nervous%2520system%2520disease%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2016%26volume%3D17%26spage%3D538%26epage%3D616%26doi%3D10.2174%2F1389450116666150316224011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noetzel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">860</span>â <span class="NLM_lpage">875</span>, <span class="refDoi">Â DOI: 10.1124/mol.112.080531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.112.080531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22863693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktLvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=860-875&author=K.+J.+Gregoryauthor=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=S.+R.+Staufferauthor=A.+L.+Rodriguezauthor=K.+A.+Emmitteauthor=Y.+Zhouauthor=A.+C.+Chunauthor=A.+S.+Feltsauthor=B.+A.+Chauderauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Investigating+metabotropic+glutamate+receptor+5+allosteric+modulator+cooperativity%2C+affinity%2C+and+agonism%3A+enriching+structure-function+studies+and+structure-activity+relationships&doi=10.1124%2Fmol.112.080531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships</span></div><div class="casAuthors">Gregory, Karen J.; Noetzel, Meredith J.; Rook, Jerri M.; Vinson, Paige N.; Stauffer, Shaun R.; Rodriguez, Alice L.; Emmitte, Kyle A.; Zhou, Ya; Chun, Aspen C.; Felts, Andrew S.; Chauder, Brian A.; Lindsley, Craig W.; Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">860-875</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Drug discovery programs increasingly are focusing on allosteric modulators as a means to modify the activity of G protein-coupled receptor (GPCR) targets.  Allosteric binding sites are topog. distinct from the endogenous ligand (orthosteric) binding site, which allows for co-occupation of a single receptor with the endogenous ligand and an allosteric modulator that can alter receptor pharmacol. characteristics.  Neg. allosteric modulators (NAMs) inhibit and pos. allosteric modulators (PAMs) enhance the affinity and/or efficacy of orthosteric agonists.  Established approaches for estn. of affinity and efficacy values for orthosteric ligands are not appropriate for allosteric modulators, and this presents challenges for fully understanding the actions of novel modulators of GPCRs.  Metabotropic glutamate receptor 5 (mGlu5) is a family C GPCR for which a large array of allosteric modulators have been identified.  We took advantage of the many tools for probing allosteric sites on mGlu5 to validate an operational model of allosterism that allows quant. estn. of modulator affinity and cooperativity values.  Affinity ests. derived from functional assays fit well with affinities measured in radioligand binding expts. for both PAMs and NAMs with diverse chem. scaffolds and varying degrees of cooperativity.  We obsd. modulation bias for PAMs when we compared mGlu5-mediated Ca2+ mobilization and extracellular signal-regulated kinase 1/2 phosphorylation data.  Furthermore, we used this model to quantify the effects of mutations that reduce binding or potentiation by PAMs.  This model can be applied to PAM and NAM potency curves in combination with maximal fold-shift data to derive reliable ests. of modulator affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczOVRJNi-orVg90H21EOLACvtfcHk0lhIXckQ5SkPmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktLvF&md5=ca035d4e987783c9cf51e0fa12c4f761</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.080531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.080531%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DA.%2BC.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DInvestigating%2520metabotropic%2520glutamate%2520receptor%25205%2520allosteric%2520modulator%2520cooperativity%252C%2520affinity%252C%2520and%2520agonism%253A%2520enriching%2520structure-function%2520studies%2520and%2520structure-activity%2520relationships%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D860%26epage%3D875%26doi%3D10.1124%2Fmol.112.080531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Practical strategies and concepts in GPCR allosteric modulator discovery: recent advances with metabotropic glutamate receptors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">6707</span>â <span class="NLM_lpage">6741</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrev.5b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=6707-6741&author=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=C.+R.+Hopkinsauthor=T.+M.+Bridgesauthor=K.+J.+Gregoryauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Practical+strategies+and+concepts+in+GPCR+allosteric+modulator+discovery%3A+recent+advances+with+metabotropic+glutamate+receptors&doi=10.1021%2Facs.chemrev.5b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors</span></div><div class="casAuthors">Lindsley, Craig W.; Emmitte, Kyle A.; Hopkins, Corey R.; Bridges, Thomas M.; Gregory, Karen J.; Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6707-6741</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats.  Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacol., unprecedented subtype selectivity, and unique signal bias.  This review provides a comprehensive overview of the basics of GPCR allosteric pharmacol., medicinal chem., drug metab., and validated approaches to address each of the major challenges and caveats.  Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("mol. switches", signal bias, heterodimers) and practical solns. to enable the development of tool compds. and clin. candidates.  The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq18XJrjVel-7Vg90H21EOLACvtfcHk0lgSRrIoUdpG-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D&md5=c12704b6602b6c50add92e7fd9350382</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DPractical%2520strategies%2520and%2520concepts%2520in%2520GPCR%2520allosteric%2520modulator%2520discovery%253A%2520recent%2520advances%2520with%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D6707%26epage%3D6741%26doi%3D10.1021%2Facs.chemrev.5b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">mGlu<sub>5</sub> negative allosteric modulators: a patent review (2013â2016)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">691</span>â <span class="NLM_lpage">706</span>, <span class="refDoi">Â DOI: 10.1080/13543776.2017.1280466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1080%2F13543776.2017.1280466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=28067079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlemsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=691-706&author=K.+A.+Emmitte&title=mGlu5+negative+allosteric+modulators%3A+a+patent+review+%282013%E2%80%932016%29&doi=10.1080%2F13543776.2017.1280466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">mGlu5 negative allosteric modulators: a patent review (2013 - 2016)</span></div><div class="casAuthors">Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">691-706</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Introduction: The pursuit of small mol. mGlu5 NAMs as treatments for a variety of psychiatric and neurodegenerative disorders has developed into a mature field.  In addn. to extensive preclin. studies, multiple compds. have advanced into clin. trials with the most advanced studies occurring in patients with FXS, PD-LID, and MDD.  Areas Covered: This review begins with an update of the clin. activity with mGlu5 NAMs, and then moves into a summary of patent applications filed since 2013.  The summaries are organized into three sep. sections: (1) inventions centered on improvements to existing clin. compds.; (2) new small mols. that maintain the prototypical disubstituted alkyne chemotype found in many mGlu5 NAM compds.; and (3) new small mols. that are not from a disubstituted alkyne chemotype.  Expert Opinion: It is a crit. moment for mGlu5 NAM research as recent reports from clin. trials have included some significant disappointments that have blunted prior optimism.  Still, research in this area remains active, and recent years have added several more attractive small mols. to this field.  There is now an arsenal of diverse chemotypes available to continue to probe this target in the hopes that a drug may yet emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWQ94UvPC2ALVg90H21EOLACvtfcHk0lgSRrIoUdpG-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlemsb0%253D&md5=f2c86384dc509c8677e4c94ec2bfabb9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1280466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1280466%26sid%3Dliteratum%253Aachs%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DmGlu5%2520negative%2520allosteric%2520modulators%253A%2520a%2520patent%2520review%2520%25282013%25E2%2580%25932016%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D691%26epage%3D706%26doi%3D10.1080%2F13543776.2017.1280466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rocher, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BolÃ©a, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¼tjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Poul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epping-Jordan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutel, V.</span></span> <span> </span><span class="NLM_article-title">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutics</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">680</span>â <span class="NLM_lpage">695</span>, <span class="refDoi">Â DOI: 10.2174/1568026611109060680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2174%2F1568026611109060680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=21261592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=680-695&author=J.+P.+Rocherauthor=B.+Bonnetauthor=C.+Bol%C3%A9aauthor=R.+L%C3%BCtjensauthor=E.+Le+Poulauthor=S.+Poliauthor=M.+Epping-Jordanauthor=A.+S.+Bessisauthor=B.+Ludwigauthor=V.+Mutel&title=mGluR5+negative+allosteric+modulators+overview%3A+a+medicinal+chemistry+approach+towards+a+series+of+novel+therapeutics&doi=10.2174%2F1568026611109060680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents</span></div><div class="casAuthors">Rocher, Jean-Philippe; Bonnet, Beatrice; Bolea, Christelle; Lutjens, Robert; Le Poul, Emmanuel; Poli, Sonia; Epping-Jordan, Mark; Bessis, Anne-Sophie; Ludwig, Bernard; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">680-695</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Allosteric modulators of metabotropic glutamate receptors (mGluRs) subtypes 1-8 have been shown to offer a valid way to develop small mol. non aminoacid-like therapeutics that can be administered orally and that readily cross the blood-brain barrier.  Allosteric modulators of glutamatergic receptors and in particular mGluR5 have emerged as a novel and highly desirable class of compds. for the treatment of central nervous system (CNS) disorders and peripheral disorders.  This article provides medicinal chem. highlights around the chem. classes of potent and highly selective mGluR5 neg. allosteric modulators (NAMs) and their therapeutic potential.  In addn., it describes the medicinal chem. approach from the discovery to the clin. candidate selection of a new series of heteroaryl-butynylpyridines targeting mGluR5.  The multiparametric optimization of the initial starting point which ended in the selection of potential clin. candidates combining the best pharmacophoric features is presented.  The pharmacol. properties are reported and support the interest of these agents for new therapeutic approaches.  Furthermore, a summary of the diverse mGluR5 Positron Emission Tomog. (PET) radioligands is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeXrv5HnHG77Vg90H21EOLACvtfcHk0ljhcgdoHvGuxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D&md5=aab29725fa93c1895f32f7dbe93a16f1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060680%26sid%3Dliteratum%253Aachs%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DBonnet%26aufirst%3DB.%26aulast%3DBol%25C3%25A9a%26aufirst%3DC.%26aulast%3DL%25C3%25BCtjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DBessis%26aufirst%3DA.%2BS.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DmGluR5%2520negative%2520allosteric%2520modulators%2520overview%253A%2520a%2520medicinal%2520chemistry%2520approach%2520towards%2520a%2520series%2520of%2520novel%2520therapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D680%26epage%3D695%26doi%3D10.2174%2F1568026611109060680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mihov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, G.</span></span> <span> </span><span class="NLM_article-title">Negative allosteric modulators of metabotropic glutamate receptors subtype 5 in addiction: a therapeutic window</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">pyw002</span>, <span class="refDoi">Â DOI: 10.1093/ijnp/pyw002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1093%2Fijnp%2Fpyw002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26802568" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=pyw002&author=Y.+Mihovauthor=G.+Hasler&title=Negative+allosteric+modulators+of+metabotropic+glutamate+receptors+subtype+5+in+addiction%3A+a+therapeutic+window&doi=10.1093%2Fijnp%2Fpyw002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyw002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyw002%26sid%3Dliteratum%253Aachs%26aulast%3DMihov%26aufirst%3DY.%26aulast%3DHasler%26aufirst%3DG.%26atitle%3DNegative%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptors%2520subtype%25205%2520in%2520addiction%253A%2520a%2520therapeutic%2520window%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2016%26volume%3D19%26spage%3Dpyw002%26doi%3D10.1093%2Fijnp%2Fpyw002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmo, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptors and neurodegenerative diseases</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">191</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2016.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.phrs.2016.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=27872019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOgt7zM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2017&pages=179-191&author=F.+M.+Ribeiroauthor=L.+B.+Vieiraauthor=R.+G.+Piresauthor=R.+P.+Olmoauthor=S.+S.+Ferguson&title=Metabotropic+glutamate+receptors+and+neurodegenerative+diseases&doi=10.1016%2Fj.phrs.2016.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors and neurodegenerative diseases</span></div><div class="casAuthors">Ribeiro, Fabiola M.; Vieira, Luciene B.; Pires, Rita G. W.; Olmo, Roenick P.; Ferguson, Stephen S. G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-191</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Glutamate is the most important excitatory neurotransmitter of the mammalian central nervous system (CNS), playing an important role in memory, synaptic plasticity and neuronal development.  However, glutamate overstimulation is also implicated in neuronal cell death.  There are two major types of glutamate receptors: ionotropic and metabotropic.  Thus far, eight metabotropic glutamate receptors (mGluRs) subtypes have been characterized and are divided into three subgroups based on sequence homol. and cell signaling activation. mGluRs activate a wide variety of cell signaling pathways by G protein-coupled pathways or via G protein-independent cell signaling activation.  Moreover, these receptors exhibit widespread distribution in the CNS and are implicated in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).  This review aims to discuss the latest updates concerning mGluRs and their role in neurodegenerative diseases. mGluRs agonists and antagonists as well as pos. and neg. allosteric modulators have been tested in several animal models of neurodegenerative diseases.  Furthermore, mGluR knockout mouse models have been crossed to mouse models of AD and HD, providing important data about mGluRs role in neurodegenerative disease progression.  Thus, mGluRs constitute potential therapeutic targets for the development of therapies to treat neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ohpCmghKrrVg90H21EOLACvtfcHk0ljhcgdoHvGuxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOgt7zM&md5=dd9b8b140e8b0094c62005eccffd923c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DF.%2BM.%26aulast%3DVieira%26aufirst%3DL.%2BB.%26aulast%3DPires%26aufirst%3DR.%2BG.%26aulast%3DOlmo%26aufirst%3DR.%2BP.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520and%2520neurodegenerative%2520diseases%26jtitle%3DPharmacol.%2520Res.%26date%3D2017%26volume%3D115%26spage%3D179%26epage%3D191%26doi%3D10.1016%2Fj.phrs.2016.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busse, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattersall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D. P.</span></span> <span> </span><span class="NLM_article-title">The behavioral profile of the potent and selective mGlu<sub>5</sub> receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) in rodent models of anxiety</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1971</span>â <span class="NLM_lpage">1979</span>, <span class="refDoi">Â DOI: 10.1038/sj.npp.1300540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fsj.npp.1300540" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1971-1979&author=C.+S.+Busseauthor=J.+Brodkinauthor=D.+Tattersallauthor=J.+J.+Andersonauthor=N.+Warrenauthor=L.+Tehraniauthor=L.+J.+Bristowauthor=M.+A.+Varneyauthor=N.+D.+P.+Cosford&title=The+behavioral+profile+of+the+potent+and+selective+mGlu5+receptor+antagonist+3-%5B%282-methyl-1%2C3-thiazol-4-yl%29ethynyl%5D-pyridine+%28MTEP%29+in+rodent+models+of+anxiety&doi=10.1038%2Fsj.npp.1300540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300540%26sid%3Dliteratum%253Aachs%26aulast%3DBusse%26aufirst%3DC.%2BS.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DTattersall%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DJ.%2BJ.%26aulast%3DWarren%26aufirst%3DN.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DThe%2520behavioral%2520profile%2520of%2520the%2520potent%2520and%2520selective%2520mGlu5%2520receptor%2520antagonist%25203-%255B%25282-methyl-1%252C3-thiazol-4-yl%2529ethynyl%255D-pyridine%2520%2528MTEP%2529%2520in%2520rodent%2520models%2520of%2520anxiety%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1971%26epage%3D1979%26doi%3D10.1038%2Fsj.npp.1300540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karras, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, J. N.</span></span> <span> </span><span class="NLM_article-title">Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">131ra51</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.3003501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1126%2Fscitranslmed.3003501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22539775" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=131ra51&author=J.+L.+Silvermanauthor=D.+G.+Smithauthor=S.+J.+Rizzoauthor=M.+N.+Karrasauthor=S.+M.+Turnerauthor=S.+S.+Toluauthor=D.+K.+Bryceauthor=D.+L.+Smithauthor=K.+Fonsecaauthor=R.+H.+Ringauthor=J.+N.+Crawley&title=Negative+allosteric+modulation+of+the+mGluR5+receptor+reduces+repetitive+behaviors+and+rescues+social+deficits+in+mouse+models+of+autism&doi=10.1126%2Fscitranslmed.3003501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003501%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DRizzo%26aufirst%3DS.%2BJ.%26aulast%3DKarras%26aufirst%3DM.%2BN.%26aulast%3DTurner%26aufirst%3DS.%2BM.%26aulast%3DTolu%26aufirst%3DS.%2BS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26atitle%3DNegative%2520allosteric%2520modulation%2520of%2520the%2520mGluR5%2520receptor%2520reduces%2520repetitive%2520behaviors%2520and%2520rescues%2520social%2520deficits%2520in%2520mouse%2520models%2520of%2520autism%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D131ra51%26doi%3D10.1126%2Fscitranslmed.3003501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pop, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span> <span> </span><span class="NLM_article-title">Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development</span>. <i>Psychopharmacology (Berl)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>231</i></span>,  <span class="NLM_fpage">1217</span>â <span class="NLM_lpage">1226</span>, <span class="refDoi">Â DOI: 10.1007/s00213-013-3330-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1007%2Fs00213-013-3330-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24232444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ms1WksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=1217-1226&author=A.+S.+Popauthor=B.+Gomez-Mancillaauthor=G.+Neriauthor=R.+Willemsenauthor=F.+Gasparini&title=Fragile+X+syndrome%3A+a+preclinical+review+on+metabotropic+glutamate+receptor+5+%28mGluR5%29+antagonists+and+drug+development&doi=10.1007%2Fs00213-013-3330-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development</span></div><div class="casAuthors">Pop Andreea S; Gomez-Mancilla Baltazar; Neri Giovanni; Willemsen Rob; Gasparini Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1217-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Fragile X syndrome (FXS) is considered the leading inherited cause of intellectual disability and autism.  In FXS, the fragile X mental retardation 1 (FMR1) gene is silenced and the fragile X mental retardation protein (FMRP) is not expressed, resulting in the characteristic features of the syndrome.  Despite recent advances in understanding the pathophysiology of FXS, there is still no cure for this condition; current treatment is symptomatic.  Preclinical research is essential in the development of potential therapeutic agents.  OBJECTIVES:  This review provides an overview of the preclinical evidence supporting metabotropic glutamate receptor 5 (mGluR5) antagonists as therapeutic agents for FXS.  RESULTS:  According to the mGluR theory of FXS, the absence of FMRP leads to enhanced glutamatergic signaling via mGluR5, which leads to increased protein synthesis and defects in synaptic plasticity including enhanced long-term depression.  As such, efforts to develop agents that target the underlying pathophysiology of FXS have focused on mGluR5 modulation.  Animal models, particularly the Fmr1 knockout mouse model, have become invaluable in exploring therapeutic approaches on an electrophysiological, behavioral, biochemical, and neuroanatomical level.  Two direct approaches are currently being investigated for FXS treatment: reactivating the FMR1 gene and compensating for the lack of FMRP.  The latter approach has yielded promising results, with mGluR5 antagonists showing efficacy in clinical trials.  CONCLUSIONS:  Targeting mGluR5 is a valid approach for the development of therapeutic agents that target the underlying pathophysiology of FXS.  Several compounds are currently in development, with encouraging results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpayJ8_eLcGekdrW1FkXG-fW6udTcc2eaQtUIc9d6Rprntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ms1WksA%253D%253D&md5=4cc3fa76ed54a0a52c624a90ac92a985</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3330-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3330-3%26sid%3Dliteratum%253Aachs%26aulast%3DPop%26aufirst%3DA.%2BS.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26aulast%3DNeri%26aufirst%3DG.%26aulast%3DWillemsen%26aufirst%3DR.%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DFragile%2520X%2520syndrome%253A%2520a%2520preclinical%2520review%2520on%2520metabotropic%2520glutamate%2520receptor%25205%2520%2528mGluR5%2529%2520antagonists%2520and%2520drug%2520development%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2014%26volume%3D231%26spage%3D1217%26epage%3D1226%26doi%3D10.1007%2Fs00213-013-3330-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Litim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, T.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as therapeutic targets in Parkinsonâs disease: an update from the last 5 years of research</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">166</span>â <span class="NLM_lpage">179</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2016.03.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.neuropharm.2016.03.036" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2017&pages=166-179&author=N.+Litimauthor=M.+Morissetteauthor=T.+Di+Paolo&title=Metabotropic+glutamate+receptors+as+therapeutic+targets+in+Parkinson%E2%80%99s+disease%3A+an+update+from+the+last+5+years+of+research&doi=10.1016%2Fj.neuropharm.2016.03.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.03.036%26sid%3Dliteratum%253Aachs%26aulast%3DLitim%26aufirst%3DN.%26aulast%3DMorissette%26aufirst%3DM.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520therapeutic%2520targets%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520an%2520update%2520from%2520the%2520last%25205%2520years%2520of%2520research%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D115%26spage%3D166%26epage%3D179%26doi%3D10.1016%2Fj.neuropharm.2016.03.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span> <span> </span><span class="NLM_article-title">Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias</span>. <i>Parkinsonism Relat. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">947</span>â <span class="NLM_lpage">956</span>, <span class="refDoi">Â DOI: 10.1016/j.parkreldis.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.parkreldis.2014.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24951359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADC%252BC2cfksFWgtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=947-956&author=O.+Rascolauthor=S.+Foxauthor=F.+Gaspariniauthor=C.+Kenneyauthor=T.+Di+Paoloauthor=B.+Gomez-Mancilla&title=Use+of+metabotropic+glutamate+5-receptor+antagonists+for+treatment+of+levodopa-induced+dyskinesias&doi=10.1016%2Fj.parkreldis.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias</span></div><div class="casAuthors">Rascol Olivier; Fox Susan; Gasparini Fabrizio; Kenney Christopher; Di Paolo Therese; Gomez-Mancilla Baltazar</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">947-56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Modulation of metabotropic glutamate receptors may be a novel therapeutic approach to manage L-Dopa-induced dyskinesias in patients with Parkinson's disease.  This article reviews the rationale for use of metabotropic glutamate 5-receptor antagonists in experimental and clinical L-Dopa-induced dyskinesias.  METHODS:  Systematic literature searches were performed (between May 2012-March 2014) for relevant English language articles using PubMed.  Additional articles of interest were identified from reference lists of included publications.  Relevant clinical abstracts from Movement Disorder Society meetings were included.  RESULTS:  16 preclinical studies of metabotropic glutamate 5-receptor antagonists in animal models of L-Dopa-induced dyskinesias and 7 clinical studies in patients with Parkinson's disease and L-Dopa-induced dyskinesias were included.  Anti-dyskinetic effects of metabotropic glutamate 5-receptor blockade (MPEP, MTEP, fenobam, or MRZ-8676) were reported in dyskinetic 6-hydroxydopamine-lesioned rats.  Studies in MPTP-lesioned non-human primates reported anti-dyskinetic effects of MPEP, MTEP, fenobam and mavoglurant (AFQ056).  Three randomized, double-blind clinical trials reported anti-dyskinetic efficacy of mavoglurant, without effects on anti-parkinsonian therapy, with dizziness the most common adverse event.  However, two further studies failed to demonstrate significant anti-dyskinetic efficacy.  A randomized, double-blind, placebo-controlled safety study of dipraglurant (ADX48621) demonstrated tolerability and positive exploratory secondary outcomes of reduced dyskinesia.  CONCLUSIONS:  Animal model studies provide evidence for anti-dyskinetic efficacy of metabotropic glutamate 5-receptor antagonists.  Initial proof-of-concept clinical trials of mavoglurant and dipraglurant showed positive results; anti-dyskinetic efficacy was not supported by two recent mavoglurant trials.  Further evaluations of optimal dosage and long-term efficacy and safety of metabotropic glutamate 5-receptor antagonists for management of L-Dopa-induced dyskinesias in Parkinson's disease are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqMEpWKJUcNC86Js-BCLiifW6udTcc2eaQtUIc9d6Rprntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfksFWgtA%253D%253D&md5=c68e2b9580c0d0b360db519ef4718f31</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.parkreldis.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parkreldis.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DFox%26aufirst%3DS.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26atitle%3DUse%2520of%2520metabotropic%2520glutamate%25205-receptor%2520antagonists%2520for%2520treatment%2520of%2520levodopa-induced%2520dyskinesias%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2014%26volume%3D20%26spage%3D947%26epage%3D956%26doi%3D10.1016%2Fj.parkreldis.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaso, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niciu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iadarola, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lally, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado-Vieira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic modulation of glutamate receptors in major depressive disorder</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">70</span>, <span class="refDoi">Â DOI: 10.2174/1570159X14666160321123221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2174%2F1570159X14666160321123221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26997505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1WlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=57-70&author=B.+A.+Jasoauthor=M.+J.+Niciuauthor=N.+D.+Iadarolaauthor=N.+Lallyauthor=E.+M.+Richardsauthor=M.+Parkauthor=E.+D.+Ballardauthor=A.+C.+Nugentauthor=R.+Machado-Vieiraauthor=C.+A.+Zarate&title=Therapeutic+modulation+of+glutamate+receptors+in+major+depressive+disorder&doi=10.2174%2F1570159X14666160321123221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder</span></div><div class="casAuthors">Jaso, Brittany A.; Niciu, Mark J.; Iadarola, Nicolas D.; Lally, Niall; Richards, Erica M.; Park, Minkyung; Ballard, Elizabeth D.; Nugent, Allison C.; Machado-Vieira, Rodrigo; Zarate, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and impairment for patients, and real world effectiveness trials further suggest that antidepressant efficacy is limited in many patients.  All currently approved antidepressant medications for MDD act primarily through monoaminergic mechanisms, e.g., receptor/reuptake agonists or antagonists with varying affinities for serotonin, norepinephrine, or dopamine.  Glutamate is the major excitatory neurotransmitter in the central nervous system, and glutamate and its cognate receptors are implicated in the pathophysiol. of MDD, as well as in the development of novel therapeutics for this disorder.  Since the rapid and robust antidepressant effects of the N-methyl-D-aspartate (NMDA) antagonist ketamine were first obsd. in 2000, other NMDA receptor antagonists have been studied in MDD.  These have been assocd. with relatively modest antidepressant effects compared to ketamine, but some have shown more favorable characteristics with increased potential in clin. practice (for instance, oral administration, decreased dissociative and/or psychotomimetic effects, and reduced abuse/diversion liability).  This article reviews the clin. evidence supporting the use of glutamate receptor modulators with direct affinity for cognate receptors: 1) non-competitive NMDA receptor antagonists (ketamine, memantine, dextromethorphan, AZD6765); 2) subunit (NR2B)-specific NMDA receptor antagonists (CP- 101,606/traxoprodil, MK-0657); 3) NMDA receptor glycine-site partial agonists (D-cycloserine, GLYX- 13); and 4) metabotropic glutamate receptor (mGluR) modulators (AZD2066, RO4917523/basimglurant).  Several other theor. glutamate receptor targets with preclin. antidepressant-like efficacy, but that have yet to be studied clin., are also briefly discussed; these include -amino-3-hydroxyl-5-methyl-4- isoxazoleproprionic acid (AMPA) agonists, mGluR2/3 neg. allosteric modulators, and mGluR7 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9HWcN60qpHrVg90H21EOLACvtfcHk0lhrDpgr9uqpxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1WlsQ%253D%253D&md5=180a395edc9d7dd01db713c249039783</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1570159X14666160321123221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X14666160321123221%26sid%3Dliteratum%253Aachs%26aulast%3DJaso%26aufirst%3DB.%2BA.%26aulast%3DNiciu%26aufirst%3DM.%2BJ.%26aulast%3DIadarola%26aufirst%3DN.%2BD.%26aulast%3DLally%26aufirst%3DN.%26aulast%3DRichards%26aufirst%3DE.%2BM.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DE.%2BD.%26aulast%3DNugent%26aufirst%3DA.%2BC.%26aulast%3DMachado-Vieira%26aufirst%3DR.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26atitle%3DTherapeutic%2520modulation%2520of%2520glutamate%2520receptors%2520in%2520major%2520depressive%2520disorder%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2017%26volume%3D15%26spage%3D57%26epage%3D70%26doi%3D10.2174%2F1570159X14666160321123221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutrick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donchev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocwieja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span> <span> </span><span class="NLM_article-title">Mavoglurant augmentation in OCD patients resistant to selective serotonin reuptake inhibitors: a proof-of-concept, randomized, placebo-controlled, phase 2 study</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">524</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1007/s12325-016-0468-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1007%2Fs12325-016-0468-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=524-541&author=D.+Rutrickauthor=D.+J.+Steinauthor=G.+Subramanianauthor=B.+Smithauthor=M.+Favaauthor=G.+Haslerauthor=J.+Chaauthor=F.+Gaspariniauthor=T.+Donchevauthor=M.+Ocwiejaauthor=D.+Johnsauthor=B.+Gomez-Mancilla&title=Mavoglurant+augmentation+in+OCD+patients+resistant+to+selective+serotonin+reuptake+inhibitors%3A+a+proof-of-concept%2C+randomized%2C+placebo-controlled%2C+phase+2+study&doi=10.1007%2Fs12325-016-0468-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs12325-016-0468-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12325-016-0468-5%26sid%3Dliteratum%253Aachs%26aulast%3DRutrick%26aufirst%3DD.%26aulast%3DStein%26aufirst%3DD.%2BJ.%26aulast%3DSubramanian%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DFava%26aufirst%3DM.%26aulast%3DHasler%26aufirst%3DG.%26aulast%3DCha%26aufirst%3DJ.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DDonchev%26aufirst%3DT.%26aulast%3DOcwieja%26aufirst%3DM.%26aulast%3DJohns%26aufirst%3DD.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26atitle%3DMavoglurant%2520augmentation%2520in%2520OCD%2520patients%2520resistant%2520to%2520selective%2520serotonin%2520reuptake%2520inhibitors%253A%2520a%2520proof-of-concept%252C%2520randomized%252C%2520placebo-controlled%252C%2520phase%25202%2520study%26jtitle%3DAdv.%2520Ther.%26date%3D2017%26volume%3D34%26spage%3D524%26epage%3D541%26doi%3D10.1007%2Fs12325-016-0468-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LingenhÃ¶hl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoehr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flor, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranesic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biollaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgeier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckendorn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urwyler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacaan, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santori, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veliocelebi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span> <span> </span><span class="NLM_article-title">Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systematically active mGlu<sub>5</sub> receptor antagonist</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1493</span>â <span class="NLM_lpage">1503</span>, <span class="refDoi">Â DOI: 10.1016/S0028-3908(99)00082-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2FS0028-3908%2899%2900082-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1493-1503&author=F.+Gaspariniauthor=K.+Lingenh%C3%B6hlauthor=N.+Stoehrauthor=P.+J.+Florauthor=M.+Heinrichauthor=I.+Vranesicauthor=M.+Biollazauthor=H.+Allgeierauthor=R.+Heckendornauthor=S.+Urwylerauthor=M.+A.+Varneyauthor=E.+C.+Johnsonauthor=S.+D.+Hessauthor=S.+P.+Raoauthor=A.+I.+Sacaanauthor=E.+M.+Santoriauthor=G.+Veliocelebiauthor=R.+Kuhn&title=Methyl-6-%28phenylethynyl%29-pyridine+%28MPEP%29%2C+a+potent%2C+selective+and+systematically+active+mGlu5+receptor+antagonist&doi=10.1016%2FS0028-3908%2899%2900082-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900082-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900082-9%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DLingenh%25C3%25B6hl%26aufirst%3DK.%26aulast%3DStoehr%26aufirst%3DN.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DBiollaz%26aufirst%3DM.%26aulast%3DAllgeier%26aufirst%3DH.%26aulast%3DHeckendorn%26aufirst%3DR.%26aulast%3DUrwyler%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DE.%2BC.%26aulast%3DHess%26aufirst%3DS.%2BD.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DSacaan%26aufirst%3DA.%2BI.%26aulast%3DSantori%26aufirst%3DE.%2BM.%26aulast%3DVeliocelebi%26aufirst%3DG.%26aulast%3DKuhn%26aufirst%3DR.%26atitle%3DMethyl-6-%2528phenylethynyl%2529-pyridine%2520%2528MPEP%2529%252C%2520a%2520potent%252C%2520selective%2520and%2520systematically%2520active%2520mGlu5%2520receptor%2520antagonist%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1493%26epage%3D1503%26doi%3D10.1016%2FS0028-3908%2899%2900082-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roppe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span> <span> </span><span class="NLM_article-title">3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">204</span>â <span class="NLM_lpage">206</span>, <span class="refDoi">Â DOI: 10.1021/jm025570j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025570j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=204-206&author=N.+D.+Cosfordauthor=L.+Tehraniauthor=J.+Roppeauthor=E.+Schweigerauthor=N.+D.+Smithauthor=J.+Andersonauthor=L.+Bristowauthor=J.+Brodkinauthor=X.+Jiangauthor=I.+McDonaldauthor=S.+Raoauthor=M.+Washburnauthor=M.+A.+Varney&title=3-%5B%282-Methyl-1%2C3-thiazol-4-yl%29ethynyl%5D-pyridine%3A+a+potent+and+highly+selective+metabotropic+glutamate+subtype+5+receptor+antagonist+with+anxiolytic+activity&doi=10.1021%2Fjm025570j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm025570j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025570j%26sid%3Dliteratum%253Aachs%26aulast%3DCosford%26aufirst%3DN.%2BD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DSchweiger%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMcDonald%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DM.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26atitle%3D3-%255B%25282-Methyl-1%252C3-thiazol-4-yl%2529ethynyl%255D-pyridine%253A%2520a%2520potent%2520and%2520highly%2520selective%2520metabotropic%2520glutamate%2520subtype%25205%2520receptor%2520antagonist%2520with%2520anxiolytic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D204%26epage%3D206%26doi%3D10.1021%2Fjm025570j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R.
H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼ttelmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolczewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼hlemann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malherbe, P.</span></span> <span> </span><span class="NLM_article-title">Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu<sub>5</sub> receptor antagonist with inverse agonist activity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>315</i></span>,  <span class="NLM_fpage">711</span>â <span class="NLM_lpage">721</span>, <span class="refDoi">Â DOI: 10.1124/jpet.105.089839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fjpet.105.089839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16040814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=711-721&author=R.%0AH.+P.+Porterauthor=G.+Jaeschkeauthor=W.+Spoorenauthor=T.+M.+Ballardauthor=B.+B%C3%BCttelmannauthor=S.+Kolczewskiauthor=J.+U.+Petersauthor=E.+Prinssenauthor=J.+Wichmannauthor=E.+Vieiraauthor=A.+M%C3%BChlemannauthor=S.+Gattiauthor=V.+Mutelauthor=P.+Malherbe&title=Fenobam%3A+a+clinically+validated+nonbenzodiazepine+anxiolytic+is+a+potent%2C+selective%2C+and+noncompetitive+mGlu5+receptor+antagonist+with+inverse+agonist+activity&doi=10.1124%2Fjpet.105.089839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fenobam: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity</span></div><div class="casAuthors">Porter, Richard H. P.; Jaeschke, Georg; Spooren, Will; Ballard, Theresa M.; Buttelmann, Bernd; Kolczewski, Sabine; Peters, Jens-Uwe; Prinseen, Eric; Wichmann, Jurgen; Vieira, Eric; Muhlemann, Andreas; Gatti, Silvia; Mutel, Vincent; Malherbe, Pari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">711-721</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea] is an atypical anxiolytic agent with unknown mol. target that has previously been demonstrated both in rodents and human to exert anxiolytic activity.  Here, we report that fenobam is a selective and potent metabotropic glutamate (mGlu)5 receptor antagonist acting at an allosteric modulatory site shared with 2-methyl-6-phenylethynyl-pyridine (MPEP), the protypical selective mGlu5 receptor antagonist.  Fenobam inhibited quisqualate-evoked intracellular calcium response mediated by human mGlu5 receptor with IC50 = 58Â±2 nM.  It acted in a noncompetitive manner, similar to MPEP and demonstrated inverse agonist properties, blocking 66% of the mGlu5 receptor basal activity (in an over expressed cell line) with an IC50 = 84Â±13 nM.  [3H]Fenobam bound to rat and human recombinant receptors with Kd values of 54Â±6 and 31Â±4 nM, resp.  MPEP inhibited [3H]fenobam binding to human mGlu5 receptors with a Ki value of 6.7Â±0.7 nM, indicating a common binding site shared by both allosteric antagonists.  Fenobam exhibits anxiolytic activity in the stress-induced hyperthermia model, Vogel conflict test, Geller-Seifter conflict test, and conditioned emotional response with a min. ED of 10 to 30 mg/kg p.o.  Furthermore, fenobam is devoid of GABAergic activity, confirming previous reports that fenobam acts by a mechanism distinct from benzodiazepines.  The non-GABAergic activity of fenobam, coupled with its robust anxiolytic activity and reported efficacy in human in a double blind placebo-controlled trial, supports the potential of developing mGlu5 receptor antagonists with an improved therapeutic window over benzodiazepines as novel anxiolytic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQg1qRiOD0cLVg90H21EOLACvtfcHk0lj7a2GHN6UB0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F&md5=8d08eb1e3f777231204024da12301a2e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089839%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DBallard%26aufirst%3DT.%2BM.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DM%25C3%25BChlemann%26aufirst%3DA.%26aulast%3DGatti%26aufirst%3DS.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DMalherbe%26aufirst%3DP.%26atitle%3DFenobam%253A%2520a%2520clinically%2520validated%2520nonbenzodiazepine%2520anxiolytic%2520is%2520a%2520potent%252C%2520selective%252C%2520and%2520noncompetitive%2520mGlu5%2520receptor%2520antagonist%2520with%2520inverse%2520agonist%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D711%26epage%3D721%26doi%3D10.1124%2Fjpet.105.089839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berry-Kravis, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuhas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snape, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranfaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagerman, R.</span></span> <span> </span><span class="NLM_article-title">A pilot open label, single dose trial of fenobam in adults with fragile X syndrome</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">266</span>â <span class="NLM_lpage">271</span>, <span class="refDoi">Â DOI: 10.1136/jmg.2008.063701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1136%2Fjmg.2008.063701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=19126569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Git7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2009&pages=266-271&author=E.+M.+Berry-Kravisauthor=D.+Hesslauthor=S.+Coffeyauthor=C.+Herveyauthor=A.+Schneiderauthor=J.+Yuhasauthor=J.+Hutchinsonauthor=M.+Snapeauthor=M.+Tranfagliaauthor=D.+V.+Nguyenauthor=R.+Hagerman&title=A+pilot+open+label%2C+single+dose+trial+of+fenobam+in+adults+with+fragile+X+syndrome&doi=10.1136%2Fjmg.2008.063701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A pilot open label, single dose trial of fenobam in adults with fragile X syndrome</span></div><div class="casAuthors">Berry-Kravis, E.; Hessl, D.; Coffey, S.; Hervey, C.; Schneider, A.; Yuhas, J.; Hutchison, J.; Snape, M.; Tranfaglia, M.; Nguyen, D. V.; Hagerman, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">266-271</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective: A pilot open label, single dose trial of fenobam, an mGluR5 antagonist, was conducted to provide an initial evaluation of safety and pharmacokinetics in adult males and females with fragile X syndrome (FXS).  Methods: Twelve subjects, recruited from two fragile X clinics, received a single oral dose of 50-150 mg of fenobam.  Blood for pharmacokinetic testing, vital signs and side effect screening was obtained at baseline and numerous time points for 6 h after dosing.  Outcome measures included prepulse inhibition (PPI) and a continuous performance test (CPT) obtained before and after dosing to explore the effects of fenobam on core phenotypic measures of sensory gating, attention and inhibition.  Results: There were no significant adverse reactions to fenobam administration.  Pharmacokinetic anal. showed that fenobam concns. were dose dependent but variable, with mean (SEM) peak values of 39.7 (18.4) ng/mL at 180 min after the 150 mg dose.  PPI met a response criterion of an improvement of at least 20% over baseline in 6 of 12 individuals (4/6 males and 2/6 females).  The CPT did not display improvement with treatment due to ceiling effects.  Conclusions: Clin. significant adverse effects were not identified in this study of single dose fenobam across the range of dosages utilized.  The pos. effects seen in animal models of FXS treated with fenobam or other mGluR5 antagonists, the apparent lack of clin. significant adverse effects, and the potential beneficial clin. effects seen in this pilot trial support further study of the compd. in adults with FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99DijLUqcQLVg90H21EOLACvtfcHk0ljUE3mMWOCm9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Git7c%253D&md5=956667f6a057902de18996447ef27400</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2008.063701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2008.063701%26sid%3Dliteratum%253Aachs%26aulast%3DBerry-Kravis%26aufirst%3DE.%2BM.%26aulast%3DHessl%26aufirst%3DD.%26aulast%3DCoffey%26aufirst%3DS.%26aulast%3DHervey%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DYuhas%26aufirst%3DJ.%26aulast%3DHutchinson%26aufirst%3DJ.%26aulast%3DSnape%26aufirst%3DM.%26aulast%3DTranfaglia%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DD.%2BV.%26aulast%3DHagerman%26aufirst%3DR.%26atitle%3DA%2520pilot%2520open%2520label%252C%2520single%2520dose%2520trial%2520of%2520fenobam%2520in%2520adults%2520with%2520fragile%2520X%2520syndrome%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2009%26volume%3D46%26spage%3D266%26epage%3D271%26doi%3D10.1136%2Fjmg.2008.063701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swedberg, M. D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span> <span> </span><span class="NLM_article-title">AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">212</span>â <span class="NLM_lpage">222</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.215137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fjpet.114.215137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24876235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=212-222&author=M.+D.+B.+Swedbergauthor=P.+Raboisson&title=AZD9272+and+AZD2066%3A+selective+and+highly+central+nervous+system+penetrant+mGluR5+antagonists+characterized+by+their+discriminative+effects&doi=10.1124%2Fjpet.114.215137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects</span></div><div class="casAuthors">Swedberg, Michael D. B.; Raboisson, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-222, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metabotropic glutamate receptor 5 (mGluR5) antagonists fenobam, MPEP (2-methyl-6-(phenylethynyl)pyridine), and MTEP (3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine) were previously shown to not cause N-methyl-d-aspartate antagonist-like psychoactive effects in phencyclidine (PCP) drug discrimination studies, but to cause MTEP-like discrimination in rats, suggesting that the psychoactive and psychotomimetic effects reported with fenobam in humans were likely mediated by mGluR5 antagonist mechanisms.  The present study was designed to characterize AZD9272 (3-fluoro-5-(3-(5-fluoropyridin-2-yl)-1,2,4-oxadiazol5-yl)benzonitrile) and AZD2066 [4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine], two mGluR5 antagonists taken to clin. development for analgesia.  AZD9272 was evaluated in several groups of rats trained to discriminate cocaine, PCP, chlordiazepoxide, (-)-Î9-tetrahydrocannabinol [(-)-Î9-THC], or MTEP from no drug.  AZD9272 shared discriminative properties with MTEP only.  The discriminative half-life was 3.23 h for MTEP and 21.93 h for AZD9272 in rats trained to discriminate MTEP from no drug.  Other rats were successfully trained to discriminate AZD9272 from no drug.  Due to the long duration of action of AZD9272, discrimination training was conducted every other day.  AZD9272 caused a dose-dependent increase in AZD9272-appropriate responding.  PCP did not cause AZD9272-appropriate responding, whereas MTEP, fenobam, and the mGluR5 antagonist AZD2066 did.  The discriminative half-life of AZD9272 was 24.3 h in rats trained to discriminate AZD9272 from no drug.  It is concluded that the discriminative effects of AZD9272 and AZD2066 are similar to those of previously investigated mGluR5 antagonists and dissimilar to those of cocaine, PCP, chlordiazepoxide, and (-)-Î9-THC.  The discriminative half-life of AZD9272 is approx. 7-fold longer than for MTEP.  These data support and extend previous findings suggesting that mGluR5 antagonism causes psychoactive effects selectively mediated by mGluR5 mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWgs3LGXT2QbVg90H21EOLACvtfcHk0ljMwPm4SZfPpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7nL&md5=814d1e196e926aaf96fd64e575207922</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.215137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.215137%26sid%3Dliteratum%253Aachs%26aulast%3DSwedberg%26aufirst%3DM.%2BD.%2BB.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DAZD9272%2520and%2520AZD2066%253A%2520selective%2520and%2520highly%2520central%2520nervous%2520system%2520penetrant%2520mGluR5%2520antagonists%2520characterized%2520by%2520their%2520discriminative%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D212%26epage%3D222%26doi%3D10.1124%2Fjpet.114.215137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">StÃ¥hle, L.</span>; <span class="NLM_string-name">Karlsten, R.</span>; <span class="NLM_string-name">Jonzon, B.</span>; <span class="NLM_string-name">Eriksson, B.</span>; <span class="NLM_string-name">KÃ¥gedal, M.</span>; <span class="NLM_string-name">Dominicus, A.</span></span> Safety evaluation of the mGluR5 antagonists AZD9272, AZD2066, and AZD2516 in healthy volunteers and patients with neuropathic pain or major depressive disorders. Abstract PT444. Proceedings of the  <i>14th World Congress on Pain</i>,  Milan, Italy, August 28, 2012; <span class="NLM_publisher-name">International Association for the Study of Pain</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=L.+St%C3%A5hle&author=R.+Karlsten&author=B.+Jonzon&author=B.+Eriksson&author=M.+K%C3%A5gedal&author=A.+Dominicus&title=14th+World+Congress+on+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSt%25C3%25A5hle%26aufirst%3DL.%26jtitle%3D14th%2520World%2520Congress%2520on%2520Pain%26pub%3DInternational%2520Association%2520for%2520the%2520Study%2520of%2520Pain%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vranesic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flor, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhelal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrayaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span> <span> </span><span class="NLM_article-title">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5790</span>â <span class="NLM_lpage">5803</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2014.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.bmc.2014.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25316499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5790-5803&author=I.+Vranesicauthor=S.+Ofnerauthor=P.+J.+Florauthor=G.+Bilbeauthor=R.+Bouhelalauthor=A.+Enzauthor=S.+Desrayaudauthor=K.+McAllisterauthor=R.+Kuhnauthor=F.+Gasparini&title=AFQ056%2Fmavoglurant%2C+a+novel+clinically+effective+mGluR5+antagonist%3A+identification%2C+SAR+and+pharmacological+characterization&doi=10.1016%2Fj.bmc.2014.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization</span></div><div class="casAuthors">Vranesic, Ivo; Ofner, Silvio; Flor, Peter Josef; Bilbe, Graeme; Bouhelal, Rochdi; Enz, Albert; Desrayaud, Sandrine; McAllister, Kevin; Kuhn, Rainer; Gasparini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5790-5803</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the identification, structure-activity relation and the initial pharmacol. characterization of AFQ056/mavoglurant, a structurally novel, non-competitive mGlu5 receptor antagonist.  AFQ056/mavoglurant was identified by chem. derivatization of a lead compd. discovered in a HTS campaign.  In vitro, AFQ056/mavoglurant had an IC50 of 30 nM in a functional assay with human mGluR5 and was selective over the other mGluR subtypes, iGluRs and a panel of 238 CNS relevant receptors, transporter or enzymes.  In vivo, AFQ056/mavoglurant showed an improved pharmacokinetic profile in rat and efficacy in the stress-induced hyperthermia test in mice as compared to the prototypic mGluR5 antagonist MPEP.  The efficacy of AFQ056/mavoglurant in humans has been assessed in L-dopa induced dyskinesia in Parkinson's disease and Fragile X syndrome in proof of principle clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomfnTAWNW_RbVg90H21EOLACvtfcHk0ljMwPm4SZfPpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ&md5=a34ab6585a186730f2fbf09d8c97180c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DMcAllister%26aufirst%3DK.%26aulast%3DKuhn%26aufirst%3DR.%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DAFQ056%252Fmavoglurant%252C%2520a%2520novel%2520clinically%2520effective%2520mGluR5%2520antagonist%253A%2520identification%252C%2520SAR%2520and%2520pharmacological%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5790%26epage%3D5803%26doi%3D10.1016%2Fj.bmc.2014.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berry-Kravis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Portes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagerman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquemont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visootsak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rerat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumaras, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaecklin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Raison, F.</span></span> <span> </span><span class="NLM_article-title">Mavoglurant in fragile X syndrome: results of two randomized, double-blind, placebo-controlled trials</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">321ra5</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.aab4109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1126%2Fscitranslmed.aab4109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26764156" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=321ra5&author=E.+Berry-Kravisauthor=V.+Des+Portesauthor=R.+Hagermanauthor=S.+Jacquemontauthor=P.+Charlesauthor=J.+Visootsakauthor=M.+Brinkmanauthor=K.+Reratauthor=B.+Koumarasauthor=L.+Zhuauthor=G.+M.+Barthauthor=T.+Jaecklinauthor=G.+Apostolauthor=F.+von+Raison&title=Mavoglurant+in+fragile+X+syndrome%3A+results+of+two+randomized%2C+double-blind%2C+placebo-controlled+trials&doi=10.1126%2Fscitranslmed.aab4109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aab4109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aab4109%26sid%3Dliteratum%253Aachs%26aulast%3DBerry-Kravis%26aufirst%3DE.%26aulast%3DDes%2BPortes%26aufirst%3DV.%26aulast%3DHagerman%26aufirst%3DR.%26aulast%3DJacquemont%26aufirst%3DS.%26aulast%3DCharles%26aufirst%3DP.%26aulast%3DVisootsak%26aufirst%3DJ.%26aulast%3DBrinkman%26aufirst%3DM.%26aulast%3DRerat%26aufirst%3DK.%26aulast%3DKoumaras%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBarth%26aufirst%3DG.%2BM.%26aulast%3DJaecklin%26aufirst%3DT.%26aulast%3DApostol%26aufirst%3DG.%26aulast%3Dvon%2BRaison%26aufirst%3DF.%26atitle%3DMavoglurant%2520in%2520fragile%2520X%2520syndrome%253A%2520results%2520of%2520two%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trials%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D321ra5%26doi%3D10.1126%2Fscitranslmed.aab4109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trenkwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poewe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dronamraju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Raison, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span> <span> </span><span class="NLM_article-title">Mavoglurant in Parkinsonâs patients with l-Dopa-induced dyskinesias: two randomized phase 2 studies</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1054</span>â <span class="NLM_lpage">1058</span>, <span class="refDoi">Â DOI: 10.1002/mds.26585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.26585" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=1054-1058&author=C.+Trenkwalderauthor=F.+Stocchiauthor=W.+Poeweauthor=N.+Dronamrajuauthor=C.+Kenneyauthor=A.+Shahauthor=F.+von+Raisonauthor=A.+Graf&title=Mavoglurant+in+Parkinson%E2%80%99s+patients+with+l-Dopa-induced+dyskinesias%3A+two+randomized+phase+2+studies&doi=10.1002%2Fmds.26585"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fmds.26585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.26585%26sid%3Dliteratum%253Aachs%26aulast%3DTrenkwalder%26aufirst%3DC.%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DPoewe%26aufirst%3DW.%26aulast%3DDronamraju%26aufirst%3DN.%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DA.%26aulast%3Dvon%2BRaison%26aufirst%3DF.%26aulast%3DGraf%26aufirst%3DA.%26atitle%3DMavoglurant%2520in%2520Parkinson%25E2%2580%2599s%2520patients%2520with%2520l-Dopa-induced%2520dyskinesias%253A%2520two%2520randomized%2520phase%25202%2520studies%26jtitle%3DMov.%2520Disord.%26date%3D2016%26volume%3D31%26spage%3D1054%26epage%3D1058%26doi%3D10.1002%2Fmds.26585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stocchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poewe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolosa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merschhemke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenkwalder, C.</span></span> <span> </span><span class="NLM_article-title">AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1838</span>â <span class="NLM_lpage">1846</span>, <span class="refDoi">Â DOI: 10.1002/mds.25561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.25561" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=1838-1846&author=F.+Stocchiauthor=O.+Rascolauthor=A.+Desteeauthor=N.+Hattoriauthor=R.+A.+Hauserauthor=A.+E.+Langauthor=W.+Poeweauthor=M.+Stacyauthor=E.+Tolosaauthor=H.+Gaoauthor=J.+Nagelauthor=M.+Merschhemkeauthor=A.+Grafauthor=C.+Kenneyauthor=C.+Trenkwalder&title=AFQ056+in+Parkinson+patients+with+levodopa-induced+dyskinesia%3A+13-week%2C+randomized%2C+dose-finding+study&doi=10.1002%2Fmds.25561"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmds.25561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25561%26sid%3Dliteratum%253Aachs%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DDestee%26aufirst%3DA.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DPoewe%26aufirst%3DW.%26aulast%3DStacy%26aufirst%3DM.%26aulast%3DTolosa%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DMerschhemke%26aufirst%3DM.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DKenney%26aufirst%3DC.%26aulast%3DTrenkwalder%26aufirst%3DC.%26atitle%3DAFQ056%2520in%2520Parkinson%2520patients%2520with%2520levodopa-induced%2520dyskinesia%253A%252013-week%252C%2520randomized%252C%2520dose-finding%2520study%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D1838%26epage%3D1846%26doi%3D10.1002%2Fmds.25561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gschwind, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittelmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocwieja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woessner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, P.</span></span> <span> </span><span class="NLM_article-title">Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1626</span>â <span class="NLM_lpage">1641</span>, <span class="refDoi">Â DOI: 10.1124/dmd.112.050716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.112.050716" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1626-1641&author=M.+Wallesauthor=T.+Wolfauthor=Y.+Jinauthor=M.+Ritzauauthor=L.+A.+Leutholdauthor=J.+Krauserauthor=H.+P.+Gschwindauthor=D.+Carcacheauthor=M.+Kittelmannauthor=M.+Ocwiejaauthor=M.+Uferauthor=R.+Woessnerauthor=A.+Chakrabortyauthor=P.+Swart&title=Metabolism+and+disposition+of+the+metabotropic+glutamate+receptor+5+antagonist+%28mGluR5%29+mavoglurant+%28AFQ056%29+in+healthy+subjects&doi=10.1124%2Fdmd.112.050716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.050716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.050716%26sid%3Dliteratum%253Aachs%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DRitzau%26aufirst%3DM.%26aulast%3DLeuthold%26aufirst%3DL.%2BA.%26aulast%3DKrauser%26aufirst%3DJ.%26aulast%3DGschwind%26aufirst%3DH.%2BP.%26aulast%3DCarcache%26aufirst%3DD.%26aulast%3DKittelmann%26aufirst%3DM.%26aulast%3DOcwieja%26aufirst%3DM.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DWoessner%26aufirst%3DR.%26aulast%3DChakraborty%26aufirst%3DA.%26aulast%3DSwart%26aufirst%3DP.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25205%2520antagonist%2520%2528mGluR5%2529%2520mavoglurant%2520%2528AFQ056%2529%2520in%2520healthy%2520subjects%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1626%26epage%3D1641%26doi%3D10.1124%2Fdmd.112.050716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolczewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitter-Stoll, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boissin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼ttelmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huwyler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuratli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhauser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¤hler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TÃ¤nnler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, L.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1358</span>â <span class="NLM_lpage">1371</span>, <span class="refDoi">Â DOI: 10.1021/jm501642c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501642c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1358-1371&author=G.+Jaeschkeauthor=S.+Kolczewskiauthor=W.+Spoorenauthor=E.+Vieiraauthor=N.+Bitter-Stollauthor=P.+Boissinauthor=E.+Borroniauthor=B.+B%C3%BCttelmannauthor=S.+Ceccarelliauthor=N.+Clemannauthor=B.+Davidauthor=C.+Funkauthor=W.+Gubaauthor=A.+Harrisonauthor=T.+Hartungauthor=M.+Honerauthor=J.+Huwylerauthor=M.+Kuratliauthor=U.+Niederhauserauthor=A.+P%C3%A4hlerauthor=J.+U.+Petersauthor=A.+Petersenauthor=E.+Prinssenauthor=A.+Ricciauthor=D.+Rueherauthor=M.+Rueherauthor=M.+Schneiderauthor=P.+Spurrauthor=T.+Stollauthor=D.+T%C3%A4nnlerauthor=J.+Wichmannauthor=R.+H.+Porterauthor=J.+G.+Wettsteinauthor=L.+Lindemann&title=Metabotropic+glutamate+receptor+5+negative+allosteric+modulators%3A+discovery+of+2-chloro-4-%5B1-%284-fluorophenyl%29-2%2C5-dimethyl-1H-imidazol-4-ylethynyl%5Dpyridine+%28basimglurant%2C+RO4917523%29%2C+a+promising+novel+medicine+for+psychiatric+diseases&doi=10.1021%2Fjm501642c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501642c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501642c%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DBitter-Stoll%26aufirst%3DN.%26aulast%3DBoissin%26aufirst%3DP.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DCeccarelli%26aufirst%3DS.%26aulast%3DClemann%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DB.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DHarrison%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DKuratli%26aufirst%3DM.%26aulast%3DNiederhauser%26aufirst%3DU.%26aulast%3DP%25C3%25A4hler%26aufirst%3DA.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DRueher%26aufirst%3DD.%26aulast%3DRueher%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSpurr%26aufirst%3DP.%26aulast%3DStoll%26aufirst%3DT.%26aulast%3DT%25C3%25A4nnler%26aufirst%3DD.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DLindemann%26aufirst%3DL.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulators%253A%2520discovery%2520of%25202-chloro-4-%255B1-%25284-fluorophenyl%2529-2%252C5-dimethyl-1H-imidazol-4-ylethynyl%255Dpyridine%2520%2528basimglurant%252C%2520RO4917523%2529%252C%2520a%2520promising%2520novel%2520medicine%2520for%2520psychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1358%26epage%3D1371%26doi%3D10.1021%2Fjm501642c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schadt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallalieu, N. L.</span></span> <span> </span><span class="NLM_article-title">A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [<sup>14</sup>C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [<sup>13</sup>C6]-labeled basimglurant in humans</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">144</span>â <span class="NLM_lpage">153</span>, <span class="refDoi">Â DOI: 10.3109/00498254.2016.1169334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.3109%2F00498254.2016.1169334" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=144-153&author=E.+Gueriniauthor=S.+Schadtauthor=G.+Greigauthor=R.+Haasauthor=C.+Husserauthor=M.+Zellauthor=C.+Funkauthor=T.+Hartungauthor=A.+Glogeauthor=N.+L.+Mallalieu&title=A+double-tracer+technique+to+characterize+absorption%2C+distribution%2C+metabolism+and+excretion+%28ADME%29+of+%5B14C%5D-basimglurant+and+absolute+bioavailability+after+oral+administration+and+concomitant+intravenous+microdose+administration+of+%5B13C6%5D-labeled+basimglurant+in+humans&doi=10.3109%2F00498254.2016.1169334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3109%2F00498254.2016.1169334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2016.1169334%26sid%3Dliteratum%253Aachs%26aulast%3DGuerini%26aufirst%3DE.%26aulast%3DSchadt%26aufirst%3DS.%26aulast%3DGreig%26aufirst%3DG.%26aulast%3DHaas%26aufirst%3DR.%26aulast%3DHusser%26aufirst%3DC.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DGloge%26aufirst%3DA.%26aulast%3DMallalieu%26aufirst%3DN.%2BL.%26atitle%3DA%2520double-tracer%2520technique%2520to%2520characterize%2520absorption%252C%2520distribution%252C%2520metabolism%2520and%2520excretion%2520%2528ADME%2529%2520of%2520%255B14C%255D-basimglurant%2520and%2520absolute%2520bioavailability%2520after%2520oral%2520administration%2520and%2520concomitant%2520intravenous%2520microdose%2520administration%2520of%2520%255B13C6%255D-labeled%2520basimglurant%2520in%2520humans%26jtitle%3DXenobiotica%26date%3D2017%26volume%3D47%26spage%3D144%26epage%3D153%26doi%3D10.3109%2F00498254.2016.1169334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quiroz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deptula, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontoura, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, L.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of basimglurant as adjunctive therapy for major depression: a randomized clinical trial</span>. <i>JAMA Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">675</span>â <span class="NLM_lpage">684</span>, <span class="refDoi">Â DOI: 10.1001/jamapsychiatry.2016.0838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1001%2Fjamapsychiatry.2016.0838" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=675-684&author=J.+A.+Quirozauthor=P.+Tamburriauthor=D.+Deptulaauthor=L.+Bankenauthor=U.+Beyerauthor=M.+Rabbiaauthor=N.+Parkarauthor=P.+Fontouraauthor=L.+Santarelli&title=Efficacy+and+safety+of+basimglurant+as+adjunctive+therapy+for+major+depression%3A+a+randomized+clinical+trial&doi=10.1001%2Fjamapsychiatry.2016.0838"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2016.0838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2016.0838%26sid%3Dliteratum%253Aachs%26aulast%3DQuiroz%26aufirst%3DJ.%2BA.%26aulast%3DTamburri%26aufirst%3DP.%26aulast%3DDeptula%26aufirst%3DD.%26aulast%3DBanken%26aufirst%3DL.%26aulast%3DBeyer%26aufirst%3DU.%26aulast%3DRabbia%26aufirst%3DM.%26aulast%3DParkar%26aufirst%3DN.%26aulast%3DFontoura%26aufirst%3DP.%26aulast%3DSantarelli%26aufirst%3DL.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520basimglurant%2520as%2520adjunctive%2520therapy%2520for%2520major%2520depression%253A%2520a%2520randomized%2520clinical%2520trial%26jtitle%3DJAMA%2520Psychiatry%26date%3D2016%26volume%3D73%26spage%3D675%26epage%3D684%26doi%3D10.1001%2Fjamapsychiatry.2016.0838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuxe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroto-Escuela, D. O.</span></span> <span> </span><span class="NLM_article-title">Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1247</span>â <span class="NLM_lpage">1260</span>, <span class="refDoi">Â DOI: 10.1517/13543784.2015.1074175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1517%2F13543784.2015.1074175" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1247-1260&author=K.+Fuxeauthor=D.+O.+Borroto-Escuela&title=Basimglurant+for+treatment+of+major+depressive+disorder%3A+a+novel+negative+allosteric+modulator+of+metabotropic+glutamate+receptor+5&doi=10.1517%2F13543784.2015.1074175"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1074175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1074175%26sid%3Dliteratum%253Aachs%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DBorroto-Escuela%26aufirst%3DD.%2BO.%26atitle%3DBasimglurant%2520for%2520treatment%2520of%2520major%2520depressive%2520disorder%253A%2520a%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%25205%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D1247%26epage%3D1260%26doi%3D10.1517%2F13543784.2015.1074175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pioli, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keywood, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tison, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, S. M.</span></span> <span> </span><span class="NLM_article-title">The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1074</span>â <span class="NLM_lpage">1079</span>, <span class="refDoi">Â DOI: 10.1002/mds.25920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.25920" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=1074-1079&author=E.+Bezardauthor=E.+Y.+Pioliauthor=Q.+Liauthor=F.+Girardauthor=V.+Mutelauthor=C.+Keywoodauthor=F.+Tisonauthor=O.+Rascolauthor=S.+M.+Poli&title=The+mGluR5+negative+allosteric+modulator+dipraglurant+reduces+dyskinesia+in+the+MPTP+macaque+model&doi=10.1002%2Fmds.25920"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fmds.25920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25920%26sid%3Dliteratum%253Aachs%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DPioli%26aufirst%3DE.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DKeywood%26aufirst%3DC.%26aulast%3DTison%26aufirst%3DF.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26atitle%3DThe%2520mGluR5%2520negative%2520allosteric%2520modulator%2520dipraglurant%2520reduces%2520dyskinesia%2520in%2520the%2520MPTP%2520macaque%2520model%26jtitle%3DMov.%2520Disord.%26date%3D2014%26volume%3D29%26spage%3D1074%26epage%3D1079%26doi%3D10.1002%2Fmds.25920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tison, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keywood, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakefield, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durif, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenkwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, O.</span></span> <span> </span><span class="NLM_article-title">A phase 2A trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in Parkinsonâs disease</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1373</span>â <span class="NLM_lpage">1380</span>, <span class="refDoi">Â DOI: 10.1002/mds.26659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1002%2Fmds.26659" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=1373-1380&author=F.+Tisonauthor=C.+Keywoodauthor=M.+Wakefieldauthor=F.+Durifauthor=J.+C.+Corvolauthor=K.+Eggertauthor=M.+Lewauthor=S.+Isaacsonauthor=E.+Bezardauthor=S.+M.+Poliauthor=C.+G.+Goetzauthor=C.+Trenkwalderauthor=O.+Rascol&title=A+phase+2A+trial+of+the+novel+mGluR5-negative+allosteric+modulator+dipraglurant+for+levodopa-induced+dyskinesia+in+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.26659"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fmds.26659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.26659%26sid%3Dliteratum%253Aachs%26aulast%3DTison%26aufirst%3DF.%26aulast%3DKeywood%26aufirst%3DC.%26aulast%3DWakefield%26aufirst%3DM.%26aulast%3DDurif%26aufirst%3DF.%26aulast%3DCorvol%26aufirst%3DJ.%2BC.%26aulast%3DEggert%26aufirst%3DK.%26aulast%3DLew%26aufirst%3DM.%26aulast%3DIsaacson%26aufirst%3DS.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DTrenkwalder%26aufirst%3DC.%26aulast%3DRascol%26aufirst%3DO.%26atitle%3DA%2520phase%25202A%2520trial%2520of%2520the%2520novel%2520mGluR5-negative%2520allosteric%2520modulator%2520dipraglurant%2520for%2520levodopa-induced%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2016%26volume%3D31%26spage%3D1373%26epage%3D1380%26doi%3D10.1002%2Fmds.26659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palanisamy, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcek, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappon, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whritenour, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span> <span> </span><span class="NLM_article-title">Drug-induced skin lesions in cynomolgus macaques treated with metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">995</span>â <span class="NLM_lpage">1003</span>, <span class="refDoi">Â DOI: 10.1177/0192623315588114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1177%2F0192623315588114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=26059827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Wqsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=995-1003&author=G.+S.+Palanisamyauthor=J.+M.+Marcekauthor=G.+D.+Capponauthor=J.+Whritenourauthor=C.+L.+Shafferauthor=J.+T.+Bradyauthor=C.+Houle&title=Drug-induced+skin+lesions+in+cynomolgus+macaques+treated+with+metabotropic+glutamate+receptor+5+%28mGluR5%29+negative+allosteric+modulators&doi=10.1177%2F0192623315588114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced skin lesions in cynomolgus macaques treated with metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators</span></div><div class="casAuthors">Palanisamy, Gopinath S.; Marcek, John M.; Cappon, Gregg D.; Whritenour, Jessica; Shaffer, Christopher L.; Brady, Joseph T.; Houle, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-1003</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Three orally administered metabotropic glutamate receptor 5 (mGluR5) neg. allosteric modulators caused skin lesions consistent with delayed type-IV hypersensitivity in cynomolgus macaques in 2- and 12-wk toxicity studies.  Several monkeys developed macroscopic skin lesions in multiple locations after 8 to 9 days of dosing; the most prominent effects involved the genital region of males and generalized erythema occurred in both sexes.  Microscopic lesions occurred in both clin. affected and unaffected areas and were characterized by lymphocytic interface inflammation, subepidermal bullae, and individual keratinocyte vacuolation/necrosis.  In the 12-wk study, clin. effects in 2 animals resolved with continued dosing, whereas in others the inflammatory process progressed with 1 female exhibiting systemic lymphocytic inflammation in multiple tissues.  The inflammatory infiltrate consisted of CD3 and CD4 pos. T lymphocytes with minimal CD68 pos. macrophages and only rare CD8 pos. T lymphocytes.  A subset of animals given a dosing holiday was subsequently rechallenged with similar lesions developing but with a more rapid clin. onset.  These skin lesions were consistent with type-IV delayed hypersensitivity with some features comparable to bullous drug eruptions in humans.  A relationship between these findings and the intended mode of action for these compds. could not be ruled out, given the occurrence across different chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS0b8GvuCkpLVg90H21EOLACvtfcHk0liYoWn3UsZO9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Wqsbo%253D&md5=99ad96bc755c182aca73a1d14dc1d614</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F0192623315588114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623315588114%26sid%3Dliteratum%253Aachs%26aulast%3DPalanisamy%26aufirst%3DG.%2BS.%26aulast%3DMarcek%26aufirst%3DJ.%2BM.%26aulast%3DCappon%26aufirst%3DG.%2BD.%26aulast%3DWhritenour%26aufirst%3DJ.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DBrady%26aufirst%3DJ.%2BT.%26aulast%3DHoule%26aufirst%3DC.%26atitle%3DDrug-induced%2520skin%2520lesions%2520in%2520cynomolgus%2520macaques%2520treated%2520with%2520metabotropic%2520glutamate%2520receptor%25205%2520%2528mGluR5%2529%2520negative%2520allosteric%2520modulators%26jtitle%3DToxicol.%2520Pathol.%26date%3D2015%26volume%3D43%26spage%3D995%26epage%3D1003%26doi%3D10.1177%2F0192623315588114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GrÃ©goire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Mancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, T.</span></span> <span> </span><span class="NLM_article-title">Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">216</span>â <span class="NLM_lpage">231</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2013.05.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.neuropharm.2013.05.028" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=216-231&author=N.+Morinauthor=M.+Morissetteauthor=L.+Gr%C3%A9goireauthor=B.+Gomez-Mancillaauthor=F.+Gaspariniauthor=T.+Di+Paolo&title=Chronic+treatment+with+MPEP%2C+an+mGlu5+receptor+antagonist%2C+normalizes+basal+ganglia+glutamate+neurotransmission+in+L-DOPA-treated+parkinsonian+monkeys&doi=10.1016%2Fj.neuropharm.2013.05.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.05.028%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DN.%26aulast%3DMorissette%26aufirst%3DM.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DL.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26atitle%3DChronic%2520treatment%2520with%2520MPEP%252C%2520an%2520mGlu5%2520receptor%2520antagonist%252C%2520normalizes%2520basal%2520ganglia%2520glutamate%2520neurotransmission%2520in%2520L-DOPA-treated%2520parkinsonian%2520monkeys%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D73%26spage%3D216%26epage%3D231%26doi%3D10.1016%2Fj.neuropharm.2013.05.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masilamoni, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogenpohl, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delevich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votaw, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span> <span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">2057</span>â <span class="NLM_lpage">2073</span>, <span class="refDoi">Â DOI: 10.1093/brain/awr137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1093%2Fbrain%2Fawr137" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=2057-2073&author=G.+J.+Masilamoniauthor=J.+W.+Bogenpohlauthor=D.+Alagilleauthor=K.+Delevichauthor=G.+Tamagnanauthor=J.+R.+Votawauthor=T.+Wichmannauthor=Y.+Smith&title=Metabotropic+glutamate+receptor+5+antagonist+protects+dopaminergic+and+noradrenergic+neurons+from+degeneration+in+MPTP-treated+monkeys&doi=10.1093%2Fbrain%2Fawr137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawr137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawr137%26sid%3Dliteratum%253Aachs%26aulast%3DMasilamoni%26aufirst%3DG.%2BJ.%26aulast%3DBogenpohl%26aufirst%3DJ.%2BW.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DDelevich%26aufirst%3DK.%26aulast%3DTamagnan%26aufirst%3DG.%26aulast%3DVotaw%26aufirst%3DJ.%2BR.%26aulast%3DWichmann%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DY.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520antagonist%2520protects%2520dopaminergic%2520and%2520noradrenergic%2520neurons%2520from%2520degeneration%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D2057%26epage%3D2073%26doi%3D10.1093%2Fbrain%2Fawr137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span> See page 862 of:<span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenard, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunetz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galatsis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reese, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleska, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1<i>H</i>-pyrazolo-[3,4-<i>b</i>]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">861</span>â <span class="NLM_lpage">877</span>, <span class="refDoi">Â DOI: 10.1021/jm401622k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401622k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtFansw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=861-877&author=L.+Zhangauthor=G.+Balanauthor=G.+Barreiroauthor=B.+P.+Boscoeauthor=L.+K.+Chenardauthor=J.+Cianfrognaauthor=M.+M.+Claffeyauthor=L.+Chenauthor=K.+J.+Coffmanauthor=S.+E.+Drozdaauthor=J.+R.+Dunetzauthor=K.+R.+Fonsecaauthor=P.+Galatsisauthor=S.+Grimwoodauthor=J.+T.+Lazzaroauthor=J.+Y.+Mancusoauthor=E.+L.+Millerauthor=M.+R.+Reeseauthor=B.+N.+Rogersauthor=I.+Sakuradaauthor=M.+Skaddanauthor=D.+L.+Smithauthor=A.+F.+Stepanauthor=P.+Trapaauthor=J.+B.+Tuttleauthor=P.+R.+Verhoestauthor=D.+P.+Walkerauthor=A.+S.+Wrightauthor=M.+M.+Zaleskaauthor=K.+Zasadnyauthor=C.+L.+Shaffer&title=Discovery+and+preclinical+characterization+of+1-methyl-3-%284-methylpyridin-3-yl%29-6-%28pyridin-2-ylmethoxy%29-1H-pyrazolo-%5B3%2C4-b%5Dpyrazine+%28PF470%29%3A+a+highly+potent%2C+selective%2C+and+efficacious+metabotropic+glutamate+receptor+5+%28mGluR5%29+negative+allosteric+modulator&doi=10.1021%2Fjm401622k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 1-Methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]-pyrazine (PF470): A Highly Potent, Selective, and Efficacious Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator</span></div><div class="casAuthors">Zhang, Lei; Balan, Gayatri; Barreiro, Gabriela; Boscoe, Brian P.; Chenard, Lois K.; Cianfrogna, Julie; Claffey, Michelle M.; Chen, Laigao; Coffman, Karen J.; Drozda, Susan E.; Dunetz, Joshua R.; Fonseca, Kari R.; Galatsis, Paul; Grimwood, Sarah; Lazzaro, John T.; Mancuso, Jessica Y.; Miller, Emily L.; Reese, Matthew R.; Rogers, Bruce N.; Sakurada, Isao; Skaddan, Marc; Smith, Deborah L.; Stepan, Antonia F.; Trapa, Patrick; Tuttle, Jamison B.; Verhoest, Patrick R.; Walker, Daniel P.; Wright, Ann S.; Zaleska, Margaret M.; Zasadny, Kenneth; Shaffer, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">861-877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of pyrazolopyrazines is herein disclosed as mGluR5 neg. allosteric modulators (NAMs).  Starting from a high-throughput screen (HTS) hit (1), a systematic structure-activity relationship (SAR) study was conducted with a specific focus on balancing pharmacol. potency with physicochem. and pharmacokinetic (PK) properties.  This effort led to the discovery of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]-pyrazine (PF470, 14) as a highly potent, selective, and orally bioavailable mGluR5 NAM.  Compd. 14 demonstrated robust efficacy in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-rendered Parkinsonian nonhuman primate model of l-DOPA-induced dyskinesia (PD-LID).  However, the progression of 14 to the clinic was terminated because of a potentially mechanism-mediated finding consistent with a delayed-type immune-mediated type IV hypersensitivity in a 90-day NHP regulatory toxicol. study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Qvow6xYg4LVg90H21EOLACvtfcHk0li2nDSYJhikmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtFansw%253D%253D&md5=d0185d833cbc1f82e287df0ff8dcb323</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm401622k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401622k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DChenard%26aufirst%3DL.%2BK.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DMiller%26aufirst%3DE.%2BL.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSakurada%26aufirst%3DI.%26aulast%3DSkaddan%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25201-methyl-3-%25284-methylpyridin-3-yl%2529-6-%2528pyridin-2-ylmethoxy%2529-1H-pyrazolo-%255B3%252C4-b%255Dpyrazine%2520%2528PF470%2529%253A%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520metabotropic%2520glutamate%2520receptor%25205%2520%2528mGluR5%2529%2520negative%2520allosteric%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D861%26epage%3D877%26doi%3D10.1021%2Fjm401622k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of VU0431316: a negative allosteric modulator of mGlu<sub>5</sub> with activity in a mouse model of anxiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3307</span>â <span class="NLM_lpage">3314</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.bmcl.2014.06.003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3307-3314&author=B.+S.+Batesauthor=A.+L.+Rodriguezauthor=A.+S.+Feltsauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=K.+P.+Lawsonauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+VU0431316%3A+a+negative+allosteric+modulator+of+mGlu5+with+activity+in+a+mouse+model+of+anxiety&doi=10.1016%2Fj.bmcl.2014.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DLawson%26aufirst%3DK.%2BP.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520VU0431316%253A%2520a%2520negative%2520allosteric%2520modulator%2520of%2520mGlu5%2520with%2520activity%2520in%2520a%2520mouse%2520model%2520of%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3307%26epage%3D3314%26doi%3D10.1016%2Fj.bmcl.2014.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of VU0409106: a negative allosteric modulator of mGlu<sub>5</sub> with activity in a mouse model of anxiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5779</span>â <span class="NLM_lpage">5785</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.bmcl.2013.09.001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5779-5785&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=J.+T.+Mankaauthor=B.+S.+Batesauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+VU0409106%3A+a+negative+allosteric+modulator+of+mGlu5+with+activity+in+a+mouse+model+of+anxiety&doi=10.1016%2Fj.bmcl.2013.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520VU0409106%253A%2520a%2520negative%2520allosteric%2520modulator%2520of%2520mGlu5%2520with%2520activity%2520in%2520a%2520mouse%2520model%2520of%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5779%26epage%3D5785%26doi%3D10.1016%2Fj.bmcl.2013.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">Evaluating the disposition of a mixed aldehyde oxidase/cytochrome P450 substrate in rats with attenuated P450 activity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1296</span>â <span class="NLM_lpage">1303</span>, <span class="refDoi">Â DOI: 10.1124/dmd.115.068338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.115.068338" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1296-1303&author=R.+D.+Crouchauthor=R.+D.+Morrisonauthor=F.+W.+Byersauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=Evaluating+the+disposition+of+a+mixed+aldehyde+oxidase%2Fcytochrome+P450+substrate+in+rats+with+attenuated+P450+activity&doi=10.1124%2Fdmd.115.068338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068338%26sid%3Dliteratum%253Aachs%26aulast%3DCrouch%26aufirst%3DR.%2BD.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DEvaluating%2520the%2520disposition%2520of%2520a%2520mixed%2520aldehyde%2520oxidase%252Fcytochrome%2520P450%2520substrate%2520in%2520rats%2520with%2520attenuated%2520P450%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D1296%26epage%3D1303%26doi%3D10.1124%2Fdmd.115.068338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantawy, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">755</span>â <span class="NLM_lpage">765</span>, <span class="refDoi">Â DOI: 10.1038/npp.2014.245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fnpp.2014.245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25241804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWntbjP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=755-765&author=J.+M.+Rookauthor=M.+N.+Tantawyauthor=M.+S.+Ansariauthor=A.+S.+Feltsauthor=S.+R.+Staufferauthor=K.+A.+Emmitteauthor=R.+M.+Kesslerauthor=C.+M.+Niswenderauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Relationship+between+in+vivo+receptor+occupancy+and+efficacy+of+metabotropic+glutamate+receptor+subtype+5+allosteric+modulators+with+different+in+vitro+binding+profiles&doi=10.1038%2Fnpp.2014.245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles</span></div><div class="casAuthors">Rook, Jerri M.; Tantawy, Mohammed N.; Ansari, Mohammad S.; Felts, Andrew S.; Stauffer, Shaun R.; Emmitte, Kyle A.; Kessler, Robert M.; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">755-765</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu5) have exciting potential as therapeutic agents for multiple brain disorders.  Translational studies with mGlu5 modulators have relied on mGlu5 allosteric site positron emission tomog. (PET) radioligands to assess receptor occupancy in the brain.  However, recent structural and modeling studies suggest that closely related mGlu5 allosteric modulators can bind to overlapping but not identical sites, which could complicate interpretation of in vivo occupancy data, even when PET ligands and drug leads are developed from the same chem. scaffold.  We now report that systemic administration of the novel mGlu5 pos. allosteric modulator VU0092273 displaced the structurally related mGlu5 PET ligand, [18F]FPEB, with measures of in vivo occupancy that closely aligned with its in vivo efficacy.  In contrast, a close analog of VU0092273 and [18F]FPEB, VU0360172, provided robust efficacy in rodent models in the absence of detectable occupancy.  Furthermore, a structurally unrelated mGlu5 neg. allosteric modulator, VU0409106, displayed measures of in vivo occupancy that correlated well with behavioral effects, despite the fact that VU0409106 is structurally unrelated to [18F]FPEB.  Interestingly, all three compds. inhibit radioligand binding to the prototypical MPEP/FPEB allosteric site in vitro.  However, VU0092273 and VU0409106 bind to this site in a fully competitive manner, whereas the interaction of VU0360172 is noncompetitive.  Thus, while close structural similarity between PET ligands and drug leads does not circumvent issues assocd. with differential binding to a given target, detailed mol. pharmacol. anal. accurately predicts utility of ligand pairs for in vivo occupancy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo519UTnt7mFLVg90H21EOLACvtfcHk0lhNY0mKwX1jpQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWntbjP&md5=1b83f3d15347d176c2504b618fc9af25</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.245%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DRelationship%2520between%2520in%2520vivo%2520receptor%2520occupancy%2520and%2520efficacy%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520allosteric%2520modulators%2520with%2520different%2520in%2520vitro%2520binding%2520profiles%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26volume%3D40%26spage%3D755%26epage%3D765%26doi%3D10.1038%2Fnpp.2014.245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santomango, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Ponce, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corlew, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span> <span> </span><span class="NLM_article-title">The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1834</span>â <span class="NLM_lpage">1845</span>, <span class="refDoi">Â DOI: 10.1124/dmd.112.046136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.112.046136" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1834-1845&author=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=T.+S.+Santomangoauthor=T.+M.+Bridgesauthor=D.+Stecauthor=K.+A.+Brewerauthor=R.+Sanchez-Ponceauthor=M.+M.+Corlewauthor=R.+Rushauthor=A.+S.+Feltsauthor=J.+Mankaauthor=B.+S.+Batesauthor=D.+F.+Venableauthor=A.+L.+Rodriguezauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=J.+S.+Daniels&title=The+role+of+aldehyde+oxidase+and+xanthine+oxidase+in+the+biotransformation+of+a+novel+negative+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5&doi=10.1124%2Fdmd.112.046136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046136%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DSantomango%26aufirst%3DT.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DStec%26aufirst%3DD.%26aulast%3DBrewer%26aufirst%3DK.%2BA.%26aulast%3DSanchez-Ponce%26aufirst%3DR.%26aulast%3DCorlew%26aufirst%3DM.%2BM.%26aulast%3DRush%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DManka%26aufirst%3DJ.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520role%2520of%2520aldehyde%2520oxidase%2520and%2520xanthine%2520oxidase%2520in%2520the%2520biotransformation%2520of%2520a%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1834%26epage%3D1845%26doi%3D10.1124%2Fdmd.112.046136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunklee, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahmi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, D.</span></span> <span> </span><span class="NLM_article-title">Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">206</span>â <span class="NLM_lpage">214</span>, <span class="refDoi">Â DOI: 10.1016/j.vascn.2008.05.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.vascn.2008.05.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=18634893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGls7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=206-214&author=M.+Zientekauthor=H.+Millerauthor=D.+Smithauthor=M.+B.+Dunkleeauthor=L.+Heinleauthor=A.+Thurstonauthor=C.+Leeauthor=R.+Hylandauthor=O.+Fahmiauthor=D.+Burdette&title=Development+of+an+in+vitro+drug-drug+interaction+assay+to+simultaneously+monitor+five+cytochrome+P450+isoforms+and+performance+assessment+using+drug+library+compounds&doi=10.1016%2Fj.vascn.2008.05.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds</span></div><div class="casAuthors">Zientek, Michael; Miller, Howard; Smith, Danielle; Dunklee, Mary Beth; Heinle, Lance; Thurston, Archie; Lee, Caroline; Hyland, Ruth; Fahmi, Odette; Burdette, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-214</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibition of cytochrome P 450 (CYP) is a principal mechanism for metab.-based drug-drug interactions (DDIs).  This article describes a robust, high-throughput CYP-mediated DDI assay using a cocktail of 5 clin. relevant probe substrates with quantification by liq. chromatog./tandem mass spectrometry (LC/MS-MS).  The assay consisted of human liver microsomes and a cocktail of probe substrates metabolized by the five major CYP isoforms (tacrine for CYP1A2, diclofenac for CYP2C9, (S)-mephenytoin for CYP2C19, dextromethorphan for CYP2D6 and midazolam for CYP3A4).  The assay was fully automated in both 96- and 384-well formats.  A series of expts. were conducted to define the optimal kinetic parameters and solvent concns., as well as, to assess potential reactant and product interference.  The assay was validated against known CYP inhibitors (miconazole, sulfaphenazole, ticlopidine, quinidine, ketoconazole, itraconazole, fluoxetine) and evaluated in a screening environment by testing 9494 compds.  Our findings show that this assay has application in early stage drug discovery to economically, reliably and accurately assess compds. for DDIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr26mBaPKv-bLVg90H21EOLACvtfcHk0lhb3NLKZeH6xw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGls7rP&md5=f8d2b450d3821b859d0830a96b968ec2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2008.05.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2008.05.131%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DDunklee%26aufirst%3DM.%2BB.%26aulast%3DHeinle%26aufirst%3DL.%26aulast%3DThurston%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DFahmi%26aufirst%3DO.%26aulast%3DBurdette%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520an%2520in%2520vitro%2520drug-drug%2520interaction%2520assay%2520to%2520simultaneously%2520monitor%2520five%2520cytochrome%2520P450%2520isoforms%2520and%2520performance%2520assessment%2520using%2520drug%2520library%2520compounds%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2008%26volume%3D58%26spage%3D206%26epage%3D214%26doi%3D10.1016%2Fj.vascn.2008.05.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, T.</span></span> <span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1093</span>â <span class="NLM_lpage">1095</span>, <span class="refDoi">Â DOI: 10.1023/A:1018943613122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans&doi=10.1023%2FA%3A1018943613122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2ebV23MkEzRb67ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095%26doi%3D10.1023%2FA%3A1018943613122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2</span>â <span class="NLM_lpage">12</span>, <span class="refDoi">Â DOI: 10.1021/jm301297f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery&doi=10.1021%2Fjm301297f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lhb3NLKZeH6xw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2%26epage%3D12%26doi%3D10.1021%2Fjm301297f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Drug-metabolizing ability of molybdenum hydroxylases</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">83</span>â <span class="NLM_lpage">98</span>, <span class="refDoi">Â DOI: 10.2133/dmpk.21.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2133%2Fdmpk.21.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16702728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=83-98&author=S.+Kitamuraauthor=K.+Sugiharaauthor=S.+Ohta&title=Drug-metabolizing+ability+of+molybdenum+hydroxylases&doi=10.2133%2Fdmpk.21.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-metabolizing ability of molybdenum hydroxylases</span></div><div class="casAuthors">Kitamura, Shigeyuki; Sugihara, Kazumi; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-98</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  Molybdenum hydroxylases, which include aldehyde oxidase and xanthine oxidoreductase, are involved in the metab. of some medicines in humans.  They exhibit oxidase activity toward various heterocyclic compds. and aldehydes.  The liver cytosol of various mammals also exhibits a significant reductase activity toward nitro, sulfoxide, N-oxide, and other moieties, catalyzed by aldehyde oxidase.  There is considerable variability of aldehyde oxidase activity in liver cytosol of mammals: humans show the highest activity, rats and mice show low activity, and dogs have no detectable activity.  On the other hand, xanthine oxidoreductase activity is present widely among species.  Interindividual variation of aldehyde oxidase activity is present in humans.  Drug-drug interactions assocd. with aldehyde oxidase and xanthine oxidoreductase are of potential clin. significance.  The drug-metabolizing ability of molybdenum hydroxylases and variation of the activity are described here by the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIDBvL67GcbVg90H21EOLACvtfcHk0ljxK1efZMLiqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D&md5=0698f203efaf5b2cf20f373af3cd4f28</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.83%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DDrug-metabolizing%2520ability%2520of%2520molybdenum%2520hydroxylases%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D83%26epage%3D98%26doi%3D10.2133%2Fdmpk.21.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noetzel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Days, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavreysen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">120</span>â <span class="NLM_lpage">133</span>, <span class="refDoi">Â DOI: 10.1124/mol.111.075184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.111.075184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22021324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSkt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=120-133&author=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=H.+Choauthor=E.+Daysauthor=Y.+Zhouauthor=A.+L.+Rodriguezauthor=H.+Lavreysenauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+W.+Lindsleyauthor=C.+D.+Weaverauthor=P.+J.+Conn&title=Functional+impact+of+allosteric+agonist+activity+of+selective+positive+allosteric+modulators+of+metabotropic+glutamate+receptor+subtype+5+in+regulating+central+nervous+system+function&doi=10.1124%2Fmol.111.075184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function</span></div><div class="casAuthors">Noetzel, Meredith J.; Rook, Jerri M.; Vinson, Paige N.; Cho, Hyekyung P.; Days, Emily; Zhou, Y.; Rodriguez, Alice L.; Lavreysen, Hilde; Stauffer, Shaun R.; Niswender, Colleen M.; Xiang, Zixiu; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Weaver, C. David; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-133</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) have emerged as an exciting new approach for the treatment of schizophrenia and other central nervous system (CNS) disorders.  Of interest, some mGlu5 PAMs act as pure PAMs, only potentiating mGlu5 responses to glutamate whereas others [allosteric agonists coupled with PAM activity (ago-PAMs)] potentiate responses to glutamate and have intrinsic allosteric agonist activity in mGlu5-expressing cell lines.  All mGlu5 PAMs previously shown to have efficacy in animal models act as ago-PAMs in cell lines, raising the possibility that allosteric agonist activity is crit. for in vivo efficacy.  We have now optimized novel mGlu5 pure PAMs that are devoid of detectable agonist activity and structurally related mGlu5 ago-PAMs that activate mGlu5 alone in cell lines.  Studies of mGlu5 PAMs in cell lines revealed that ago-PAM activity is dependent on levels of mGlu5 receptor expression in human embryonic kidney 293 cells, whereas PAM potency is relatively unaffected by levels of receptor expression.  Furthermore, ago-PAMs have no agonist activity in the native systems tested, including cortical astrocytes and subthalamic nucleus neurons and in measures of long-term depression at the hippocampal Schaffer collateral-CA1 synapse.  Finally, studies with pure PAMs and ago-PAMs chem. optimized to provide comparable CNS exposure revealed that both classes of mGlu5 PAMs have similar efficacy in a rodent model predictive of antipsychotic activity.  These data suggest that the level of receptor expression influences the ability of mGlu5 PAMs to act as allosteric agonists in vitro and that ago-PAM activity obsd. in cell-based assays may not be important for in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgBNVLHUParVg90H21EOLACvtfcHk0ljxK1efZMLiqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSkt7s%253D&md5=a3b948ee64cd97a9046ab91004549ca1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.075184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.075184%26sid%3Dliteratum%253Aachs%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DFunctional%2520impact%2520of%2520allosteric%2520agonist%2520activity%2520of%2520selective%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520in%2520regulating%2520central%2520nervous%2520system%2520function%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D120%26epage%3D133%26doi%3D10.1124%2Fmol.111.075184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. D.</span></span> <span> </span><span class="NLM_article-title">A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1213</span>â <span class="NLM_lpage">1224</span>, <span class="refDoi">Â DOI: 10.1124/mol.107.041053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.107.041053" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1213-1224&author=C.+M.+Niswenderauthor=K.+A.+Johnsonauthor=Q.+Luoauthor=J.+E.+Ayalaauthor=C.+Kimauthor=P.+J.+Connauthor=C.+D.+Weaver&title=A+novel+assay+of+Gi%2Fo-linked+G+protein-coupled+receptor+coupling+to+potassium+channels+provides+new+insights+into+the+pharmacology+of+the+group+III+metabotropic+glutamate+receptors&doi=10.1124%2Fmol.107.041053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.041053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.041053%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520assay%2520of%2520Gi%252Fo-linked%2520G%2520protein-coupled%2520receptor%2520coupling%2520to%2520potassium%2520channels%2520provides%2520new%2520insights%2520into%2520the%2520pharmacology%2520of%2520the%2520group%2520III%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1213%26epage%3D1224%26doi%3D10.1124%2Fmol.107.041053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span> <i>LeadProfilingScreen</i> (catalog #68); <span class="NLM_publisher-name">Eurofins
Panlabs, Inc.</span>: <span class="NLM_publisher-loc">St. Charles, MO</span>. <a href="https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0aCrd3Mu4RA%3d&amp;path=128&amp;leaf=128&amp;track=Add%2f2%2fPackages%2fMolecular+Packages" class="extLink">https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0aCrd3Mu4RA%3d&path=128&leaf=128&track=Add%2f2%2fPackages%2fMolecular+Packages</a> (accessed April 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LeadProfilingScreen+%28catalog+%2368%29%3B+Eurofins%0APanlabs%2C+Inc.%3A+St.+Charles%2C+MO.+https%3A%2F%2Fwww.eurofinspanlabs.com%2FCatalog%2FProducts%2FProductDetails.aspx%3FprodId%3D0aCrd3Mu4RA%253d%26path%3D128%26leaf%3D128%26track%3DAdd%252f2%252fPackages%252fMolecular%2BPackages+%28accessed+April+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DLeadProfilingScreen%26pub%3DEurofins%250APanlabs%252C%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zahniser, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorkin, A.</span></span> <span> </span><span class="NLM_article-title">Rapid regulation of the dopamine transporter: role in stimulant addiction?</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">S1</span>),  <span class="NLM_fpage">80</span>â <span class="NLM_lpage">91</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2004.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.neuropharm.2004.07.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=80-91&issue=S1&author=N.+R.+Zahniserauthor=A.+Sorkin&title=Rapid+regulation+of+the+dopamine+transporter%3A+role+in+stimulant+addiction%3F&doi=10.1016%2Fj.neuropharm.2004.07.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DZahniser%26aufirst%3DN.%2BR.%26aulast%3DSorkin%26aufirst%3DA.%26atitle%3DRapid%2520regulation%2520of%2520the%2520dopamine%2520transporter%253A%2520role%2520in%2520stimulant%2520addiction%253F%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26issue%3DS1%26spage%3D80%26epage%3D91%26doi%3D10.1016%2Fj.neuropharm.2004.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span> <i>Dopamine
uptake</i> (catalog #316010); <span class="NLM_publisher-name">Eurofins
Panlabs, Inc.</span>: <span class="NLM_publisher-loc">St. Charles, MO</span>. <a href="https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0WVKOLUf1Bw%3d" class="extLink">https://www.eurofinspanlabs.com/Catalog/Products/ProductDetails.aspx?prodId=0WVKOLUf1Bw%3d</a> (accessed April 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Dopamine%0Auptake+%28catalog+%23316010%29%3B+Eurofins%0APanlabs%2C+Inc.%3A+St.+Charles%2C+MO.+https%3A%2F%2Fwww.eurofinspanlabs.com%2FCatalog%2FProducts%2FProductDetails.aspx%3FprodId%3D0WVKOLUf1Bw%253d+%28accessed+April+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DDopamine%250Auptake%26pub%3DEurofins%250APanlabs%252C%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosford, N. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roppe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiders, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M. A.</span></span> <span> </span><span class="NLM_article-title">[<sup>3</sup>H]-Methoxymethyl-MTEP and [<sup>3</sup>H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">351</span>â <span class="NLM_lpage">354</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(02)00997-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2FS0960-894X%2802%2900997-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=351-354&author=N.+D.+P.+Cosfordauthor=J.+Roppeauthor=L.+Tehraniauthor=E.+J.+Schweigerauthor=T.+J.+Seidersauthor=A.+Chaudaryauthor=S.+Raoauthor=M.+A.+Varney&title=%5B3H%5D-Methoxymethyl-MTEP+and+%5B3H%5D-methoxy-PEPy%3A+potent+and+selective+radioligands+for+the+metabotropic+glutamate+subtype+5+%28mGlu5%29+receptor&doi=10.1016%2FS0960-894X%2802%2900997-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900997-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900997-6%26sid%3Dliteratum%253Aachs%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DSchweiger%26aufirst%3DE.%2BJ.%26aulast%3DSeiders%26aufirst%3DT.%2BJ.%26aulast%3DChaudary%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26atitle%3D%255B3H%255D-Methoxymethyl-MTEP%2520and%2520%255B3H%255D-methoxy-PEPy%253A%2520potent%2520and%2520selective%2520radioligands%2520for%2520the%2520metabotropic%2520glutamate%2520subtype%25205%2520%2528mGlu5%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D351%26epage%3D354%26doi%3D10.1016%2FS0960-894X%2802%2900997-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekaran, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1793</span>â <span class="NLM_lpage">1802</span>, <span class="refDoi">Â DOI: 10.1124/mol.105.016139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fmol.105.016139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16155210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktr7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1793-1802&author=A.+L.+Rodriguezauthor=Y.+Nongauthor=N.+K.+Sekaranauthor=D.+Alagilleauthor=G.+D.+Tamagnanauthor=P.+J.+Conn&title=A+close+structural+analog+of+2-methyl-6-%28phenylethynyl%29-pyridine+acts+as+a+neutral+allosteric+site+ligand+on+metabotropic+glutamate+receptor+subtype+5+and+blocks+the+effects+of+multiple+allosteric+modulators&doi=10.1124%2Fmol.105.016139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A close structural analog of 2-methyl-6-(phenylethynyl)pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators</span></div><div class="casAuthors">Rodriguez, Alice L.; Nong, Yi; Sekaran, Nishant K.; Alagille, David; Tamagnan, Gilles D.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1793-1802</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metabotropic glutamate receptor subtype 5 (mGlu5) activates calcium mobilization via binding of glutamate, the major excitatory neurotransmitter in the central nervous system.  Allosteric modulation of the receptor has recently emerged as a promising alternative method of regulation to traditional regulation through orthosteric ligands.  We now report three novel compds. that bind to the allosteric 2-methyl-6-(phenylethynyl)-pyridine (MPEP) site on mGlu5 but have only partial inhibition or no functional effects on the mGlu5 response.  Two of these compds., 2-(2-(3-methoxyphenyl)ethynyl)-5-methylpyridine (M-5MPEP) and 2-(2-(5-bromopyridin-3-yl)ethynyl)-5-methylpyridine (Br-5MPEPy), act as partial antagonists of mGlu5 in that they only partially inhibit the response of this receptor to glutamate.  The third compd., 5-methyl-6-(phenylethynyl)-pyridine (5MPEP), acts as a neutral allosteric site ligand that binds to the MPEP site and has no effects alone.  However, 5MPEP blocks the effects of both the allosteric antagonist MPEP and potentiators 3,3'-difluorobenzaldazine and 3-cyanol-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB).  This compd. also blocks depolarization effects of both MPEP and CDPPB in neurons in the subthalamic nucleus.  These novel compds. provide valuable new insight into the pharmacol. of allosteric sites on G protein-coupled receptors and provide valuable new tools for detg. the effects of allosteric site ligands in native systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19VhRAjS5FLVg90H21EOLACvtfcHk0lhccaY0yX7Grw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktr7M&md5=c89d04464e403e6c0b044f09f94fec89</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.016139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.016139%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DNong%26aufirst%3DY.%26aulast%3DSekaran%26aufirst%3DN.%2BK.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520close%2520structural%2520analog%2520of%25202-methyl-6-%2528phenylethynyl%2529-pyridine%2520acts%2520as%2520a%2520neutral%2520allosteric%2520site%2520ligand%2520on%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520and%2520blocks%2520the%2520effects%2520of%2520multiple%2520allosteric%2520modulators%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1793%26epage%3D1802%26doi%3D10.1124%2Fmol.105.016139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rager, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardos, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the MDR-MDCK cell line as a permeability screen for the bloodâbrain barrier</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">349</span>â <span class="NLM_lpage">359</span>, <span class="refDoi">Â DOI: 10.1016/j.ijpharm.2004.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.ijpharm.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=15620875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=349-359&author=Q.+Wangauthor=J.+D.+Ragerauthor=K.+Weinsteinauthor=P.+S.+Kardosauthor=G.+L.+Dobsonauthor=J.+Liauthor=I.+J.+Hidalgo&title=Evaluation+of+the+MDR-MDCK+cell+line+as+a+permeability+screen+for+the+blood%E2%80%93brain+barrier&doi=10.1016%2Fj.ijpharm.2004.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Wang, Qing; Rager, Joseph D.; Weinstein, Kathryn; Kardos, Paula S.; Dobson, Glenn L.; Li, Jibin; Hidalgo, Ismael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objectives of this study were to (1) characterize MDR-MDCK monolayers as an in vitro model to predict brain uptake potential; (2) examine the ability of MDR-MDCK monolayers to identify the brain uptake potential of compds. that interact with P-glycoprotein (P-gp).  The study measured the bi-directional transport of 28 compds. across MDR-MDCK monolayers.  The brain uptake of a subset of the compds. was detd. in the rat brain perfusion model.  Drug concns. were analyzed by LC-MS-MS.  CNS-pos. drugs exhibited absorptive permeability coeffs. (Papp, A-B) values ranging from 3.4 Ã 10-6 to 20.2 Ã 10-6 cm/s; whereas CNS-neg. drugs showed Papp (A-B) ranging from 0.03 Ã 10-6 to 0.83 Ã 10-6 cm/s.  Inhibition of P-gp by cyclosporin A (CsA) significantly reduced secretory flux of compds. known to be P-pg substrates, but only enhanced the absorptive flux of compds. with high efflux ratio (>100).  In vitro results were confirmed by brain perfusion studies on selected compds.  MDR-MDCK monolayers can be used to classify compds. into CNS-pos. or CNS-neg. based on the permeability coeffs. (Papp, A-B).  Under the authors' exptl. conditions, compds. with Papp (A-B) >3 Ã 10-6 cm/s have high brain uptake potential; compds. with Papp (A-B) < 1 Ã 10-6 cm/s are unable to penetrate the blood-brain barrier (BBB); the brain uptake of compds. with Papp (A-B) < 1 Ã 10-6 cm/s and a P-gp-mediated efflux ratio of >100 may be enhanced by inhibiting P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvF-zoLte8trVg90H21EOLACvtfcHk0lhccaY0yX7Grw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE&md5=7d2cb9e13b2767b337bf808e73141ae1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRager%26aufirst%3DJ.%2BD.%26aulast%3DWeinstein%26aufirst%3DK.%26aulast%3DKardos%26aufirst%3DP.%2BS.%26aulast%3DDobson%26aufirst%3DG.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520MDR-MDCK%2520cell%2520line%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D288%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.ijpharm.2004.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, J.</span></span> <span> </span><span class="NLM_article-title">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">880</span>â <span class="NLM_lpage">885</span>, <span class="refDoi">Â DOI: 10.1016/0006-291X(91)91647-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2F0006-291X%2891%2991647-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1673839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1991&pages=880-885&author=P.+Arturssonauthor=J.+Karlsson&title=Correlation+between+oral+drug+absorption+in+humans+and+apparent+drug+permeability+coefficients+in+human+intestinal+epithelial+%28Caco-2%29+cells&doi=10.1016%2F0006-291X%2891%2991647-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span></div><div class="casAuthors">Artursson, P.; Karlsson, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium.  Absorption rate consts. (expressed as apparent permeability coeffs.) were detd. for 20 drugs and peptides with different structural properties.  The permeability coeffs. ranged from approx. 5 Ã 10-8 to 5 Ã 10-5 cm/s.  A good correlation was obtained between data on oral absorption in humans and the results in the Caco-2 model.  Drugs that are completely absorbed in humans had permeability coeffs. >1 Ã 10-6 cm/s.  Drugs that are absorbed to >1% but <100% had permeability coeffs. of 0.1-1.0 Ã 10-6 cm/s while drugs and peptides that are absorbed to <1% had permeability coeffs. of â¤1 Ã 10-7 cm/s.  The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvsEluSXCILVg90H21EOLACvtfcHk0ljmyJLrWDBR0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D&md5=3b1e14cae3beb0345014284e3aa6a7c0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991647-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991647-U%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCorrelation%2520between%2520oral%2520drug%2520absorption%2520in%2520humans%2520and%2520apparent%2520drug%2520permeability%2520coefficients%2520in%2520human%2520intestinal%2520epithelial%2520%2528Caco-2%2529%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D175%26spage%3D880%26epage%3D885%26doi%3D10.1016%2F0006-291X%2891%2991647-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullenwider, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmenk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepaotcytes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">267</span>â <span class="NLM_lpage">275</span>, <span class="refDoi">Â DOI: 10.1124/dmd.111.042861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fdmd.111.042861" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=267-275&author=J.+M.+Hutzlerauthor=Y.-S.+Yangauthor=D.+Albaughauthor=C.+L.+Fullenwiderauthor=J.+Schmenkauthor=M.+B.+Fisher&title=Characterization+of+aldehyde+oxidase+enzyme+activity+in+cryopreserved+human+hepaotcytes&doi=10.1124%2Fdmd.111.042861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042861%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DY.-S.%26aulast%3DAlbaugh%26aufirst%3DD.%26aulast%3DFullenwider%26aufirst%3DC.%2BL.%26aulast%3DSchmenk%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26atitle%3DCharacterization%2520of%2520aldehyde%2520oxidase%2520enzyme%2520activity%2520in%2520cryopreserved%2520human%2520hepaotcytes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D267%26epage%3D275%26doi%3D10.1124%2Fdmd.111.042861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span> <i>ChanTest Cardiac Channel Panel</i>; <span class="NLM_publisher-name">Charles
River Laboratories International, Inc.</span>: <span class="NLM_publisher-loc">Wilmington, MA</span>. <a href="http://www.criver.com/products-services/drug-discovery/therapeutic-areas/oncology/safety-assessment/cardiac-risk/cardiac-ion-channel-panel" class="extLink">http://www.criver.com/products-services/drug-discovery/therapeutic-areas/oncology/safety-assessment/cardiac-risk/cardiac-ion-channel-panel</a> (accessed April 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ChanTest+Cardiac+Channel+Panel%3B+Charles%0ARiver+Laboratories+International%2C+Inc.%3A+Wilmington%2C+MA.+http%3A%2F%2Fwww.criver.com%2Fproducts-services%2Fdrug-discovery%2Ftherapeutic-areas%2Foncology%2Fsafety-assessment%2Fcardiac-risk%2Fcardiac-ion-channel-panel+%28accessed+April+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DChanTest%2520Cardiac%2520Channel%2520Panel%26pub%3DCharles%250ARiver%2520Laboratories%2520International%252C%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">5135</span>â <span class="NLM_lpage">5139</span>, <span class="refDoi">Â DOI: 10.1073/pnas.72.12.5135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1073%2Fpnas.72.12.5135" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1975&pages=5135-5139&author=J.+McCannauthor=E.+Choiauthor=E.+Yamasakiauthor=B.+N.+Ames&title=Detection+of+carcinogens+as+mutagens+in+the+Salmonella%2Fmicrosome+test%3A+assay+of+300+chemicals&doi=10.1073%2Fpnas.72.12.5135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.72.12.5135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.72.12.5135%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%26aulast%3DYamasaki%26aufirst%3DE.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DDetection%2520of%2520carcinogens%2520as%2520mutagens%2520in%2520the%2520Salmonella%252Fmicrosome%2520test%253A%2520assay%2520of%2520300%2520chemicals%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1975%26volume%3D72%26spage%3D5135%26epage%3D5139%26doi%3D10.1073%2Fpnas.72.12.5135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E. P. M.</span></span> <span> </span><span class="NLM_article-title">A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>547</i></span>,  <span class="NLM_fpage">106</span>â <span class="NLM_lpage">115</span>, <span class="refDoi">Â DOI: 10.1016/j.ejphar.2006.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2Fj.ejphar.2006.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=16934246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1OmtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2006&pages=106-115&author=L.+B.+Nicolasauthor=Y.+Kolbauthor=E.+P.+M.+Prinssen&title=A+combined+marble+burying-locomotor+activity+test+in+mice%3A+a+practical+screening+test+with+sensitivity+to+different+classes+of+anxiolytics+and+antidepressants&doi=10.1016%2Fj.ejphar.2006.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A combined marble burying-locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants</span></div><div class="casAuthors">Nicolas, Laurent B.; Kolb, Yeter; Prinssen, Eric P. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the last decades, the inhibition of spontaneous burying of glass marbles by mice has been used as an index of anxiolytic drug action in the so-called marble burying test.  Indeed, acute administration of rapid-onset (e.g. diazepam) and slow-onset (e.g. fluoxetine) anxiolytics inhibit marble burying.  However, non-anxiolytic compds. such as classical antipsychotics also reduce marble burying thus suggesting that the predictive validity of this procedure for anxiety may be limited.  In the present study, after having selected a strain of mice (C57BL/6J) that showed spontaneous avoidance of glass marbles, we tried to improve the predictive validity of the marble burying test for anxiety by measuring locomotor activity during the marble burying test and - if needed - in control expts. by using a videotracking system.  Twenty-four ref. compds. were tested including anxiolytics, anxiogenics, antidepressants, antipsychotics and other classes.  By comparing marble burying scores with locomotor measures, we found that, based on our criteria, most of the anxiolytics and antidepressants selectively inhibited marble burying in contrast to most of the other compds. (e.g. haloperidol, morphine).  Two putative anxiolytics, i.e. the nociceptin orphanin FQ peptide receptor agonist Ro 64-6198 and the metabotropic glutamate 5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine, also showed a selective profile.  We propose this modified procedure, requiring only a limited no. of animals, as a valuable screening test for the detection of compds. having anxiolytic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwO1R3IOmPbVg90H21EOLACvtfcHk0lgNCKHTd9RbSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1OmtLo%253D&md5=459a1e0324f23fe9437f95dee46d350c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DNicolas%26aufirst%3DL.%2BB.%26aulast%3DKolb%26aufirst%3DY.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%2BM.%26atitle%3DA%2520combined%2520marble%2520burying-locomotor%2520activity%2520test%2520in%2520mice%253A%2520a%2520practical%2520screening%2520test%2520with%2520sensitivity%2520to%2520different%2520classes%2520of%2520anxiolytics%2520and%2520antidepressants%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D547%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.ejphar.2006.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burant, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuva-Paylor, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paylor, R.</span></span> <span> </span><span class="NLM_article-title">Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">361</span>â <span class="NLM_lpage">373</span>, <span class="refDoi">Â DOI: 10.1007/s00213-009-1466-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1007%2Fs00213-009-1466-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=19189082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyhsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2009&pages=361-373&author=A.+Thomasauthor=A.+Burantauthor=N.+Buiauthor=D.+Grahamauthor=L.+A.+Yuva-Paylorauthor=R.+Paylor&title=Marble+burying+reflects+a+repetitive+and+perseverative+behavior+more+than+novelty-induced+anxiety&doi=10.1007%2Fs00213-009-1466-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety</span></div><div class="casAuthors">Thomas, Alexia; Burant, April; Bui, Nghiem; Graham, Deanna; Yuva-Paylor, Lisa A.; Paylor, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-373</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale An increasing no. of investigators utilize the marble-burying assay despite the paucity of information available regarding what underlies the behavior.  Objectives We tested the possibility that a genetic component underlies marble burying in mice and if there is a genetic correlation with other anxiety-like traits.  Since findings reported in the literature indicate that marble-burying behavior reflects an anxiety-like response, we explored the assumption that the novel nature of a marble induces this anxiety.  Finally, we investigated how the natural response of a mouse to dig relates to the marble-burying phenomenon.  Methods We examd. ten different inbred mouse strains to det. if marble-burying behavior is genetically regulated and correlated with anxiety-like traits in two other assays.  We employed multiple variants of the "traditional" marble-burying assay to address how issues such as the novelty of marbles and digging behavior contribute to marble burying.  Results Marble-burying behavior varied across strain and did not correlate with anxiety measures in other assays.  Multiple tests conducted to reduce the novelty of marbles failed to alter burying behavior.  Addnl., digging behavior correlated with marble burying, and the presence of marbles did not significantly impact the digging response.  Conclusions Our results indicate that mouse marble burying is genetically regulated, not correlated with other anxiety-like traits, not stimulated by novelty, and is a repetitive behavior that persists/perseveres with little change across multiple exposures.  Marble burying is related to digging behavior and may in fact be more appropriately considered as an indicative measure of repetitive digging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfiaqRWC5NHLVg90H21EOLACvtfcHk0lgNCKHTd9RbSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyhsrk%253D&md5=50c19b59c7493766238cab5a68ffcedf</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1466-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1466-y%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DBurant%26aufirst%3DA.%26aulast%3DBui%26aufirst%3DN.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DYuva-Paylor%26aufirst%3DL.%2BA.%26aulast%3DPaylor%26aufirst%3DR.%26atitle%3DMarble%2520burying%2520reflects%2520a%2520repetitive%2520and%2520perseverative%2520behavior%2520more%2520than%2520novelty-induced%2520anxiety%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D204%26spage%3D361%26epage%3D373%26doi%3D10.1007%2Fs00213-009-1466-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slattery, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cryan, J. F.</span></span> <span> </span><span class="NLM_article-title">Using the rat forced swim test to assess antidepressant-like activity in rodents</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1009</span>â <span class="NLM_lpage">1014</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2012.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fnprot.2012.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=22555240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFClsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1009-1014&author=D.+A.+Slatteryauthor=J.+F.+Cryan&title=Using+the+rat+forced+swim+test+to+assess+antidepressant-like+activity+in+rodents&doi=10.1038%2Fnprot.2012.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Using the rat forced swim test to assess antidepressant-like activity in rodents</span></div><div class="casAuthors">Slattery, David A.; Cryan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1009-1014</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The forced swim test (FST) is one of the most commonly used animal models for assessing antidepressant-like behavior.  This protocol details using the FST in rats, which takes place over 48 h and is followed by the video anal. of the behavior.  The swim test involves the scoring of active (swimming and climbing) or passive (immobility) behavior when rodents are forced to swim in a cylinder from which there is no escape.  There are two versions that are used, namely the traditional and modified FSTs, which differ in their exptl. setup.  For both versions, a pretest of 15 min (although a no. of labs. have used a 10-min pretest with success) is included, as this accentuates the different behaviors in the 5-min swim test following drug treatment.  Redn. in passive behavior is interpreted as an antidepressant-like effect of the manipulation, provided it does not increase general locomotor activity, which could provide a false pos. result in the FST.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYcYTFaBQwLVg90H21EOLACvtfcHk0lg-x7q4TgMG3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFClsLg%253D&md5=233fde8d745f3edacb78d2a38b6249f9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2012.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2012.044%26sid%3Dliteratum%253Aachs%26aulast%3DSlattery%26aufirst%3DD.%2BA.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26atitle%3DUsing%2520the%2520rat%2520forced%2520swim%2520test%2520to%2520assess%2520antidepressant-like%2520activity%2520in%2520rodents%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1009%26epage%3D1014%26doi%3D10.1038%2Fnprot.2012.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharf, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuennecke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kienlin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paehler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrott, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhauser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morairty, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilduff, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolczewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinssen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">233</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.222463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1124%2Fjpet.114.222463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=25665805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvV2gtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=213-233&author=L.+Lindemannauthor=R.+H.+Porterauthor=S.+H.+Scharfauthor=B.+Kuenneckeauthor=A.+Brunsauthor=M.+von+Kienlinauthor=A.+C.+Harrisonauthor=A.+Paehlerauthor=C.+Funkauthor=A.+Glogeauthor=M.+Schneiderauthor=N.+J.+Parrottauthor=L.+Polonchukauthor=U.+Niederhauserauthor=S.+R.+Morairtyauthor=T.+S.+Kilduffauthor=E.+Vieiraauthor=S.+Kolczewskiauthor=J.+Wichmannauthor=T.+Hartungauthor=M.+Honerauthor=E.+Borroniauthor=J.+L.+Moreauauthor=E.+Prinssenauthor=W.+Spoorenauthor=J.+G.+Wettsteinauthor=G.+Jaeschke&title=Pharmacology+of+basimglurant+%28RO4917523%2C+RG7090%29%2C+a+unique+metabotropic+glutamate+receptor+5+negative+allosteric+modulator+in+clinical+development+for+depression&doi=10.1124%2Fjpet.114.222463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression</span></div><div class="casAuthors">Lindemann, Lothar; Porter, Richard H.; Scharf, Sebastian H.; Kuennecke, Basil; Bruns, Andreas; von Kienlin, Markus; Harrison, Anthony C.; Paehler, Axel; Funk, Christoph; Gloge, Andreas; Schneider, Manfred; Parrott, Neil J.; Polonchuk, Liudmila; Niederhauser, Urs; Morairty, Stephen R.; Kilduff, Thomas S.; Vieira, Eric; Kolczewski, Sabine; Wichmann, Juergen; Hartung, Thomas; Honer, Michael; Borroni, Edilio; Moreau, Jean-Luc; Prinssen, Eric; Spooren, Will; Wettstein, Joseph G.; Jaeschke, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-233</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability.  Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics.  Recently, glutamatergic approaches for the treatment of MDD have increasingly received attention, and preclin. research suggests that metabotropic glutamate receptor 5 (mGlu5) inhibitors have antidepressant-like properties.  Basimglurant (2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine) is a novel mGlu5 neg. allosteric modulator currently in phase 2 clin. development for MDD and fragile X syndrome.  Here, the comprehensive preclin. pharmacol. profile of basimglurant is presented with a focus on its therapeutic potential for MDD and drug-like properties.  Basimglurant is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency.  It has antidepressant properties that are corroborated by its functional magnetic imaging profile as well as anxiolytic-like and antinociceptive features.  In electroencephalog. recordings, basimglurant shows wake-promoting effects followed by increased delta power during subsequent non-rapid eye movement sleep.  In microdialysis studies, basimglurant had no effect on monoamine transmitter levels in the frontal cortex or nucleus accumbens except for a moderate increase of accumbal dopamine, which is in line with its lack of pharmacol. activity on monoamine reuptake transporters.  These data taken together, basimglurant has favorable drug-like properties, a differentiated mol. mechanism of action, and antidepressant-like features that suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphweERNWGN57Vg90H21EOLACvtfcHk0lg-x7q4TgMG3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvV2gtL8%253D&md5=a9cb923e5f3704ebb4835684e962fb9f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.222463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.222463%26sid%3Dliteratum%253Aachs%26aulast%3DLindemann%26aufirst%3DL.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DScharf%26aufirst%3DS.%2BH.%26aulast%3DKuennecke%26aufirst%3DB.%26aulast%3DBruns%26aufirst%3DA.%26aulast%3Dvon%2BKienlin%26aufirst%3DM.%26aulast%3DHarrison%26aufirst%3DA.%2BC.%26aulast%3DPaehler%26aufirst%3DA.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGloge%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DParrott%26aufirst%3DN.%2BJ.%26aulast%3DPolonchuk%26aufirst%3DL.%26aulast%3DNiederhauser%26aufirst%3DU.%26aulast%3DMorairty%26aufirst%3DS.%2BR.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DJaeschke%26aufirst%3DG.%26atitle%3DPharmacology%2520of%2520basimglurant%2520%2528RO4917523%252C%2520RG7090%2529%252C%2520a%2520unique%2520metabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulator%2520in%2520clinical%2520development%2520for%2520depression%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D213%26epage%3D233%26doi%3D10.1124%2Fjpet.114.222463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Browne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucki, I.</span></span> <span> </span><span class="NLM_article-title">Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>, <span class="refDoi">Â DOI: 10.3389/fphar.2013.00161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.3389%2Ffphar.2013.00161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=24409146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A280%3ADC%252BC2cflsFWguw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=161&author=C.+A.+Browneauthor=I.+Lucki&title=Antidepressant+effects+of+ketamine%3A+mechanisms+underlying+fast-acting+novel+antidepressants&doi=10.3389%2Ffphar.2013.00161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants</span></div><div class="casAuthors">Browne Caroline A; Lucki Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Newer antidepressants are needed for the many individuals with major depressive disorder (MDD) that do not respond adequately to treatment and because of a delay of weeks before the emergence of therapeutic effects.  Recent evidence from clinical trials shows that the NMDA antagonist ketamine is a revolutionary novel antidepressant because it acts rapidly and is effective for treatment-resistant patients.  A single infusion of ketamine alleviates depressive symptoms in treatment-resistant depressed patients within hours and these effects may be sustained for up to 2 weeks.  Although the discovery of ketamine's effects has reshaped drug discovery for antidepressants, the psychotomimetic properties of this compound limit the use of this therapy to the most severely ill patients.  In order to develop additional antidepressants like ketamine, adequate preclinical behavioral screening paradigms for fast-acting antidepressants need to be established and used to identify the underlying neural mechanisms.  This review examines the preclinical literature attempting to model the antidepressant-like effects of ketamine.  Acute administration of ketamine has produced effects in behavioral screens for antidepressants like the forced swim test, novelty suppression of feeding and in rodent models for depression.  Protracted behavioral effects of ketamine have been reported to appear after a single treatment that last for days.  This temporal pattern is similar to its clinical effects and may serve as a new animal paradigm for rapid antidepressant effects in humans.  In addition, protracted changes in molecules mediating synaptic plasticity have been implicated in mediating the antidepressant-like behavioral effects of ketamine.  Current preclinical studies are examining compounds with more specific pharmacological effects at glutamate receptors and synapses in order to develop additional rapidly acting antidepressants without the hallucinogenic side effects or abuse potential of ketamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuDJ7Ng-_tWZPq5LRczm8ffW6udTcc2eYhgeAA6As5bLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflsFWguw%253D%253D&md5=12ece8b57b8dd91cac6ece8313c77239</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00161%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DC.%2BA.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAntidepressant%2520effects%2520of%2520ketamine%253A%2520mechanisms%2520underlying%2520fast-acting%2520novel%2520antidepressants%26jtitle%3DFront.%2520Pharmacol.%26date%3D2013%26volume%3D4%26spage%3D161%26doi%3D10.3389%2Ffphar.2013.00161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moaddel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkondon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribut, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossou, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainer, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T. D.</span></span> <span> </span><span class="NLM_article-title">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>533</i></span>,  <span class="NLM_fpage">481</span>â <span class="NLM_lpage">486</span>, <span class="refDoi">Â DOI: 10.1038/nature17998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1038%2Fnature17998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=27144355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=481-486&author=P.+Zanosauthor=R.+Moaddelauthor=P.+J.+Morrisauthor=P.+Georgiouauthor=J.+Fischellauthor=G.+I.+Elmerauthor=M.+Alkondonauthor=P.+Yuanauthor=H.+J.+Pributauthor=N.+S.+Singhauthor=K.+S.+Dossouauthor=Y.+Fangauthor=X.+P.+Huangauthor=C.+L.+Mayoauthor=I.+W.+Wainerauthor=E.+X.+Albuquerqueauthor=S.+M.+Thompsonauthor=C.+J.+Thomasauthor=C.+A.+Zarateauthor=T.+D.+Gould&title=NMDAR+inhibition-independent+antidepressant+actions+of+ketamine+metabolites&doi=10.1038%2Fnature17998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span></div><div class="casAuthors">Zanos, Panos; Moaddel, Ruin; Morris, Patrick J.; Georgiou, Polymnia; Fischell, Jonathan; Elmer, Greg I.; Alkondon, Manickavasagom; Yuan, Peixiong; Pribut, Heather J.; Singh, Nagendra S.; Dossou, Katina S. S.; Fang, Yuhong; Huang, Xi-Ping; Mayo, Cheryl L.; Wainer, Irving W.; Albuquerque, Edson X.; Thompson, Scott M.; Thomas, Craig J.; Zarate, Carlos A., Jr; Gould, Todd D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7604</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Major depressive disorder affects around 16% of the world population at some point in their lives.  Despite the availability of numerous monoaminergic-based antidepressants, most patients require several weeks, if not months, to respond to these treatments, and many patients never attain sustained remission of their symptoms.  The noncompetitive, glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist (R,S)-ketamine exerts rapid and sustained antidepressant effects after a single dose in patients with depression, but its use is assocd. with undesirable side effects.  Here the authors show that the metab. of (R,S)-ketamine to (2S,6S;2R,6R)-hydroxynorketamine (HNK) is essential for its antidepressant effects, and that the (2R,6R)-HNK enantiomer exerts behavioral, electroencephalog., electrophysiol. and cellular antidepressant-related actions in mice.  These antidepressant actions are independent of NMDAR inhibition but involve early and sustained activation of AMPARs (Î±-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors).  The authors also establish that (2R,6R)-HNK lacks ketamine-related side effects.  The data implicate a novel mechanism underlying the antidepressant properties of (R,S)-ketamine and have relevance for the development of next-generation, rapid-acting antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzu3ydujHJ37Vg90H21EOLACvtfcHk0ljd5B-satOX6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D&md5=fcb8479079696cf3dc0ee89f5fadd72a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature17998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17998%26sid%3Dliteratum%253Aachs%26aulast%3DZanos%26aufirst%3DP.%26aulast%3DMoaddel%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DP.%2BJ.%26aulast%3DGeorgiou%26aufirst%3DP.%26aulast%3DFischell%26aufirst%3DJ.%26aulast%3DElmer%26aufirst%3DG.%2BI.%26aulast%3DAlkondon%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DPribut%26aufirst%3DH.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%2BS.%26aulast%3DDossou%26aufirst%3DK.%2BS.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMayo%26aufirst%3DC.%2BL.%26aulast%3DWainer%26aufirst%3DI.%2BW.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DThompson%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26aulast%3DGould%26aufirst%3DT.%2BD.%26atitle%3DNMDAR%2520inhibition-independent%2520antidepressant%2520actions%2520of%2520ketamine%2520metabolites%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature17998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pomierny-ChamioÅo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poleszak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, G.</span></span> <span> </span><span class="NLM_article-title">NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1186</span>â <span class="NLM_lpage">1190</span>, <span class="refDoi">Â DOI: 10.1016/S1734-1140(10)70381-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.1016%2FS1734-1140%2810%2970381-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=21273676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlCjsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1186-1190&author=L.+Pomierny-Chamio%C5%82oauthor=E.+Poleszakauthor=A.+Pilcauthor=G.+Nowak&title=NMDA+but+not+AMPA+glutamatergic+receptors+are+involved+in+the+antidepressant-like+activity+of+MTEP+during+the+forced+swim+test+in+mice&doi=10.1016%2FS1734-1140%2810%2970381-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice</span></div><div class="casAuthors">Pomierny-Chamiolo, Lucyna; Poleszak, Ewa; Pilc, Andrzej; Nowak, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1186-1190</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">Several lines of evidence suggest an antidepressant-like activity for 3-[(methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP), a highly selective, non-competitive antagonist of metabotropic glutamate receptors subtype 5 (mGluR5).  This effect has been obsd. following both acute and chronic MTEP treatments in behavioral tests and exptl. models of depression, such as the forced swim test (FST), the tail suspension test, and the olfactory bulbectomy model of depression.  However, the mechanism of action for mGluR5 antagonists remains unclear.  The aim of this study was to investigate whether the antidepressant-like action of MTEP is dependent on ionotropic glutamatergic receptors.  Male Albino Swiss mice were used, and antidepressant-like activity was evaluated using the FST.  The antidepressant-like effect of MTEP (0.3 mg/kg) was significantly antagonized by pre-treatment with the NMDA receptor agonist N-methyl-D-aspartic acid (NMDA, 75 mg/kg, i.p.).  The AMPA receptor antagonist NBQX (10 mg/kg, i.p.) did not affect the MTEP activity.  Our results indicate that the antidepressant-like activity of MTEP in the FST involves NMDA but not AMPA receptors and suggest that the interaction between mGluR5 and NMDA receptors plays an important role in the underlying antidepressant mechanism(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvGosZc_aGmrVg90H21EOLACvtfcHk0lg9dRpQxPjFhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlCjsrs%253D&md5=ff430c21cc5a56049bca53d69c66773e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2810%2970381-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252810%252970381-9%26sid%3Dliteratum%253Aachs%26aulast%3DPomierny-Chamio%25C5%2582o%26aufirst%3DL.%26aulast%3DPoleszak%26aufirst%3DE.%26aulast%3DPilc%26aufirst%3DA.%26aulast%3DNowak%26aufirst%3DG.%26atitle%3DNMDA%2520but%2520not%2520AMPA%2520glutamatergic%2520receptors%2520are%2520involved%2520in%2520the%2520antidepressant-like%2520activity%2520of%2520MTEP%2520during%2520the%2520forced%2520swim%2520test%2520in%2520mice%26jtitle%3DPharmacol.%2520Rep.%26date%3D2010%26volume%3D62%26spage%3D1186%26epage%3D1190%26doi%3D10.1016%2FS1734-1140%2810%2970381-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BraÅ¡iÄ, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamroonrat, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stabins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dannals, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamill, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, P. D.</span></span> <span> </span><span class="NLM_article-title"><sup>18</sup>F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">388</span>â <span class="NLM_lpage">396</span>, <span class="refDoi">Â DOI: 10.2967/jnumed.112.107995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;key=10.2967%2Fjnumed.112.107995" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=388-396&author=D.+F.+Wongauthor=R.+Waterhouseauthor=H.+Kuwabaraauthor=J.+Kimauthor=J.+R.+Bra%C5%A1i%C4%87author=W.+Chamroonratauthor=M.+Stabinsauthor=D.+P.+Holtauthor=R.+F.+Dannalsauthor=T.+G.+Hamillauthor=P.+D.+Mozley&title=18F-FPEB%2C+a+PET+radiopharmaceutical+for+quantifying+metabotropic+glutamate+5+receptors%3A+a+first-in-human+study+of+radiochemical+safety%2C+biokinetics%2C+and+radiation+dosimetry&doi=10.2967%2Fjnumed.112.107995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.107995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.107995%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DWaterhouse%26aufirst%3DR.%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DBra%25C5%25A1i%25C4%2587%26aufirst%3DJ.%2BR.%26aulast%3DChamroonrat%26aufirst%3DW.%26aulast%3DStabins%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DMozley%26aufirst%3DP.%2BD.%26atitle%3D18F-FPEB%252C%2520a%2520PET%2520radiopharmaceutical%2520for%2520quantifying%2520metabotropic%2520glutamate%25205%2520receptors%253A%2520a%2520first-in-human%2520study%2520of%2520radiochemical%2520safety%252C%2520biokinetics%252C%2520and%2520radiation%2520dosimetry%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D388%26epage%3D396%26doi%3D10.2967%2Fjnumed.112.107995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span>; <span class="NLM_string-name">Lindsley, C. W.</span>; <span class="NLM_string-name">Emmitte</span>; , <span class="NLM_string-name">Kyle, A.</span>; <span class="NLM_string-name">Rodriguez, A. L.</span>; <span class="NLM_string-name">Felts, A. S.</span>; <span class="NLM_string-name">Jones, C. K.</span>; <span class="NLM_string-name">Bates, B. S.</span>; <span class="NLM_string-name">Chauder, B. A.</span></span> <span> </span><span class="NLM_article-title">6-Alkyl-<i>N</i>-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same</span>. U.S. Patent <span class="NLM_patent">9085562</span>, July 21, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+J.+Conn&author=C.+W.+Lindsley&author=+Emmitte&author=A.+Kyle&author=A.+L.+Rodriguez&author=A.+S.+Felts&author=C.+K.+Jones&author=B.+S.+Bates&author=B.+A.+Chauder&title=6-Alkyl-N-%28pyridin-2-yl%29-4-aryloxypicolinamide+analogs+as+mGluR5+negative+allosteric+modulators+and+methods+of+making+and+using+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3D6-Alkyl-N-%2528pyridin-2-yl%2529-4-aryloxypicolinamide%2520analogs%2520as%2520mGluR5%2520negative%2520allosteric%2520modulators%2520and%2520methods%2520of%2520making%2520and%2520using%2520the%2520same%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00410">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77712"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00410">10.1021/acs.jmedchem.7b00410</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular pharmacology methods, complete ancillary pharmacology profile details for <b>27</b> and <b>28</b>, drug metabolism and pharmacokinetic (DMPK) methods, behavioral pharmacology methods, and in vivo occupancy methods (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_001.pdf">jm7b00410_si_001.pdf (675.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00410/suppl_file/jm7b00410_si_002.csv">jm7b00410_si_002.csv (2.17 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-12%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00410%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00410" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992d91ff763c76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
